{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3e1f908c-6a61-400a-ae59-126349806e3b",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "\n",
    "Using dbutils.fs.ls command to check the file that been uploaded"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "48f04d95-393a-477a-b4f0-545118c66c8f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[1]: [FileInfo(path='dbfs:/FileStore/tables/account-models/', name='account-models/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/accounts/', name='accounts/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/accounts.zip', name='accounts.zip', size=5297592, modificationTime=1706721501000),\n FileInfo(path='dbfs:/FileStore/tables/accounts2/', name='accounts2/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/activations/', name='activations/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/activations.zip', name='activations.zip', size=8411369, modificationTime=1706718610000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023/', name='clinicaltrial_2023/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023-1.zip', name='clinicaltrial_2023-1.zip', size=52785750, modificationTime=1712308832000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023.zip', name='clinicaltrial_2023.zip', size=52785750, modificationTime=1713044880000),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023___test/', name='clinicaltrial_2023___test/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/clinicaltrial_2023___test.zip', name='clinicaltrial_2023___test.zip', size=52785750, modificationTime=1709465069000),\n FileInfo(path='dbfs:/FileStore/tables/flood.csv', name='flood.csv', size=128984, modificationTime=1707931801000),\n FileInfo(path='dbfs:/FileStore/tables/logs/', name='logs/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/logs.zip', name='logs.zip', size=18168065, modificationTime=1706721504000),\n FileInfo(path='dbfs:/FileStore/tables/logs2/', name='logs2/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/pharma-1.zip', name='pharma-1.zip', size=109982, modificationTime=1712749243000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-2.zip', name='pharma-2.zip', size=109982, modificationTime=1712828641000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-3.zip', name='pharma-3.zip', size=109982, modificationTime=1712854877000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-4.zip', name='pharma-4.zip', size=109982, modificationTime=1713035267000),\n FileInfo(path='dbfs:/FileStore/tables/pharma-5.zip', name='pharma-5.zip', size=109982, modificationTime=1713044529000),\n FileInfo(path='dbfs:/FileStore/tables/pharma.zip', name='pharma.zip', size=109982, modificationTime=1712308719000),\n FileInfo(path='dbfs:/FileStore/tables/test.json', name='test.json', size=17958, modificationTime=1706113735000),\n FileInfo(path='dbfs:/FileStore/tables/webpage/', name='webpage/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/webpage-1.zip', name='webpage-1.zip', size=1582, modificationTime=1707324494000),\n FileInfo(path='dbfs:/FileStore/tables/webpage.zip', name='webpage.zip', size=1582, modificationTime=1707324436000),\n FileInfo(path='dbfs:/FileStore/tables/webpage_files_all/', name='webpage_files_all/', size=0, modificationTime=0),\n FileInfo(path='dbfs:/FileStore/tables/webpage_files_jpg/', name='webpage_files_jpg/', size=0, modificationTime=0)]"
     ]
    }
   ],
   "source": [
    "#Using dbutils.fs.ls command to check the file that been uploaded\n",
    "\n",
    "dbutils.fs.ls(\"/FileStore/tables/\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "bd341c0f-500e-4c72-8f97-9960e7120d39",
     "showTitle": false,
     "title": ""
    },
    "jupyter": {
     "outputs_hidden": true
    }
   },
   "source": [
    "\n",
    "Defining Reusable code to unzip all files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "583b680e-bfb0-4066-9229-1fe83377f5f4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[149]: True"
     ]
    }
   ],
   "source": [
    "#Copy unzipped file\n",
    "fileroot = \"pharma\"\n",
    "\n",
    "dbutils.fs.cp(\"FileStore/tables/\" + fileroot + \".zip\", \"file:/tmp/\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e61a0111-9650-4040-b8e7-5e5fb6184453",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "#import os library\n",
    "\n",
    "import os\n",
    "os.environ['fileroot'] = fileroot\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "557c3673-916e-45dc-929c-1f0723bf5ae2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Archive:  /tmp/pharma.zip\n  inflating: /tmp/pharma.csv         \n"
     ]
    }
   ],
   "source": [
    "%sh\n",
    "\n",
    "unzip -d /tmp /tmp/$fileroot.zip"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ce2a11ed-036a-4c1a-9c89-c1f895b441eb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "file:/tmp/hsperfdata_root/\nfile:/tmp/clinicaltrial_2023.zip\nfile:/tmp/systemd-private-088e693699db4ad8957720cbacbb19fd-systemd-resolved.service-aI4sZf/\nfile:/tmp/systemd-private-088e693699db4ad8957720cbacbb19fd-ntp.service-UFh8Hh/\nfile:/tmp/driver-env.sh\nfile:/tmp/chauffeur-env.sh\nfile:/tmp/.java_pid542\nfile:/tmp/.font-unix/\nfile:/tmp/pharma.csv\nfile:/tmp/.ICE-unix/\nfile:/tmp/chauffeur-daemon-params\nfile:/tmp/pharma.zip\nfile:/tmp/driver-daemon-params\nfile:/tmp/chauffeur-daemon.pid\nfile:/tmp/driver-daemon.pid\nfile:/tmp/.XIM-unix/\nfile:/tmp/.Test-unix/\nfile:/tmp/systemd-private-088e693699db4ad8957720cbacbb19fd-apache2.service-V9cZQe/\nfile:/tmp/Rserv/\nfile:/tmp/RtmprdSLZ1/\nfile:/tmp/tmp.msYPOARKSF\nfile:/tmp/custom-spark.conf\nfile:/tmp/systemd-private-088e693699db4ad8957720cbacbb19fd-systemd-logind.service-jAUPci/\nfile:/tmp/.X11-unix/\nfile:/tmp/python_lsp_logs/\n"
     ]
    }
   ],
   "source": [
    "# List the contents of the /tmp/ directory\n",
    "files_in_tmp = dbutils.fs.ls(\"file:/tmp/\")\n",
    "\n",
    "# Print the list of files and directories in /tmp/\n",
    "for file_info in files_in_tmp:\n",
    "    print(file_info.path)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "614ec6ae-67e4-4858-bc2e-5ec527a0de1a",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[153]: True"
     ]
    }
   ],
   "source": [
    "#Make directory\n",
    "\n",
    "dbutils.fs.mkdirs(\"FileStore/tables/\" + fileroot)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5387fe44-b2f3-48a5-ab7c-bb3c4a8fc469",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[154]: True"
     ]
    }
   ],
   "source": [
    "#Move files\n",
    "\n",
    "dbutils.fs.mv(\"file:/tmp/\" + fileroot + \".csv\" , \"/FileStore/tables/\" + fileroot , True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "96e114ea-0250-47f7-b9ce-74f336088966",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[155]: [FileInfo(path='dbfs:/FileStore/tables/pharma/pharma.csv', name='pharma.csv', size=678999, modificationTime=1713053871000)]"
     ]
    }
   ],
   "source": [
    "# remove the .zip file\n",
    "\n",
    "dbutils.fs.rm(\"/FileStore/tables/\" + fileroot + \".zip\")\n",
    "\n",
    "dbutils.fs.ls(\"/FileStore/tables/\" + fileroot)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "339a56ca-b20f-4856-a9e1-d481c245263f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Truncated to first 65536 bytes]\nOut[9]: 'NCT Number \\\\t Study Title \\\\t Acronym \\\\t Study Status \\\\t Conditions \\\\t Interventions \\\\t Sponsor \\\\t Collaborators \\\\t Enrollment \\\\t Funder Type \\\\t Study Type \\\\t Study Design,Start Date,Completion Date\\r\\n\"NCT03630471 \\\\t Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India \\\\t PRIDE \\\\t COMPLETED \\\\t Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) \\\\t BEHAVIORAL: PRIDE \\'Step 1\\' problem-solving intervention|BEHAVIORAL: Enhanced usual care \\\\t Sangath \\\\t Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine \\\\t 250 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",20 August 2018,28 February 2019\\r\\n\"NCT05992571 \\\\t Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity \\\\t RECRUITING \\\\t Cerebrovascular Function|Cognition \\\\t OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB \\\\t McMaster University \\\\t Alzheimer\\'s Society of Brant, Haldimand Norfolk, Hamilton Halton \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\",25 October 2023,2024-08\\r\\nNCT01854671 \\\\t Investigating the Effect of a Prenatal Family Planning Counseling Intervention Led by Community Health Workers on Postpartum Contraceptive Use Among Women in the West Bank \\\\t COMPLETED \\\\t Focus: Contraceptive Counseling|Focus: Postpartum Contraception \\\\t OTHER: family planning counseling let by community health workers \\\\t Planned Parenthood League of Massachusetts \\\\t Society for Family Planning Research Fund \\\\t 176 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: ,2013-08,2014-12\\r\\nNCT03820271 \\\\t New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation \\\\t SUPERMELD \\\\t RECRUITING \\\\t Decompensated Cirrhosis|Liver Transplantation \\\\t OTHER: SuperMELD \\\\t Assistance Publique - Hôpitaux de Paris \\\\t 500 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,01 October 2020,01 October 2023\\r\\nNCT01160471 \\\\t Noninvasive Imaging of Heart Failure: A Pilot Study \\\\t COMPLETED \\\\t MRI|Acquired Heart Disease|Myocardial Fibrosis \\\\t National Institutes of Health Clinical Center (CC) \\\\t 62 \\\\t NIH \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 July 2010,30 October 2019\\r\\n\"NCT04338971 \\\\t Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes \\\\t COMPLETED \\\\t Stroke \\\\t DEVICE: IpsiHand Therapy \\\\t Neurolutions, Inc. \\\\t 24 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",05 May 2017,09 October 2020\\r\\n\"NCT05843071 \\\\t PMCF Study to Evaluate Performance and Safety of \"\"NASAL SPRAYS \"\" Used to Relieve Nasal Congestion and Dryness \\\\t RECRUITING \\\\t Nasal Congestion|Nasal Dryness \\\\t DEVICE: Nasal sprays with sea salts \\\\t C.O.C. Farmaceutici S.r.l. \\\\t 105 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",01 September 2022,15 June 2023\\r\\nNCT06174571 \\\\t Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer. \\\\t NOT_YET_RECRUITING \\\\t Breast Cancer \\\\t Assiut University \\\\t 90 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 February 2024,01 March 2026\\r\\nNCT03700671 \\\\t High Intensity Interval Training Versus Circuit Training \\\\t COMPLETED \\\\t High Intensity Interval Training \\\\t OTHER: High intensity interval training|OTHER: Circuit training \\\\t University of Central Lancashire \\\\t University of Hull \\\\t 42 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,11 May 2016,13 December 2017\\r\\n\"NCT02633371 \\\\t A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults \\\\t COMPLETED \\\\t Hyperhidrosis \\\\t DRUG: Oxybutynin 3% gel \\\\t University of Colorado, Denver \\\\t Society for Pediatric Dermatology \\\\t 10 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",2016-02,2017-05\\r\\n\"NCT03400371 \\\\t Biology of Juvenile Myoclonic Epilepsy \\\\t BIOJUME \\\\t RECRUITING \\\\t Juvenile Myoclonic Epilepsy \\\\t OTHER: Blood draw|OTHER: Existing samples \\\\t King\\'s College London \\\\t King\\'s College Hospital NHS Trust|Charles University, Czech Republic|Hopital Universitaire Robert-Debre|Vestre Viken Hospital Trust|The Hospital for Sick Children|Cardiff University|Odense University Hospital \\\\t 1000 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",13 July 2017,30 June 2026\\r\\n\"NCT00221871 \\\\t Proper Dosage of Ketamine in Intravenous Regional Anesthesia \\\\t UNKNOWN \\\\t Pain. \\\\t DRUG: Different dosages of Ketamine \\\\t University Health Network, Toronto \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT\",2004-01,2005-01\\r\\n\"NCT05664971 \\\\t JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer \\\\t RECRUITING \\\\t Advanced Lung Cancer \\\\t BIOLOGICAL: Recombinant humanized anti-BTLA monoclonal antibody (JS004) injection|BIOLOGICAL: Toripalimab|DRUG: Docetaxel|DRUG: Pemetrexed|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Etoposide \\\\t Shanghai Junshi Bioscience Co., Ltd. \\\\t 240 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",09 February 2023,17 November 2024\\r\\nNCT02383771 \\\\t Reversal of the Anti-platelet Effects of Ticagrelor \\\\t REVERSAL \\\\t COMPLETED \\\\t Coronary Artery Disease \\\\t DRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor \\\\t The First Affiliated Hospital with Nanjing Medical University \\\\t National Natural Science Foundation of China \\\\t 64 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2015-03,2016-12\\r\\n\"NCT01897571 \\\\t Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL \\\\t COMPLETED \\\\t B-cell Lymphomas (Phase 1)|Advanced Solid Tumors (Phase 1)|Diffuse Large B-cell Lymphoma (Phase 2)|Follicular Lymphoma (Phase 2)|Transformed Follicular Lymphoma|Primary Mediastinal Large B-Cell Lymphoma \\\\t DRUG: Tazemetostat|DRUG: Prednisolone|DRUG: Tazemetostat \\\\t Epizyme, Inc. \\\\t 400 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",13 June 2013,02 November 2021\\r\\n\"NCT03928171 \\\\t The Effect of Intra-abdominal Pressure on Peritoneal Perfusion During Laparoscopic Colorectal Surgery \\\\t PERFUSION \\\\t COMPLETED \\\\t Laparoscopic Surgery|Pneumoperitoneum \\\\t OTHER: Intra-abdominal pressure during laparoscopy \\\\t Radboud University Medical Center \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",13 June 2018,24 December 2018\\r\\nNCT00848471 \\\\t Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems) \\\\t Protocol Quark \\\\t UNKNOWN \\\\t Healthy|Obesity \\\\t DEVICE: Quark RMR|DEVICE: Deltatrac II \\\\t Hospices Civils de Lyon \\\\t Centre de Recherche en Nutrition Humaine Rhone-Alpe \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,2009-01,2009-12\\r\\n\"NCT01189071 \\\\t Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain \\\\t TERMINATED \\\\t Overactive Bladder|Renal Colic|Pain, Postoperative \\\\t DRUG: Darifenacin \\\\t University of Missouri-Columbia \\\\t 3 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2009-08,2011-07\\r\\n\"NCT01005771 \\\\t Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions \\\\t COMPLETED \\\\t Secondarily Infected Traumatic Lesions \\\\t DRUG: GF-001001-00|DRUG: Placebo \\\\t Ferrer Internacional S.A. \\\\t 200 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2009-09,2010-03\\r\\nNCT05321771 \\\\t Family Caregiver Role in Decreasing Delirium in Older Patients With Fractured Femur Using HELP Principles. \\\\t FamHelp \\\\t RECRUITING \\\\t Delirium|Femoral Fracture \\\\t OTHER: Family caregiver application of HELP principles \\\\t Rambam Health Care Campus \\\\t 50 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,02 December 2021,31 December 2023\\r\\nNCT00520871 \\\\t The Water-Blueberry Study \\\\t COMPLETED \\\\t Cardiovascular Disease \\\\t DRUG: Blueberry juice \\\\t University of Oslo \\\\t Ullevaal University Hospital \\\\t 62 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION,2003-03,2004-04\\r\\nNCT05913271 \\\\t Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure \\\\t RECRUITING \\\\t Heart Failure|Levosimendan|Efficacy|Safety \\\\t Yi Han \\\\t Qianfoshan Hospital \\\\t 352 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,30 May 2023,30 May 2025\\r\\n\"NCT04006171 \\\\t Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women \\\\t CNP \\\\t COMPLETED \\\\t Polycystic Ovary Syndrome|c Type Natriuretic Peptide|Menstrual Irregularity|Hyperandrogenism \\\\t DIAGNOSTIC_TEST: C type natriuretic peptide \\\\t Near East University, Turkey \\\\t 90 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC\",15 July 2019,01 September 2020\\r\\n\"NCT04340271 \\\\t The Clinical Utility of Extracorporeal Shock Wave Therapy on Burns \\\\t COMPLETED \\\\t Burn Scar \\\\t OTHER: Extracorporeal shock wave therapy|OTHER: conventional occupational therapy \\\\t Hangang Sacred Heart Hospital \\\\t 48 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",15 April 2020,31 May 2020\\r\\nNCT03075371 \\\\t Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa \\\\t COMPLETED \\\\t Anorexia Nervosa|Healthy \\\\t OTHER: Glucose|OTHER: Placebo \\\\t University of Heidelberg Medical Center \\\\t German Research Foundation \\\\t 85 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE,2014-09,2019-02\\r\\nNCT05966571 \\\\t Ovarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS) \\\\t RECRUITING \\\\t Polycystic Ovary Syndrome \\\\t PROCEDURE: Ovary Biopsie \\\\t Albanian University \\\\t 50 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 July 2023,01 December 2024\\r\\nNCT03490071 \\\\t Long-term Follow up of Patients With Longstanding Hip and Groin Pain \\\\t Lund LHGP \\\\t RECRUITING \\\\t Hip Pain Chronic \\\\t Lund University \\\\t 81 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 January 2018,31 December 2024\\r\\nNCT05801471 \\\\t Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression \\\\t RECRUITING \\\\t Glaucoma \\\\t Centervue SpA \\\\t 200 \\\\t INDUSTRY \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,06 May 2022,06 November 2025\\r\\n\"NCT00266071 \\\\t Study of the Cutaneous Microcirculation in Elderly People \\\\t UNKNOWN \\\\t Elderly People \\\\t BEHAVIORAL: Cutaneous response \\\\t University Hospital, Angers \\\\t OTHER_GOV \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",2005-12,\\r\\nNCT03097471 \\\\t BPK-S Integration (Ceramic) Post Market Clinical Follow-Up \\\\t UNKNOWN \\\\t Restoration if Knee Joint Function \\\\t DEVICE: BPK-S Integration (Ceramic) \\\\t Klemens Trieb \\\\t 40 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2011-05,2018-03\\r\\nNCT01746771 \\\\t A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer \\\\t COMPLETED \\\\t HER-2 Positive Advanced Gastric Cancer \\\\t DRUG: HM781-36B(Poziotinib)|DRUG: Paclitaxel|DRUG: Trastuzumab \\\\t Hanmi Pharmaceutical Company Limited \\\\t National OncoVenture \\\\t 44 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2012-11,2015-08\\r\\n\"NCT01068171 \\\\t Developing a Diabetic Foot Ulcer Protocol \\\\t WITHDRAWN \\\\t Diabetic Foot Ulcers \\\\t OTHER: type of footwear|OTHER: collagen dressing with and without silver \\\\t The University of Texas Health Science Center, Houston \\\\t Harris County Hospital District|Baylor College of Medicine \\\\t 0 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\",2010-05,2012-06\\r\\nNCT00455871 \\\\t Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD \\\\t UNKNOWN \\\\t Age-Related Macular Degeneration \\\\t DRUG: reduced fluence photodynamic therapy with Visudyne|DRUG: Lucentis \\\\t Barnes Retina Institute \\\\t QLT Inc. \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2007-04,2010-10\\r\\nNCT01334671 \\\\t The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI \\\\t UNKNOWN \\\\t ST-elevation Myocardial Infarction|(STEMI) \\\\t DRUG: Atorvastatin \\\\t General Hospital of Chinese Armed Police Forces \\\\t 150 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2011-02,2013-03\\r\\nNCT00553371 \\\\t Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer \\\\t UNKNOWN \\\\t Testicular Germ Cell Tumor \\\\t OTHER: biomarker analysis|PROCEDURE: computed tomography \\\\t Royal Marsden NHS Foundation Trust \\\\t 300 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2006-04,\\r\\nNCT01993771 \\\\t Monitoring of Anaesthesic Depth in the Cerebral Cortex Using Bispectral Bilateral System. \\\\t COMPLETED \\\\t Breast Surgery \\\\t PROCEDURE: Surgery with general anaesthesia.|PROCEDURE: Raw EEG \\\\t Parc de Salut Mar \\\\t 25 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2013-09,2015-10\\r\\n\"NCT00041171 \\\\t Docetaxel and St. John\\'s Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery \\\\t WITHDRAWN \\\\t Adult Solid Tumor|Breast Cancer|Head and Neck Cancer|Kidney and Urinary Cancer|Male Reproductive Cancer|Thorax and Respiratory Cancer \\\\t DRUG: Hypericum perforatum|DRUG: docetaxel|OTHER: placebo \\\\t Alliance for Clinical Trials in Oncology \\\\t National Cancer Institute (NCI) \\\\t 0 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",,\\r\\nNCT03354871 \\\\t Developing Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables \\\\t IoT4Resident \\\\t UNKNOWN \\\\t Fatigue \\\\t Hillel Yaffe Medical Center \\\\t International Business Machines (IBM) \\\\t 6 \\\\t OTHER_GOV \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2017-11,28 February 2018\\r\\nNCT02804971 \\\\t Cardiovascular Comorbidities and Bronchiectasis \\\\t BRONCOCA \\\\t ACTIVE_NOT_RECRUITING \\\\t Bronchiectasis \\\\t Centre Hospitalier Intercommunal Creteil \\\\t 200 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,25 October 2016,2023-12\\r\\n\"NCT04591171 \\\\t Assessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease \\\\t COMPLETED \\\\t Hypertension|Chronic Kidney Diseases \\\\t PROCEDURE: n-of-1 trial guided clinical decision making \\\\t The University of Texas Health Science Center, Houston \\\\t Children\\'s Hospital of Philadelphia|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) \\\\t 9 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",25 January 2021,18 February 2022\\r\\n\"NCT04814771 \\\\t Mass Balance Study of TS-142 in Healthy Adult Subjects. \\\\t COMPLETED \\\\t Healthy Male Subjects \\\\t DRUG: [14C] TS-142 \\\\t Taisho Pharmaceutical Co., Ltd. \\\\t 6 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\",19 April 2021,19 May 2021\\r\\nNCT02920671 \\\\t Muscle OXPHOS and Nutrient Homeostasis \\\\t ACTIVE_NOT_RECRUITING \\\\t Mitochondrial Diseases|Obesity \\\\t OTHER: Tracer-enhanced oral glucose tolerance test (OGTT*)|OTHER: Muscle MRI|OTHER: Dual energy x-ray absorptiometry (DXA)|OTHER: Questionnaires \\\\t University of Pennsylvania \\\\t 45 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,14 February 2017,30 June 2024\\r\\nNCT04756271 \\\\t Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection \\\\t COMPLETED \\\\t Vaccine Adverse Reaction|Seroconversion \\\\t BIOLOGICAL: SARS-Cov-2 neutralizing antibody titer \\\\t Zagazig University \\\\t 246 \\\\t OTHER_GOV \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,11 February 2021,22 December 2021\\r\\nNCT02022371 \\\\t Prostate Cancer Genomic Heterogeneity \\\\t PROGENY \\\\t COMPLETED \\\\t PROSTATE CANCER \\\\t PROCEDURE: Targeted biopsies of the prostate \\\\t University College London Hospitals \\\\t 50 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2014-09,2016-06\\r\\n\"NCT04585971 \\\\t A Study on Hemodynamic Relationship Including Cerebral Blood Flow Using Phase Contrast and Signal Intensity Gradient of Brain Magnetic Resonance Imaging, and Carotid Doppler Ultrasound \\\\t UNKNOWN \\\\t Cerebral Blood Flow \\\\t DIAGNOSTIC_TEST: Signal intensity gradient \\\\t Chonbuk National University Hospital \\\\t Medi Image, Inc \\\\t 30 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",03 September 2020,31 January 2021\\r\\n\"NCT05473871 \\\\t Enhancing Capacity in Churches to Implement PA Programs \\\\t RECRUITING \\\\t Cardiovascular Diseases \\\\t BEHAVIORAL: Faith in Action|BEHAVIORAL: Faith in Action+|BEHAVIORAL: Faith in Action++ \\\\t San Diego State University \\\\t Washington University School of Medicine|University of California, Berkeley|University of California, San Diego \\\\t 812 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\",15 November 2022,31 October 2026\\r\\nNCT00103571 \\\\t Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia \\\\t COMPLETED \\\\t Schizophrenia \\\\t DRUG: Olanzapine|DRUG: Aripiprazole \\\\t Eli Lilly and Company \\\\t 600 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2004-07,2006-08\\r\\n\"NCT00000571 \\\\t Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease \\\\t COMPLETED \\\\t Lung Diseases|Lung Diseases, Obstructive|Chronic Obstructive Pulmonary Disease \\\\t DEVICE: ventilators, negative pressure \\\\t McGill University \\\\t National Heart, Lung, and Blood Institute (NHLBI) \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT\",1986-02,\\r\\n\"NCT01053871 \\\\t Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy \\\\t COMPLETED \\\\t Gastritis|Functional Dyspepsia \\\\t DRUG: propofol|DRUG: midazolam with fentanyl \\\\t Shandong University \\\\t 104 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: \",2010-01,2010-05\\r\\n\"NCT02370771 \\\\t Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis \\\\t PASEO \\\\t COMPLETED \\\\t Erosive Hand Osteoarthritis \\\\t PROCEDURE: Biological sampling|DEVICE: Radiographic evaluation \\\\t University Hospital, Rouen \\\\t 32 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\",09 June 2015,17 November 2019\\r\\nNCT05974371 \\\\t Episodic Memory Integration and Interference \\\\t NOT_YET_RECRUITING \\\\t Episodic Memory \\\\t OTHER: emotional context similarity \\\\t Boston College \\\\t 150 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2024-08,2027-08\\r\\nNCT03631771 \\\\t Pediatric Risk of Hypothyroidism With Iodinated Contrast Media \\\\t WITHDRAWN \\\\t Hypothyroidism \\\\t DRUG: Iohexol|DRUG: Iodixanol|DRUG: Iopromide|DRUG: Ioversol \\\\t GE Healthcare \\\\t Bayer|Guerbet/Liebel-Flarsheim \\\\t 0 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2022-03,2025-02\\r\\nNCT02645071 \\\\t Brief Program in Reducing Sedentary Behavior and Promoting Physical Exercise \\\\t COMPLETED \\\\t Physical Activity \\\\t BEHAVIORAL: Physical Activity \\\\t The University of Hong Kong \\\\t Hong Kong Jockey Club Charities Trust \\\\t 141 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,2015-07,2017-07\\r\\n\"NCT04004871 \\\\t Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma \\\\t UNKNOWN \\\\t Nasopharyngeal Carcinoma|Nasopharyngeal Cancer|Nasopharynx Cancer \\\\t DRUG: Nab-paclitaxel, Cisplatin and Fluorouracil|RADIATION: concurrent chemoradiotherapy \\\\t Guangxi Medical University \\\\t Second Affiliated Hospital of Guangxi Medical University|Guilin Medical University, China|Liuzhou Workers Hospital|Wuzhou Red Cross Hospital \\\\t 60 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",05 July 2019,30 June 2022\\r\\nNCT05953571 \\\\t Laparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics \\\\t COMPLETED \\\\t Uretro-pelvic Junction Obstruction|Poorly Function Kidney \\\\t PROCEDURE: Dismembered Pyeloplasty \\\\t Al-Azhar University \\\\t University Hospital Fattouma Bourguiba \\\\t 65 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,08 January 2022,30 June 2023\\r\\n\"NCT02570971 \\\\t Mannitol Versus Supportive Care in Ciguatera Fish Poisoning \\\\t UNKNOWN \\\\t Ciguatoxin \\\\t DRUG: Mannitol \\\\t University of South Florida \\\\t Florida Poison Control Center \\\\t 200 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT\",2015-10,\\r\\n\"NCT01425671 \\\\t Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States \\\\t ACTIVE_NOT_RECRUITING \\\\t Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder \\\\t University of Maryland, Baltimore \\\\t National Institute of Mental Health (NIMH) \\\\t 800 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",30 November 2010,2024-06\\r\\nNCT04962971 \\\\t Comparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women \\\\t COMPLETED \\\\t Recurrent Cystitis \\\\t DIETARY_SUPPLEMENT: X|DIETARY_SUPPLEMENT: Y|DIETARY_SUPPLEMENT: Z \\\\t CEN Biotech \\\\t Nexira|CEN Nutriment \\\\t 216 \\\\t INDUSTRY \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 September 2020,01 February 2022\\r\\n\"NCT02827071 \\\\t Ocular Imaging Study Using Advanced OCT \\\\t UNKNOWN \\\\t Retinal Vascular Disorder|Macular Degeneration \\\\t University of California, Los Angeles \\\\t 1000 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",2016-07,\\r\\nNCT04236271 \\\\t TELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE \\\\t TELE-PEACE \\\\t COMPLETED \\\\t Coronary Artery Bypass \\\\\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n\\\\t OTHER: early neurological rehabilitation|OTHER: no-early neurological rehabilitation \\\\t Ospedale Generale Di Zona Moriggia-Pelascini \\\\t 80 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2016-05,\\r\\n\"NCT05727371 \\\\t Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis \\\\t RECRUITING \\\\t Knee Osteoarthritis \\\\t COMBINATION_PRODUCT: Regen Matrix-PRP-XLHA|DEVICE: Hylan G-F 20|DRUG: Placebo \\\\t RegenLab France SAS \\\\t 280 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT\",21 August 2023,21 August 2025\\r\\nNCT02269371 \\\\t Auricular Acupuncture in the Treatment of Obesity \\\\t AcupObesity \\\\t COMPLETED \\\\t Obesity \\\\t OTHER: Auricular Acupuncture|OTHER: Sham Acupuncture \\\\t Mike O\\'Callaghan Military Hospital \\\\t 82 \\\\t FED \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2015-02,2016-12\\r\\n\"NCT04550871 \\\\t A Pilot Study Investigating the Detection of Episodes of Severe Patient-Ventilator Asynchrony \\\\t RECRUITING \\\\t Respiratory Failure \\\\t Autonomous Healthcare, Inc. \\\\t 30 \\\\t INDUSTRY \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",21 July 2021,31 December 2022\\r\\nNCT04242771 \\\\t Mindfulness Meditation for Insomnia \\\\t RECRUITING \\\\t Insomnia \\\\t BEHAVIORAL: Mindfulness \\\\t Beth Israel Deaconess Medical Center \\\\t 12 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,02 December 2022,01 December 2023\\r\\nNCT05121571 \\\\t The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study \\\\t COMPLETED \\\\t Hepatocellular Carcinoma \\\\t PROCEDURE: HAIC|DRUG: Sorafenib \\\\t Sun Yat-sen University \\\\t 114 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,21 April 2016,01 May 2021\\r\\nNCT00912171 \\\\t Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children \\\\t SB-OSAS \\\\t COMPLETED \\\\t Obstructive Sleep Apnea Syndrome \\\\t DRUG: budesonide (Aircort 50 nasal spray)|DRUG: montelukast (Singulair) \\\\t University of Bologna \\\\t 45 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2009-01,2010-06\\r\\nNCT01640171 \\\\t Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival \\\\t COMPLETED \\\\t Age-related Macular Degeneration|Central Retinal Vein Occlusion|Diabetic Macular Edema \\\\t PROCEDURE: Xylocaine 2% Injectable Anesthetic|DRUG: Proparacaine Hydrochloride 0.5% Drop|DRUG: Tetravisc 0.5% Gel|DRUG: Acuvail|DRUG: Intra-vitreal Anti-VEGF Drug \\\\t Retina Vitreous Associates of Florida \\\\t 57 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2012-07,2013-10\\r\\n\"NCT00734071 \\\\t An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder \\\\t COMPLETED \\\\t Generalized Anxiety Disorder \\\\t DRUG: Vortioxetine|DRUG: Placebo \\\\t Takeda \\\\t H. Lundbeck A/S \\\\t 304 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2008-06,2009-03\\r\\nNCT03673371 \\\\t Women\\'s-Specific Footwear With Prosthetic Feet \\\\t WSF \\\\t COMPLETED \\\\t Lower Limb Amputation Below Knee (Injury)|Lower Limb Amputation Above Knee (Injury) \\\\t OTHER: Questionnaire \\\\t Minneapolis Veterans Affairs Medical Center \\\\t United States Department of Defense \\\\t 100 \\\\t FED \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,04 March 2019,06 January 2023\\r\\nNCT05898971 \\\\t Robotic Hand on Hand Functions in Strokes \\\\t ACTIVE_NOT_RECRUITING \\\\t CVA (Cerebrovascular Accident) \\\\t OTHER: Robotic|OTHER: Mirror|OTHER: Traditional Physical Therapy \\\\t Cairo University \\\\t Batterjee Medical College \\\\t 70 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,12 April 2023,11 October 2023\\r\\nNCT04429971 \\\\t Pre-Exposure Prophylaxis in the Emergency Department \\\\t PrEPPED \\\\t COMPLETED \\\\t HIV/AIDS|PrEP \\\\t OTHER: PrEP screening program|OTHER: PrEP starter pack \\\\t Icahn School of Medicine at Mount Sinai \\\\t 26 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING,18 March 2020,31 July 2023\\r\\n\"NCT02635971 \\\\t Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer \\\\t UNKNOWN \\\\t Carcinoma, Pancreatic \\\\t PROCEDURE: Transcatheter arterial infusion|PROCEDURE: Intravenous chemotherapy|DRUG: Gemcitabine|DRUG: Oxaliplatin \\\\t Fudan University \\\\t 168 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\",2015-12,2022-12\\r\\nNCT02528071 \\\\t Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis \\\\t SLA \\\\t TERMINATED \\\\t ALS (Amyotrophic Lateral Sclerosis) \\\\t OTHER: Diaphragmatic endurance test \\\\t Centre Hospitalier Universitaire de Saint Etienne \\\\t 136 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,29 September 2014,28 October 2020\\r\\nNCT00241371 \\\\t A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma \\\\t TERMINATED \\\\t Multiple Myeloma \\\\t DRUG: Clofarabine \\\\t Washington University School of Medicine \\\\t 8 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2005-03,2007-12\\r\\n\"NCT02271971 \\\\t Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis \\\\t COMPLETED \\\\t Psoriasis|Metabolic Syndrome|Vitamin D Deficiency \\\\t DIETARY_SUPPLEMENT: Vitamin D3|DIETARY_SUPPLEMENT: Placebo \\\\t Pontificia Universidad Catolica de Chile \\\\t 39 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",2014-10,2015-10\\r\\nNCT01866371 \\\\t High Resolution Retinal Imaging \\\\t AOSLO \\\\t RECRUITING \\\\t Stargardts|Retinitis Pigmentosa|Age-related Macular Degeneration|Choroideremia|Geographic Atrophy \\\\t PROCEDURE: Retinal imaging \\\\t University of Pennsylvania \\\\t National Eye Institute (NEI) \\\\t 600 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2013-05,2027-12\\r\\n\"NCT00741871 \\\\t A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies \\\\t COMPLETED \\\\t Lymphoma, Malignant|Hodgkin\\'s Lymphoma|B Cell Lymphoma \\\\t DRUG: SB1518 \\\\t S*BIO \\\\t 35 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",2008-07,2011-10\\r\\nNCT03986671 \\\\t Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx \\\\t COMPLETED \\\\t Obstructive Sleep Apnea|Amyotrophic Lateral Sclerosis|Muscular Dystrophies|Healthy \\\\t DEVICE: Transmembrane EMG Oropharynx Probe \\\\t Powell Mansfield Inc. \\\\t 50 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,30 April 2019,26 March 2021\\r\\nNCT03366571 \\\\t Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy \\\\t ACTIVE_NOT_RECRUITING \\\\t Chronic Hepatitis B \\\\t DRUG: Nucleos(t)ide Analogues \\\\t Beijing Friendship Hospital \\\\t Peking University First Hospital|Peking University People\\'s Hospital|Beijing YouAn Hospital|Beijing Ditan Hospital \\\\t 600 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2016-01,2024-12\\r\\n\"NCT04701671 \\\\t Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids \\\\t RECRUITING \\\\t Pediatric Obesity|Binge-Eating Disorder \\\\t BEHAVIORAL: Observational (not including MRI scanning)|BEHAVIORAL: Observational (including MRI scanning) \\\\t University of Pittsburgh \\\\t Brown University|The Miriam Hospital|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) \\\\t 180 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",10 December 2020,09 December 2025\\r\\n\"NCT01982071 \\\\t A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia \\\\t TERMINATED \\\\t Candidemia|Candidiasis \\\\t DRUG: Micafungin \\\\t Astellas Pharma China, Inc. \\\\t 59 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",26 September 2013,28 August 2015\\r\\nNCT00831571 \\\\t Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin \\\\t COMPLETED \\\\t Colorectal Cancer|Esophageal Cancer|Gastric Cancer|Small Bowel Cancer|Pancreatic Cancer \\\\t Dana-Farber Cancer Institute \\\\t Sanofi \\\\t 112 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2009-02,2022-04\\r\\n\"NCT03016871 \\\\t Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL \\\\t ACTIVE_NOT_RECRUITING \\\\t Recurrent Hodgkin Lymphoma|Refractory Hodgkin Lymphoma \\\\t DRUG: Carboplatin|DRUG: Etoposide|DRUG: Ifosfamide|OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Nivolumab \\\\t City of Hope Medical Center \\\\t National Cancer Institute (NCI) \\\\t 78 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\",24 April 2017,30 January 2026\\r\\n\"NCT01729871 \\\\t A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy \\\\t VENTURE-AF \\\\t COMPLETED \\\\t Atrial Fibrillation \\\\t DRUG: rivaroxaban|DRUG: uninterrupted vitamin K antagonist (VKA) \\\\t Janssen Scientific Affairs, LLC \\\\t Bayer \\\\t 253 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\",2013-02,2014-10\\r\\n\"NCT04856371 \\\\t Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer \\\\t UNKNOWN \\\\t Advanced Breast Cancer \\\\t DRUG: CYH33|DRUG: Fulvestrant|DRUG: Letrozole|DRUG: Palbociclib \\\\t Haihe Biopharma Co., Ltd. \\\\t 228 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\",2021-04,2022-12\\r\\n\"NCT00769171 \\\\t Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections) \\\\t DRAGON \\\\t COMPLETED \\\\t Infection, Intra-abdominal \\\\t DRUG: Avelox (Moxifloxacin, BAY12-8039)|DRUG: Ceftriaxone + Metronidazole \\\\t Bayer \\\\t 364 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT\",2005-10,2007-01\\r\\nNCT03522571 \\\\t Experimental Gingivitis in Patients With Altered Passive Eruption \\\\t COMPLETED \\\\t Altered Passive Eruption of Teeth \\\\t BEHAVIORAL: Experimental gingivitis \\\\t Rustam Aghazada \\\\t 18 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING,21 February 2017,19 July 2017\\r\\nNCT00782171 \\\\t Evaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface \\\\t COMPLETED \\\\t Partial Edentulism \\\\t DEVICE: SLActive dental implant \\\\t Institut Straumann AG \\\\t 266 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2004-07,2010-02\\r\\nNCT00581971 \\\\t Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer \\\\t RAD0201 \\\\t COMPLETED \\\\t Cancer \\\\t DRUG: celecoxib|DRUG: Carboplatin|DRUG: Paclitaxel|RADIATION: Radiation Therapy \\\\t University of Alabama at Birmingham \\\\t Bristol-Myers Squibb|Pharmacia \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2002-09,2012-03\\r\\n\"NCT03066271 \\\\t Pre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer \\\\t PRIME \\\\t ACTIVE_NOT_RECRUITING \\\\t Non-Small Cell Lung Cancer Stage|Chemoradiation \\\\t OTHER: Exercise +|OTHER: Control + \\\\t Rigshospitalet, Denmark \\\\t University of Copenhagen \\\\t 40 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE\",03 April 2017,31 December 2023\\r\\nNCT02125071 \\\\t Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation \\\\t LT \\\\t COMPLETED \\\\t Liver Cirrhosis|Chronic Hepatitis B \\\\t OTHER: Blood Sample Collection \\\\t Dong-Gu Kim \\\\t Green Cross Corporation \\\\t 20 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2013-11,2015-09\\r\\n\"NCT01289171 \\\\t Acquired Epidermodysplasia Verruciformis (EV) Syndrome in HIV-infected Pediatric Patients \\\\t COMPLETED \\\\t Flat Warts|HIV \\\\t DRUG: Glycolic acid \\\\t University of Pennsylvania \\\\t NeoStrata Company, Inc.|Penn Center for AIDS Research (CFAR) \\\\t 38 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",2009-01,2010-10\\r\\nNCT01801371 \\\\t 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma \\\\t GRGDG \\\\t UNKNOWN \\\\t Glioma \\\\t DRUG: 68Ga-BNOTA-PRGD2 \\\\t Peking Union Medical College Hospital \\\\t Beijing Tiantan Hospital \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2012-10,2017-12\\r\\nNCT05800171 \\\\t Efficacy of Single Use Disposable Elevator Cap (DEC) Duodenoscopy \\\\t RECRUITING \\\\t Cholangitis \\\\t Seoul National University Hospital \\\\t 5000 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,24 April 2023,21 February 2025\\r\\nNCT04293471 \\\\t Prediction of Outcome by Echocardiography in Left Bundle Branch Block \\\\t EchoLBBB \\\\t RECRUITING \\\\t Left Bundle-Branch Block \\\\t University Hospital of North Norway \\\\t Oslo University Hospital|University of Bergen|Norwegian University of Science and Technology|University of Tromso|KU Leuven \\\\t 2000 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,15 April 2021,31 December 2036\\r\\n\"NCT02832271 \\\\t Green Tea Extract for Endometriosis Treatment \\\\t COMPLETED \\\\t Endometriosis \\\\t DRUG: SUNPHENON EGCg|DRUG: Placebo \\\\t Chinese University of Hong Kong \\\\t Cancer Institute and Hospital, Chinese Academy of Medical Sciences|Sun Yat-sen University|Guangdong Provincial Hospital of Traditional Chinese Medicine|Jiangxi University of Traditional Chinese Medicine \\\\t 185 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",08 December 2016,2022-12\\r\\n\"NCT03118271 \\\\t Comparison of the Effect of Lumbar Traction, Spinal Manipulation, and Surgery in the Treatment of Lumbar Disc Herniation \\\\t TERMINATED \\\\t Lumbar Disc Herniation|Lumbar Traction|Spinal Manipulation|Lumbar Surgery \\\\t DEVICE: lumbar traction|PROCEDURE: spinal manipulation|PROCEDURE: surgery \\\\t Shin Kong Wu Ho-Su Memorial Hospital \\\\t 60 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\",2017-01,2019-12\\r\\n\"NCT00708071 \\\\t Efficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin, Vapor Heated, Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures \\\\t COMPLETED \\\\t Facial Rhytidectomy (Face-lift) \\\\t BIOLOGICAL: Fibrin Sealant with 4 IU/ml Thrombin, Vapor-Heated, Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4) \\\\t Baxter Healthcare Corporation \\\\t 45 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",2008-06,2008-09\\r\\n\"NCT01216371 \\\\t Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) \\\\t SMAT \\\\t UNKNOWN \\\\t Renal Cell Carcinoma|Pulmonary Metastases \\\\t DRUG: Sunitinib|DRUG: Placebo \\\\t Association of Urologic Oncology (AUO) \\\\t University Hospital, Essen \\\\t 60 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2010-10,2015-10\\r\\nNCT01465971 \\\\t Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude \\\\t PerOxySleep \\\\t COMPLETED \\\\t Environmental Sleep Disorder|Cheyne-Stokes Respiration|Altitude Sickness \\\\t Goethe University \\\\t 6 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2011-05,2011-12\\r\\n\"NCT05958771 \\\\t The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E \\\\t RECRUITING \\\\t Rotavirus Gastroenteritis \\\\t DRUG: ROTAVAC 5D|DRUG: Placebo \\\\t University of Chile \\\\t Bharat Biotech International Limited \\\\t 5800 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION\",06 July 2023,01 June 2025\\r\\n\"NCT03532971 \\\\t Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease\\'s Natural History, Clinical Spectrum, Immunology, and Outcomes \\\\t ACTIVE_NOT_RECRUITING \\\\t BK Virus Infection \\\\t OTHER: Symptom index questionnaire|DIAGNOSTIC_TEST: BK polyomavirus PCR|OTHER: quality of life questionnaires \\\\t Dana-Farber Cancer Institute \\\\t 100 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",30 July 2018,31 December 2024\\r\\n\"NCT04039971 \\\\t Tendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial \\\\t RECRUITING \\\\t Anterior Cruciate Ligament Injuries|Anterior Cruciate Ligament Rupture|Anterior Cruciate Ligament Tear \\\\t PROCEDURE: ACL Reconstruction \\\\t University of Colorado, Denver \\\\t Children\\'s Hospital Colorado \\\\t 150 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\",01 August 2020,31 August 2029\\r\\nNCT01943071 \\\\t Effects and Costs of a Day Care Centre Program Designed for People With Dementia \\\\t ECOD \\\\t COMPLETED \\\\t Dementia \\\\t BEHAVIORAL: Day care for patients with dementia \\\\t Norwegian Centre for Ageing and Health \\\\t The Research Council of Norway \\\\t 261 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,01 August 2013,31 December 2017\\r\\n\"NCT05451771 \\\\t Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis \\\\t RECRUITING \\\\t AL Amyloidosis \\\\t DRUG: Venetoclax Oral Tablet, 200 mg|DEVICE: FISH assay|DRUG: Venetoclax Oral Tablet, 400 mg|DRUG: Dexamethasone Oral, 10 mg|DRUG: Dexamethasone Oral, 20 mg|DRUG: Daratumumab Injection|DRUG: Bendamustine|DRUG: Pomalidomide|DRUG: Ixazomib|DRUG: Venetoclax MTD with Dexamethasone \\\\t Rajshekhar Chakraborty, MD \\\\t Genentech, Inc. \\\\t 53 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\",26 October 2022,2026-09\\r\\nNCT02521571 \\\\t The Resilience Alliance \\\\t COMPLETED \\\\t Secondary Traumatic Stress \\\\t BEHAVIORAL: Resiliance Alliance|BEHAVIORAL: Secondary traumatic stress training \\\\t NYU Langone Health \\\\t 357 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2011-12,2012-07\\r\\nNCT06197971 \\\\t Instrument Assisted Soft Tissue Mobilization vs Therapeutic Cupping on Hamstring Tightness Among Football Players \\\\t RECRUITING \\\\t Flexibility|Hamstring Tightness|Instrument Assisted Soft Tissue Mobilization|Range of Motion \\\\t OTHER: Instrument Assisted Soft Tissue Mobilization|OTHER: Therapeutic Cupping Technique \\\\t Riphah International University \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER,20 October 2023,20 February 2024\\r\\nNCT05284071 \\\\t Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation \\\\t ADMSUK01 \\\\t COMPLETED \\\\t Diabetes type1|Diabetes type2 \\\\t DEVICE: Device: Actiste 1.0 and the Companion app with TBL Backend \\\\t Northern Care Alliance NHS Foundation Trust \\\\t Brighter AB \\\\t 13 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,14 March 2022,21 December 2022\\r\\n\"NCT03132571 \\\\t Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia \\\\t NBC \\\\t TERMINATED \\\\t Schizophrenia|Diabetes Mellitus, Type 2|Obesity \\\\t DRUG: Naltrexone|DRUG: Bupropion|OTHER: Placebo \\\\t Yale University \\\\t 5 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",01 June 2017,31 July 2018\\r\\n\"NCT04597671 \\\\t Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28) \\\\t NVALT28 \\\\t RECRUITING \\\\t Carcinoma, Non-Small-Cell Lung \\\\t DRUG: Durvalumab|RADIATION: low-dose PCI \\\\t Association NVALT Studies \\\\t 170 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\",06 December 2021,2032-12\\r\\nNCT05710471 \\\\t Treatment of Recalcitrant Neovascular AMD Using Brolocizumab With Immediate T&E \\\\t RECRUITING \\\\t Age-Related Macular Degeneration \\\\t DRUG: Brolucizumab|DRUG: Aflibercept \\\\t The University of Hong Kong \\\\t 64 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,25 July 2022,30 August 2023\\r\\n\"NCT03994471 \\\\t Efficacy and Safety of XyloCore Peritoneal Dialysis Solution. \\\\t ELIXIR \\\\t RECRUITING \\\\t End Stage Renal Disease \\\\t DRUG: XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght|DRUG: 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution \\\\t Iperboreal Pharma Srl \\\\t 170 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",14 December 2022,2024-12\\r\\nNCT03474471 \\\\t A Trial on the Effects of Bronchoscopic Lung Volume Reduction in Severe Emphysema. \\\\t SOLVE \\\\t COMPLETED \\\\t Emphysema \\\\t BEHAVIORAL: Pulmonary rehabilitation|DEVICE: EBV treatment \\\\t University Medical Center Groningen \\\\t Maastricht University Medical Center|Center of Expertise for Chronic Organ Failure \\\\t 96 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,31 July 2018,20 April 2023\\r\\n\"NCT06143371 \\\\t A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis. \\\\t RECRUITING \\\\t Healthy|Plaque Psoriasis \\\\t BIOLOGICAL: CAN10|BIOLOGICAL: CAN10 - Placebo \\\\t Cantargia AB \\\\t 80 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",21 August 2023,24 April 2025\\r\\nNCT02080871 \\\\t A Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries. \\\\t VBXFLEX \\\\t COMPLETED \\\\t Peripheral Arterial Disease \\\\t DEVICE: Stenting of the Common and/or External Iliac Arteries \\\\t W.L.Gore & Associates \\\\t 134 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-07,2018-10\\r\\n\"NCT04628871 \\\\t Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX \\\\t LTFU \\\\t ACTIVE_NOT_RECRUITING \\\\t Hemophilia B|Mucopolysaccharidosis I|Mucopolysaccharidosis II \\\\t BIOLOGICAL: SB-318|BIOLOGICAL: SB-913|BIOLOGICAL: SB-FIX \\\\t Sangamo Therapeutics \\\\t 13 \\\\t INDUSTRY \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",03 November 2020,01 January 2030\\r\\nNCT01044771 \\\\t Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria \\\\t RALPIR \\\\t COMPLETED \\\\t HIV Infections|Proteinuria \\\\t DRUG: change from tenofovir to raltegrav'"
     ]
    }
   ],
   "source": [
    "file = \"/FileStore/tables/clinicaltrial_2023/clinicaltrial_2023.csv\"\n",
    "\n",
    "dbutils.fs.head(file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "10091503-d489-443e-a969-5b9a2647e47b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[10]: ['NCT Number \\\\t Study Title \\\\t Acronym \\\\t Study Status \\\\t Conditions \\\\t Interventions \\\\t Sponsor \\\\t Collaborators \\\\t Enrollment \\\\t Funder Type \\\\t Study Type \\\\t Study Design,Start Date,Completion Date',\n '\"NCT03630471 \\\\t Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India \\\\t PRIDE \\\\t COMPLETED \\\\t Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) \\\\t BEHAVIORAL: PRIDE \\'Step 1\\' problem-solving intervention|BEHAVIORAL: Enhanced usual care \\\\t Sangath \\\\t Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine \\\\t 250 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",20 August 2018,28 February 2019',\n '\"NCT05992571 \\\\t Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity \\\\t RECRUITING \\\\t Cerebrovascular Function|Cognition \\\\t OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB \\\\t McMaster University \\\\t Alzheimer\\'s Society of Brant, Haldimand Norfolk, Hamilton Halton \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\",25 October 2023,2024-08']"
     ]
    }
   ],
   "source": [
    "# Create rdd\n",
    "\n",
    "rdd1 = sc.textFile(file)\n",
    "\n",
    "rdd1.take(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7e1c4b09-d2da-47b9-b3dd-82438e196733",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NCT Number \\t Study Title \\t Acronym \\t Study Status \\t Conditions \\t Interventions \\t Sponsor \\t Collaborators \\t Enrollment \\t Funder Type \\t Study Type \\t Study Design,Start Date,Completion Date\n"
     ]
    }
   ],
   "source": [
    "#Extract header\n",
    "\n",
    "header = rdd1.first()\n",
    "\n",
    "print(header)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c25deb1e-f010-4bb7-a7d2-18ac16c6d950",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "\n",
    "Data Cleaning"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "2932e833-26cb-4400-bd26-5d73fdef14eb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['NCT Number \\\\t Study Title \\\\t Acronym \\\\t Study Status \\\\t Conditions \\\\t Interventions \\\\t Sponsor \\\\t Collaborators \\\\t Enrollment \\\\t Funder Type \\\\t Study Type \\\\t Study Design', 'Start Date', 'Completion Date']\n"
     ]
    }
   ],
   "source": [
    "#Let's split Header\n",
    "\n",
    "# Extract header\n",
    "header = rdd1.first()\n",
    "\n",
    "# Split the header based on \\t\n",
    "header_elements = header.split(\"\\t\")\n",
    "\n",
    "# Split the last element based on comma\n",
    "last_element_split = header_elements[-1].split(',')\n",
    "\n",
    "# Combine the split elements into the header list\n",
    "header_elements[-1:] = last_element_split\n",
    "\n",
    "# Print the modified header\n",
    "print(header_elements)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "aee1584c-9497-4b39-9586-c30c4e8d4f81",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[15]: [['NCT Number ',\n  ' Study Title ',\n  ' Acronym ',\n  ' Study Status ',\n  ' Conditions ',\n  ' Interventions ',\n  ' Sponsor ',\n  ' Collaborators ',\n  ' Enrollment ',\n  ' Funder Type ',\n  ' Study Type ',\n  ' Study Design',\n  'Start Date',\n  'Completion Date'],\n ['\"NCT03630471 ',\n  ' Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India ',\n  ' PRIDE ',\n  ' COMPLETED ',\n  ' Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) ',\n  \" BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care \",\n  ' Sangath ',\n  ' Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine ',\n  ' 250 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR',\n  ' OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\"',\n  '20 August 2018',\n  '28 February 2019']]"
     ]
    }
   ],
   "source": [
    "#Define function to split lines in text\n",
    "\n",
    "def split_line(line):\n",
    "    # Split the line by tab character\n",
    "    parts = line.split(\"\\\\t\")\n",
    "    # Split the last part by commas and extend the list\n",
    "    last_part_split = parts[-1].split(\",\")\n",
    "    return parts[:-1] + last_part_split\n",
    "\n",
    "# Apply the split_line function to the input list and save as rdd2\n",
    "rdd2 = rdd1.map(split_line)\n",
    "\n",
    "rdd2.take(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "95a7b56a-b567-4d49-a1ad-51d11ebd7d74",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[16]: ['Completion Date', '28 February 2019', '2024-08', '2014-12']"
     ]
    }
   ],
   "source": [
    "#Cleaning date\n",
    "#Extract first line data\n",
    "first_line = rdd2.map(lambda x: x[-1])\n",
    "\n",
    "first_line.take(4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "b4842098-3db4-490d-bf53-969caed568ba",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['NCT Number ', ' Study Title ', ' Acronym ', ' Study Status ', ' Conditions ', ' Interventions ', ' Sponsor ', ' Collaborators ', ' Enrollment ', ' Funder Type ', ' Study Type ', ' Study Design', 'Start Date', 'Completion Date']]\n"
     ]
    }
   ],
   "source": [
    "#Check the first row\n",
    "\n",
    "Header_row = rdd2.take(1)\n",
    "\n",
    "print(Header_row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "9728a7c4-678e-4505-aa6a-690dd676cea6",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[18]: [('Start Date', 'Completion Date'),\n ('20 August 2018', '28 February 2019'),\n ('25 October 2023', '2024-08'),\n ('2013-08', '2014-12'),\n ('01 October 2020', '01 October 2023'),\n ('01 July 2010', '30 October 2019'),\n ('05 May 2017', '09 October 2020'),\n ('01 September 2022', '15 June 2023'),\n ('01 February 2024', '01 March 2026'),\n ('11 May 2016', '13 December 2017'),\n ('2016-02', '2017-05'),\n ('13 July 2017', '30 June 2026'),\n ('2004-01', '2005-01'),\n ('09 February 2023', '17 November 2024'),\n ('2015-03', '2016-12'),\n ('13 June 2013', '02 November 2021'),\n ('13 June 2018', '24 December 2018'),\n ('2009-01', '2009-12'),\n ('2009-08', '2011-07'),\n ('2009-09', '2010-03'),\n ('02 December 2021', '31 December 2023'),\n ('2003-03', '2004-04'),\n ('30 May 2023', '30 May 2025'),\n ('15 July 2019', '01 September 2020'),\n ('15 April 2020', '31 May 2020'),\n ('2014-09', '2019-02'),\n ('01 July 2023', '01 December 2024'),\n ('01 January 2018', '31 December 2024'),\n ('06 May 2022', '06 November 2025'),\n ('2005-12', ''),\n ('2011-05', '2018-03'),\n ('2012-11', '2015-08'),\n ('2010-05', '2012-06'),\n ('2007-04', '2010-10'),\n ('2011-02', '2013-03'),\n ('2006-04', ''),\n ('2013-09', '2015-10'),\n ('', ''),\n ('2017-11', '28 February 2018'),\n ('25 October 2016', '2023-12'),\n ('25 January 2021', '18 February 2022'),\n ('19 April 2021', '19 May 2021'),\n ('14 February 2017', '30 June 2024'),\n ('11 February 2021', '22 December 2021'),\n ('2014-09', '2016-06'),\n ('03 September 2020', '31 January 2021'),\n ('15 November 2022', '31 October 2026'),\n ('2004-07', '2006-08'),\n ('1986-02', ''),\n ('2010-01', '2010-05'),\n ('09 June 2015', '17 November 2019'),\n ('2024-08', '2027-08'),\n ('2022-03', '2025-02'),\n ('2015-07', '2017-07'),\n ('05 July 2019', '30 June 2022'),\n ('08 January 2022', '30 June 2023'),\n ('2015-10', ''),\n ('30 November 2010', '2024-06'),\n ('01 September 2020', '01 February 2022'),\n ('2016-07', ''),\n ('13 March 2020', '31 December 2022'),\n ('15 December 2021', '31 December 2025'),\n ('2015-09', '2015-10'),\n ('2014-12', '2016-09'),\n ('01 April 2019', '31 December 2022'),\n ('23 February 2022', '31 July 2024'),\n ('10 November 2019', '25 August 2020'),\n ('25 August 2023', '31 March 2024'),\n ('2005-09', '2008-08'),\n ('01 December 2016', '2018-06'),\n ('2016-04', '2017-01'),\n ('26 April 2018', '01 May 2025'),\n ('2014-04', '2018-12'),\n ('15 September 2021', '29 August 2022'),\n ('2003-01', '2004-10'),\n ('08 November 2015', '15 October 2019'),\n ('12 February 2023', '31 December 2024'),\n ('2002-07', '2010-05'),\n ('01 November 2020', '01 May 2021'),\n ('01 January 2024', '31 December 2026'),\n ('2006-08', '2007-05'),\n ('2008-10', ''),\n ('2009-04', '2011-12'),\n ('15 May 2022', '30 May 2025'),\n ('', '2004-11'),\n ('15 July 2023', '15 January 2025'),\n ('2023-12', '2026-11'),\n ('2024-01', '2025-01'),\n ('2013-02', '2018-12'),\n ('31 March 2022', '30 June 2023'),\n ('2014-11', '2020-01'),\n ('29 April 2020', '01 July 2020'),\n ('2015-05', '13 May 2017'),\n ('15 January 2024', '30 June 2024'),\n ('2013-11', '2017-11'),\n ('29 April 2019', '30 December 2020'),\n ('01 February 2014', '30 April 2015'),\n ('2010-10', '2013-06'),\n ('2010-09', '2014-09'),\n ('05 April 2019', '31 August 2021'),\n ('2009-10', '2011-07'),\n ('2014-11', '2015-04'),\n ('2016-05', ''),\n ('21 August 2023', '21 August 2025'),\n ('2015-02', '2016-12'),\n ('21 July 2021', '31 December 2022'),\n ('02 December 2022', '01 December 2023'),\n ('21 April 2016', '01 May 2021'),\n ('2009-01', '2010-06'),\n ('2012-07', '2013-10'),\n ('2008-06', '2009-03'),\n ('04 March 2019', '06 January 2023'),\n ('12 April 2023', '11 October 2023'),\n ('18 March 2020', '31 July 2023'),\n ('2015-12', '2022-12'),\n ('29 September 2014', '28 October 2020'),\n ('2005-03', '2007-12'),\n ('2014-10', '2015-10'),\n ('2013-05', '2027-12'),\n ('2008-07', '2011-10'),\n ('30 April 2019', '26 March 2021'),\n ('2016-01', '2024-12'),\n ('10 December 2020', '09 December 2025'),\n ('26 September 2013', '28 August 2015'),\n ('2009-02', '2022-04'),\n ('24 April 2017', '30 January 2026'),\n ('2013-02', '2014-10'),\n ('2021-04', '2022-12'),\n ('2005-10', '2007-01'),\n ('21 February 2017', '19 July 2017'),\n ('2004-07', '2010-02'),\n ('2002-09', '2012-03'),\n ('03 April 2017', '31 December 2023'),\n ('2013-11', '2015-09'),\n ('2009-01', '2010-10'),\n ('2012-10', '2017-12'),\n ('24 April 2023', '21 February 2025'),\n ('15 April 2021', '31 December 2036'),\n ('08 December 2016', '2022-12'),\n ('2017-01', '2019-12'),\n ('2008-06', '2008-09'),\n ('2010-10', '2015-10'),\n ('2011-05', '2011-12'),\n ('06 July 2023', '01 June 2025'),\n ('30 July 2018', '31 December 2024'),\n ('01 August 2020', '31 August 2029'),\n ('01 August 2013', '31 December 2017'),\n ('26 October 2022', '2026-09'),\n ('2011-12', '2012-07'),\n ('20 October 2023', '20 February 2024'),\n ('14 March 2022', '21 December 2022'),\n ('01 June 2017', '31 July 2018'),\n ('06 December 2021', '2032-12'),\n ('25 July 2022', '30 August 2023'),\n ('14 December 2022', '2024-12'),\n ('31 July 2018', '20 April 2023'),\n ('21 August 2023', '24 April 2025'),\n ('2014-07', '2018-10'),\n ('03 November 2020', '01 January 2030'),\n ('2010-01', '2011-06'),\n ('17 April 2023', '08 December 2023'),\n ('28 March 2018', '30 November 2019'),\n ('2016-11', '24 March 2020'),\n ('05 January 2023', '2025-01'),\n ('25 July 2014', '11 June 2016'),\n ('03 November 2008', '30 November 2024'),\n ('04 April 2022', '01 October 2023'),\n ('2014-02', '2015-07'),\n ('20 August 2020', '20 November 2021'),\n ('25 April 2020', '02 October 2021'),\n ('2005-07', ''),\n ('21 December 2016', '01 April 2019'),\n ('2005-11', '2008-01'),\n ('2003-12', '2007-02'),\n ('29 January 2023', '17 March 2023'),\n ('2006-01', '2010-07'),\n ('2009-07', '2014-09'),\n ('22 January 2020', '22 January 2021'),\n ('01 January 2018', '05 April 2018'),\n ('15 April 2021', '07 May 2022'),\n ('15 August 2017', '28 January 2024'),\n ('01 January 2019', '31 December 2019'),\n ('01 April 2007', '01 May 2010'),\n ('2012-12', '2015-09'),\n ('01 November 2022', '01 July 2023'),\n ('01 February 2023', '2023-12'),\n ('27 July 2017', '27 July 2017'),\n ('2009-11', '2010-10'),\n ('2012-01', '2012-01'),\n ('2015-10', '10 May 2017'),\n ('13 September 2021', '01 December 2023'),\n ('01 July 2022', '2028-01'),\n ('21 November 2014', '14 February 2020'),\n ('01 July 2021', '01 January 2023'),\n ('14 February 2011', '29 November 2017'),\n ('10 March 2022', '2023-12'),\n ('14 January 2021', '2028-01'),\n ('01 February 2019', '31 May 2019'),\n ('2009-06', '2011-07'),\n ('2014-01', '2017-03'),\n ('28 June 2019', '28 June 2022'),\n ('2011-04', '2011-12'),\n ('2009-12', '2010-03'),\n ('25 November 2014', '26 November 2019'),\n ('12 August 2019', '31 March 2021'),\n ('11 June 2021', '31 December 2027'),\n ('01 January 2022', '01 November 2023'),\n ('01 March 2018', '18 December 2020'),\n ('2011-02', '2012-05'),\n ('2007-10', '2012-11'),\n ('01 June 2021', '31 October 2023'),\n ('2011-01', '2016-09'),\n ('2009-04', '2009-09'),\n ('08 January 2024', '01 July 2027'),\n ('01 August 2016', '01 October 2017'),\n ('25 April 2018', '14 March 2019'),\n ('22 October 2018', '13 November 2019'),\n ('05 December 2017', '30 January 2019'),\n ('18 February 2014', '29 December 2023'),\n ('20 April 2017', '27 March 2019'),\n ('1996-06', '1997-12'),\n ('20 July 2005', '24 September 2010'),\n ('2022-05', '2022-11'),\n ('2010-03', '2010-10'),\n ('2011-01', '23 December 2016'),\n ('2009-02', '2009-04'),\n ('2013-04', '28 November 2017'),\n ('07 December 2018', '29 April 2020'),\n ('2016-10', '2017-11'),\n ('2009-02', ''),\n ('15 August 2022', '20 January 2023'),\n ('10 March 2015', '21 October 2020'),\n ('26 April 2023', '30 October 2025'),\n ('2016-09', '2017-11'),\n ('03 August 2018', '21 February 2021'),\n ('02 November 2020', '30 September 2024'),\n ('2007-11', '2008-12'),\n ('2012-12', '2013-12'),\n ('23 November 2021', '31 December 2022'),\n ('2007-12', '2009-02'),\n ('2011-12', '2013-10'),\n ('01 July 2022', '01 December 2022'),\n ('2022-09', '2024-09'),\n ('08 October 2019', '19 December 2019'),\n ('07 September 2023', '25 September 2025'),\n ('2004-06', '2005-08'),\n ('30 May 2018', '2025-03'),\n ('2012-09', '2014-06'),\n ('2001-03', '2006-02'),\n ('19 December 2016', '01 November 2018'),\n ('2008-01', '2012-01'),\n ('2007-10', '30 April 2008'),\n ('01 January 2020', '01 January 2021'),\n ('2025-01', '2026-12'),\n ('2012-03', '2012-10'),\n ('2016-03', '2018-09'),\n ('01 November 2022', '2024-12'),\n ('2014-10', '2015-05'),\n ('2014-12', '2015-09'),\n ('01 January 2017', ''),\n ('16 April 2021', '2022-04'),\n ('04 February 2022', '2023-06'),\n ('2010-07', '2012-08'),\n ('2014-04', '04 June 2021'),\n ('07 December 2016', '16 November 2017'),\n ('01 February 2024', '01 August 2028'),\n ('09 July 2020', '29 March 2025'),\n ('2007-07', '2011-06'),\n ('27 September 2021', '21 June 2022'),\n ('19 March 2014', '23 March 2019'),\n ('2005-09', '2008-10'),\n ('2012-04', '2017-12'),\n ('2020-10', '2021-01'),\n ('01 March 2017', '12 July 2018'),\n ('2016-03', '2016-09'),\n ('2004-06', '2011-02'),\n ('30 April 2015', '05 August 2019'),\n ('03 February 2017', '2018-10'),\n ('01 June 2018', '15 June 2019'),\n ('2012-02', '2024-12'),\n ('2013-06', '2016-12'),\n ('01 October 2019', '01 December 2020'),\n ('2005-01', ''),\n ('2015-02', '28 February 2017'),\n ('2016-10', '2017-07'),\n ('2012-08', '2015-01'),\n ('01 October 2020', '21 December 2022'),\n ('2012-11', '2014-06'),\n ('2012-07', '2014-10'),\n ('01 March 2024', '2025-09'),\n ('18 February 2021', '31 December 2024'),\n ('23 December 2017', '08 April 2036'),\n ('10 June 2009', ''),\n ('2011-05', '2012-01'),\n ('2014-07', '2016-12'),\n ('2012-11', '2020-09'),\n ('10 March 2022', '15 September 2023'),\n ('2013-03', '2014-07'),\n ('01 May 2005', '01 December 2016'),\n ('2015-10', '18 October 2017'),\n ('16 January 2015', '12 January 2017'),\n ('2011-10', '2014-04'),\n ('2016-02', '2017-03'),\n ('11 November 2016', '2019-02'),\n ('31 July 2017', '15 August 2025'),\n ('', ''),\n ('23 December 2019', '02 June 2026'),\n ('25 October 2019', '30 December 2023'),\n ('31 August 2018', '11 December 2019'),\n ('2015-07', '25 February 2020'),\n ('30 March 2022', '12 December 2022'),\n ('2013-07', '2017-04'),\n ('01 June 2019', '30 June 2021'),\n ('28 April 2019', '31 December 2024'),\n ('01 September 2021', '11 October 2022'),\n ('01 December 2022', '31 December 2023'),\n ('01 August 2023', '2023-11'),\n ('11 December 2023', '30 June 2024'),\n ('10 March 2019', '10 February 2020'),\n ('2008-12', '2010-02'),\n ('01 January 2019', '31 December 2023'),\n ('2004-11', '2011-01'),\n ('27 October 2020', '08 August 2023'),\n ('23 May 2022', '2024-12'),\n ('21 February 2018', '07 September 2018'),\n ('2011-01', '2016-01'),\n ('2014-04', '2014-08'),\n ('30 March 2023', '30 January 2024'),\n ('01 March 2011', '23 September 2011'),\n ('13 June 2019', '31 December 2023'),\n ('01 June 2023', '01 June 2026'),\n ('12 August 2010', '16 December 2011'),\n ('2012-01', '2014-04'),\n ('22 November 2018', '01 November 2022'),\n ('2008-01', '2013-10'),\n ('2010-12', '2016-03'),\n ('30 May 2023', '31 May 2027'),\n ('2017-01', '23 August 2018'),\n ('08 November 2017', '01 February 2019'),\n ('2013-06', '2013-07'),\n ('02 October 2023', '2024-05'),\n ('2008-10', '2009-08'),\n ('18 March 2020', '17 April 2020'),\n ('2014-06', '2016-01'),\n ('2013-01', '02 May 2023'),\n ('01 December 2016', '25 November 2019'),\n ('24 November 2009', '06 December 2009'),\n ('2007-09', '2009-05'),\n ('01 October 2023', '2024-03'),\n ('2015-07', '2016-10'),\n ('2013-05', ''),\n ('01 June 2013', '30 July 2020'),\n ('2015-12', '2022-12'),\n ('29 January 2018', '27 September 2019'),\n ('08 November 2021', '01 June 2026'),\n ('03 January 2018', '01 July 2020'),\n ('2016-08', '2017-01'),\n ('11 January 2022', '29 September 2023'),\n ('2002-08', '2004-09'),\n ('2017-09', '2019-09'),\n ('2004-05', '2025-05'),\n ('2007-04', '2010-04'),\n ('2009-07', '2009-11'),\n ('2008-05', '2012-06'),\n ('2013-08', '2014-07'),\n ('01 April 2022', '2023-10'),\n ('2010-12', '2011-04'),\n ('01 June 2020', '01 September 2020'),\n ('01 December 2023', '31 December 2028'),\n ('10 February 2019', '15 February 2019'),\n ('21 February 2023', '2024-06'),\n ('15 September 2010', '2025-09'),\n ('12 December 2017', '26 November 2019'),\n ('18 September 2018', '08 September 2022'),\n ('2014-08', '2016-12'),\n ('1999-06', '2007-05'),\n ('2006-01', '2014-12'),\n ('2004-04', '2006-09'),\n ('2007-11', '2008-09'),\n ('31 October 2019', '2021-07'),\n ('01 August 2023', '31 December 2025'),\n ('17 May 2016', '03 August 2016'),\n ('2004-01', '2006-12'),\n ('29 March 2023', '01 January 2026'),\n ('20 March 2018', '19 November 2018'),\n ('10 August 2021', '31 December 2022'),\n ('31 January 2023', '31 August 2025'),\n ('01 June 2021', '01 October 2021'),\n ('01 September 2021', '14 October 2021'),\n ('13 December 2022', '30 June 2026'),\n ('2012-11', '2013-10'),\n ('01 May 2017', '30 March 2018'),\n ('2024-01', '2025-12'),\n ('2009-06', '2011-09'),\n ('2002-11', '2005-08'),\n ('21 April 2016', '03 July 2017'),\n ('2008-12', '2009-06'),\n ('2015-01', '2016-05'),\n ('01 August 2018', '01 November 2019'),\n ('01 April 2021', '01 November 2021'),\n ('2015-04', '2015-09'),\n ('2012-03', '2015-03'),\n ('26 February 2020', '01 October 2021'),\n ('2014-07', '2016-11'),\n ('26 December 2013', '15 January 2015'),\n ('2008-08', '2009-09'),\n ('06 December 2023', '2026-10'),\n ('11 June 2007', '08 October 2007'),\n ('30 April 2019', '06 June 2021'),\n ('07 January 2021', '07 January 2024'),\n ('2017-01', '01 March 2021'),\n ('1996-04', '1997-06'),\n ('01 November 2018', '30 June 2022'),\n ('2006-01', '2013-11'),\n ('2018-06', '2020-07'),\n ('1999-12', '2009-02'),\n ('2002-05', '2005-03'),\n ('2010-07', '2013-11'),\n ('15 February 2022', '15 December 2022'),\n ('2010-12', '2011-10'),\n ('01 July 2019', '31 January 2026'),\n ('2007-05', '2013-03'),\n ('10 October 2017', '25 September 2019'),\n ('2008-01', ''),\n ('02 March 2021', '30 June 2024'),\n ('01 March 2017', '30 December 2019'),\n ('21 June 2017', '29 September 2020'),\n ('2008-03', '2012-05'),\n ('05 July 2022', '2023-12'),\n ('2013-07', '2014-09'),\n ('2015-08', '2025-08'),\n ('01 December 2023', '01 March 2025'),\n ('2015-06', '2017-11'),\n ('2010-11', '2014-12'),\n ('2005-12', '2007-12'),\n ('2011-03', '19 August 2016'),\n ('2014-07', '2015-07'),\n ('2007-07', '2014-03'),\n ('2007-02', '2011-12'),\n ('2011-08', '2012-12'),\n ('01 July 2022', '06 June 2023'),\n ('13 January 2023', '01 November 2027'),\n ('12 March 2019', '31 January 2020'),\n ('2001-11', '2002-05'),\n ('27 October 2021', '01 December 2021'),\n ('2016-01', '2019-06'),\n ('2007-04', '2008-12'),\n ('01 February 2016', '31 August 2018'),\n ('2011-03', '2012-01'),\n ('12 December 2018', '14 June 2019'),\n ('04 April 2023', '2027-08'),\n ('2001-01', '2002-03'),\n ('2005-05', '2009-06'),\n ('09 February 2021', '15 February 2024'),\n ('01 December 2016', '01 March 2019'),\n ('2015-03', '2018-07'),\n ('2016-08', '2018-07'),\n ('01 September 2020', '31 March 2021'),\n ('2006-02', '2008-08'),\n ('2008-08', '2013-12'),\n ('2013-01', '2013-07'),\n ('20 July 2014', '11 August 2015'),\n ('2014-01', '2015-12'),\n ('27 May 2021', '31 December 2023'),\n ('2007-05', '2015-04'),\n ('01 July 2020', '01 December 2021'),\n ('03 December 2018', '01 November 2019'),\n ('2023-10', '2027-12'),\n ('2009-10', '2010-04'),\n ('02 June 2021', '22 July 2021'),\n ('23 August 2023', '30 June 2027'),\n ('2009-11', '2011-05'),\n ('01 June 2012', '12 August 2014'),\n ('1998-11', ''),\n ('01 May 2010', '18 April 2016'),\n ('21 January 2020', '01 June 2022'),\n ('01 January 2021', '01 June 2021'),\n ('01 August 2019', '30 December 2021'),\n ('01 January 2018', '31 December 2019'),\n ('2011-07', '2015-01'),\n ('01 February 2019', '01 March 2023'),\n ('2001-02', '2002-08'),\n ('18 July 2018', '24 June 2019'),\n ('2013-05', '2015-07'),\n ('05 October 2020', '27 July 2021'),\n ('22 September 2020', '04 May 2023'),\n ('2015-01', '2015-06'),\n ('22 December 2019', '30 December 2021'),\n ('27 February 2018', '30 March 2020'),\n ('2013-05', '2017-04'),\n ('2006-01', '2009-01'),\n ('10 October 2022', '31 December 2024'),\n ('25 June 2016', '2016-09'),\n ('2008-10', '19 November 2015'),\n ('04 June 2018', '04 June 2019'),\n ('2012-07', '2013-07'),\n ('01 August 2022', '2025-05'),\n ('2005-08', ''),\n ('2006-11', '2011-05'),\n ('2012-10', '2016-10'),\n ('01 February 2019', '31 December 2027'),\n ('01 July 2019', '31 December 2024'),\n ('16 February 2020', '01 October 2020'),\n ('29 September 2008', '29 June 2017'),\n ('2015-01', '22 June 2021'),\n ('01 August 2019', '20 August 2021'),\n ('2015-04', '2021-05'),\n ('07 November 2011', '08 March 2012'),\n ('13 July 2023', '25 June 2025'),\n ('13 November 2017', '22 June 2021'),\n ('01 November 2019', '01 December 2021'),\n ('30 May 2011', '30 September 2011'),\n ('2005-06', '2009-06'),\n ('01 September 2021', '16 August 2022'),\n ('17 December 2018', '01 September 2021'),\n ('2005-01', '2009-12'),\n ('2006-07', '2009-09'),\n ('15 June 2023', '24 December 2024'),\n ('15 January 2018', '30 May 2018'),\n ('07 January 2016', '24 July 2019'),\n ('01 October 2020', '30 September 2022'),\n ('2023-12', '2032-09'),\n ('2008-11', '2015-12'),\n ('01 October 2017', '22 February 2023'),\n ('28 October 2021', '03 December 2021'),\n ('2010-12', '2012-12'),\n ('09 May 2023', '20 January 2024'),\n ('23 August 2006', ''),\n ('2015-04', '2015-07'),\n ('2007-04', '2010-01'),\n ('02 March 2023', '2026-03'),\n ('21 November 2018', '31 December 2022'),\n ('22 May 2017', '24 June 2020'),\n ('2014-12', ''),\n ('2013-06', '2018-11'),\n ('2009-05', '2009-07'),\n ('15 May 2022', '01 December 2023'),\n ('2012-03', '2013-04'),\n ('01 March 2020', '2021-01'),\n ('11 November 2019', '31 December 2022'),\n ('2014-02', '2014-04'),\n ('01 May 2018', '01 March 2019'),\n ('2013-06', '2013-07'),\n ('09 May 2022', '2022-09'),\n ('2008-10', '2009-10'),\n ('01 March 2022', '01 January 2023'),\n ('2007-02', ''),\n ('18 March 2019', '18 March 2024'),\n ('2011-01', '2011-03'),\n ('2014-08', '06 May 2015'),\n ('2003-08', ''),\n ('18 October 2019', '10 August 2021'),\n ('2010-08', '2014-12'),\n ('2006-02', '2012-12'),\n ('2009-03', '2013-11'),\n ('05 December 2023', '05 December 2026'),\n ('15 June 2021', '31 December 2023'),\n ('01 January 2023', '01 December 2027'),\n ('2005-04', '2007-06'),\n ('14 October 2017', '15 February 2019'),\n ('2013-05', '2013-06'),\n ('2013-12', '2015-12'),\n ('01 July 2018', '12 December 2021'),\n ('01 December 2023', '01 August 2024'),\n ('21 June 2021', '24 September 2021'),\n ('2013-01', '2019-12'),\n ('2008-03', '2009-01'),\n ('01 January 2021', '01 June 2022'),\n ('07 June 2018', '2025-03'),\n ('2012-03', '2015-08'),\n ('21 March 2018', '29 November 2023'),\n ('27 June 2017', '30 July 2018'),\n ('01 September 2023', '29 February 2024'),\n ('2006-03', '2008-12'),\n ('2014-04', '2017-06'),\n ('01 September 2021', '28 February 2024'),\n ('14 June 2022', '01 October 2024'),\n ('12 November 2018', '20 August 2020'),\n ('25 April 2014', '31 December 2015'),\n ('2005-10', '2007-12'),\n ('01 September 2019', '31 August 2020'),\n ('18 October 2018', '30 December 2023'),\n ('02 July 2018', '28 May 2020'),\n ('02 May 2018', '24 October 2018'),\n ('2008-08', '2010-12'),\n ('2015-12', '2018-05'),\n ('2001-06', '2004-10'),\n ('01 March 2020', '01 July 2020'),\n ('2012-07', '2014-06'),\n ('2004-01', '2004-07'),\n ('01 July 2023', '01 July 2028'),\n ('2015-07', '2016-04'),\n ('12 July 2018', '31 December 2023'),\n ('2023-01', '2025-12'),\n ('25 January 2012', '29 January 2015'),\n ('2008-01', '2013-09'),\n ('2015-02', '2015-07'),\n ('2015-04', '26 June 2020'),\n ('2010-03', '2013-05'),\n ('24 April 2023', '03 December 2024'),\n ('2015-07', '2016-11'),\n ('2022-01', '2022-12'),\n ('2015-01', '2015-04'),\n ('04 February 2019', '31 August 2019'),\n ('2012-08', '2013-01'),\n ('01 September 2017', '31 August 2018'),\n ('15 August 2021', '30 June 2022'),\n ('01 January 2010', '01 December 2017'),\n ('2008-05', '2014-02'),\n ('08 October 2019', '17 July 2021'),\n ('15 December 2018', '30 March 2019'),\n ('15 May 2018', '28 February 2023'),\n ('28 August 2017', '06 July 2019'),\n ('', '2007-01'),\n ('01 October 2022', '22 December 2022'),\n ('06 May 2021', '01 March 2026'),\n ('13 December 2001', '24 March 2009'),\n ('01 June 2019', '31 December 2024'),\n ('01 July 2017', '01 July 2020'),\n ('26 July 2013', '12 August 2014'),\n ('2013-09', '2015-12'),\n ('01 April 2022', '01 December 2022'),\n ('28 February 2016', '31 December 2016'),\n ('2015-04', '2015-12'),\n ('2017-12', '2019-04'),\n ('01 October 2020', '01 December 2023'),\n ('29 January 2021', '02 December 2025'),\n ('2006-06', '2008-04'),\n ('11 May 2021', '08 July 2022'),\n ('2012-01', '2015-04'),\n ('18 August 2020', '31 October 2020'),\n ('2004-09', '2006-12'),\n ('08 November 2018', '19 April 2019'),\n ('2005-10', '2008-09'),\n ('2012-01', ''),\n ('12 February 2018', '30 March 2020'),\n ('2008-01', '2013-10'),\n ('06 May 2020', '20 September 2021'),\n ('2011-01', '2012-05'),\n ('27 February 2023', '31 October 2024'),\n ('2003-06', '2006-10'),\n ('01 January 2017', '01 January 2023'),\n ('07 September 2018', '2021-09'),\n ('2009-05', '2013-02'),\n ('2009-10', '2009-12'),\n ('01 January 2024', '31 December 2027'),\n ('2013-01', ''),\n ('26 April 2019', '01 September 2021'),\n ('2000-01', '2006-04'),\n ('2011-01', '2016-12'),\n ('2004-05', '2005-08'),\n ('09 May 2019', '28 February 2024'),\n ('01 May 2021', '31 December 2024'),\n ('2012-05', '15 May 2020'),\n ('01 August 2017', '01 December 2017'),\n ('2014-03', '2014-07'),\n ('13 October 2022', '30 March 2023'),\n ('2016-07', '01 February 2019'),\n ('2018-10', '2019-12'),\n ('06 January 2020', '31 January 2024'),\n ('2007-02', '2011-07'),\n ('23 March 2020', '16 June 2020'),\n ('22 July 2022', '19 August 2025'),\n ('2015-01', '2016-01'),\n ('2016-04', '2021-12'),\n ('2016-04', '2016-12'),\n ('2012-07', '2014-10'),\n ('05 November 2022', '05 June 2023'),\n ('28 October 2021', '26 July 2023'),\n ('2014-04', '2015-07'),\n ('1991-07', '2001-04'),\n ('2012-01', '2012-12'),\n ('01 May 2021', '01 December 2023'),\n ('15 November 2018', '30 June 2022'),\n ('2003-06', '2006-02'),\n ('18 September 2017', '30 November 2019'),\n ('02 October 2013', '20 April 2021'),\n ('28 February 2023', '31 December 2023'),\n ('28 August 2018', '03 September 2019'),\n ('15 February 2021', '25 May 2026'),\n ('20 September 2021', '02 August 2022'),\n ('21 January 2023', '2027-09'),\n ('18 November 2020', '04 April 2024'),\n ('09 November 2022', '2024-11'),\n ('2008-10', '2012-02'),\n ('13 May 2019', '2023-04'),\n ('04 May 2018', '05 February 2021'),\n ('01 November 2020', '31 December 2021'),\n ('2007-01', '2008-10'),\n ('09 November 2020', '18 February 2022'),\n ('02 February 2021', '30 December 2023'),\n ('2023-10', '2026-12'),\n ('10 January 2023', '02 March 2024'),\n ('01 September 2023', '01 June 2025'),\n ('2020-12', '2021-12'),\n ('03 October 2007', '01 September 2009'),\n ('2020-09', '2021-06'),\n ('2009-10', '2011-08'),\n ('04 May 2020', '02 February 2021'),\n ('2017-01', '01 June 2019'),\n ('18 October 2013', '2017-05'),\n ('2005-12', '2015-12'),\n ('01 October 2021', '01 October 2021'),\n ('01 January 2024', '2026-12'),\n ('2010-02', '2010-12'),\n ('2012-08', '2015-05'),\n ('2016-05', '2018-03'),\n ('2005-05', ''),\n ('2012-05', '2012-08'),\n ('01 November 2022', '31 December 2025'),\n ('2001-09', '2005-07'),\n ('2006-01', '2011-12'),\n ('2007-07', ''),\n ('2002-05', '2007-11'),\n ('13 April 2023', '2024-03'),\n ('2009-10', '2012-01'),\n ('2012-09', '2014-09'),\n ('2008-09', '2010-12'),\n ('01 July 2020', '2024-12'),\n ('2016-05', '2016-06'),\n ('22 March 2019', '31 July 2023'),\n ('2003-07', '2005-01'),\n ('2011-08', '2015-03'),\n ('2007-10', '2009-09'),\n ('08 June 2020', '15 November 2022'),\n ('05 March 2017', '01 December 2018'),\n ('12 April 2022', '2025-09'),\n ('15 June 2020', '15 December 2024'),\n ('2016-07', '2019-10'),\n ('1997-02', '2000-12'),\n ('04 February 2022', '2025-04'),\n ('2013-09', '2014-08'),\n ('01 December 2020', '28 December 2022'),\n ('2012-01', '2013-01'),\n ('01 June 2021', '01 September 2024'),\n ('15 January 2021', '10 May 2023'),\n ('01 March 2023', '01 July 2023'),\n ('18 March 2023', '06 October 2024'),\n ('24 April 2019', '17 May 2019'),\n ('01 January 2014', '30 December 2015'),\n ('11 May 2016', '04 December 2017'),\n ('27 December 2017', '15 September 2020'),\n ('21 March 2017', '20 June 2017'),\n ('2015-03', '2016-08'),\n ('01 May 2013', '01 January 2017'),\n ('01 June 2021', '20 January 2023'),\n ('2002-04', '2006-11'),\n ('01 September 2021', '22 September 2022'),\n ('2003-12', '2011-11'),\n ('20 April 2021', '30 June 2022'),\n ('2013-12', '2015-04'),\n ('1996-03', '2003-07'),\n ('19 October 2020', '28 February 2022'),\n ('2015-03', '2015-07'),\n ('2002-07', '2005-07'),\n ('2014-08', '2018-12'),\n ('28 September 2018', '20 February 2019'),\n ('2010-06', '2012-05'),\n ('27 April 2016', '09 March 2021'),\n ('30 November 2019', '09 March 2020'),\n ('01 April 2023', '02 January 2026'),\n ('01 June 2023', '31 December 2023'),\n ('17 April 2022', '30 May 2023'),\n ('27 May 2016', '09 April 2019'),\n ('15 November 2019', '29 February 2020'),\n ('2012-06', '2013-02'),\n ('2010-02', '2020-02'),\n ('15 December 2023', '31 May 2031'),\n ('19 February 2020', '30 April 2020'),\n ('', '1998-10'),\n ('2014-07', '2022-06'),\n ('30 August 2014', '01 May 2018'),\n ('26 July 2022', '2023-12'),\n ('', ''),\n ('18 December 2019', '2023-12'),\n ('26 April 2021', '26 April 2022'),\n ('15 November 2020', '04 February 2022'),\n ('01 November 2022', '31 December 2026'),\n ('12 September 2019', '19 May 2020'),\n ('16 October 2023', '01 December 2023'),\n ('15 October 2020', '15 February 2021'),\n ('19 June 2017', '2071-01'),\n ('2008-09', '2011-06'),\n ('22 February 2022', '01 September 2024'),\n ('2007-10', '01 April 2014'),\n ('20 September 2017', '2019-10'),\n ('14 June 2008', '08 January 2009'),\n ('27 February 2008', '28 February 2016'),\n ('2014-06', '2014-07'),\n ('2012-05', '2016-06'),\n ('2022-02', '2023-02'),\n ('2008-12', '2013-06'),\n ('2014-01', '2014-04'),\n ('01 April 2024', '15 September 2027'),\n ('18 February 2021', '2025-01'),\n ('19 January 2017', '30 May 2019'),\n ('02 October 2023', '2026-11'),\n ('23 October 2019', '31 October 2023'),\n ('2008-05', '2010-06'),\n ('01 August 2008', '01 September 2009'),\n ('01 June 2015', '01 February 2017'),\n ('18 January 2022', '26 July 2022'),\n ('11 March 2019', '23 April 2019'),\n ('2010-08', '2016-02'),\n ('2013-05', '2013-12'),\n ('01 March 2017', '31 December 2020'),\n ('15 November 2023', '15 November 2025'),\n ('22 November 2016', '04 April 2020'),\n ('1995-03', ''),\n ('01 May 2021', '31 December 2022'),\n ('01 January 2020', '30 May 2022'),\n ('2015-07', '2016-12'),\n ('2000-01', '2016-07'),\n ('16 April 2021', '10 February 2022'),\n ('07 December 2016', '2024-12'),\n ('2009-08', ''),\n ('2011-02', '2012-06'),\n ('26 March 2019', '28 June 2019'),\n ('2011-04', '2011-07'),\n ('30 January 2011', '08 February 2011'),\n ('2009-06', '2012-06'),\n ('2014-05', '2014-09'),\n ('29 November 2022', '29 November 2023'),\n ('25 April 2020', '25 July 2023'),\n ('2006-05', '2016-02'),\n ('2016-10', '08 April 2025'),\n ('2011-04', '2018-12'),\n ('01 September 2020', '01 January 2021'),\n ('15 December 2021', '03 August 2022'),\n ('01 March 2024', '01 June 2025'),\n ('2002-11', '2011-04'),\n ('13 April 2020', '2024-07'),\n ('01 June 2021', '31 December 2024'),\n ('06 October 2017', '28 February 2018'),\n ('16 November 2018', '25 March 2019'),\n ('2015-05', '2020-04'),\n ('2013-05', '2018-01'),\n ('2012-09', '2013-12'),\n ('2009-05', '2013-06'),\n ('2009-08', '2012-01'),\n ('2009-02', '2012-08'),\n ('2004-10', '2006-06'),\n ('01 January 2021', '30 November 2024'),\n ('01 August 2022', '01 January 2027'),\n ('2009-07', '2009-08'),\n ('2008-12', '2010-01'),\n ('14 March 2017', '09 November 2023'),\n ('2005-10', '2012-07'),\n ('01 April 2021', '30 July 2024'),\n ('15 March 2023', '15 September 2025'),\n ('12 January 2021', '2022-04'),\n ('01 July 2023', '2025-08'),\n ('10 June 2015', '01 February 2017'),\n ('2007-09', '2008-12'),\n ('2011-06', '2015-09'),\n ('2002-01', '2004-07'),\n ('2013-07', '2014-10'),\n ('26 June 2023', '2025-06'),\n ('2001-11', '2007-07'),\n ('16 November 2022', '03 December 2022'),\n ('04 January 2022', '31 August 2024'),\n ('2015-12', '2017-02'),\n ('01 January 2015', '01 December 2017'),\n ('2008-11', '2011-01'),\n ('28 September 2020', '20 December 2024'),\n ('10 August 2020', '2026-06'),\n ('2014-02', '2015-10'),\n ('2011-08', '2012-01'),\n ('2018-11', '2019-12'),\n ('10 January 2023', '20 April 2023'),\n ('2008-09', '2013-01'),\n ('01 May 2019', '31 December 2022'),\n ('15 November 2023', '15 April 2024'),\n ('2009-05', '2009-10'),\n ('20 March 2018', '05 July 2022'),\n ('23 July 2015', '29 December 2017'),\n ('2006-12', '2008-06'),\n ('2014-07', '2017-10'),\n ('2007-12', '2008-09'),\n ('26 November 2020', '2023-01'),\n ('13 November 2019', '30 June 2020'),\n ('24 March 2019', '20 February 2022'),\n ('15 July 2020', '2027-08'),\n ('01 August 2023', '01 May 2025'),\n ('2009-06', '2014-05'),\n ('01 October 2018', '31 December 2025'),\n ('08 March 2016', '2018-12'),\n ('2005-04', '2005-05'),\n ('30 June 2021', '20 March 2025'),\n ('2005-05', '2011-01'),\n ('2014-01', '2016-02'),\n ('01 June 2023', '2024-06'),\n ('01 November 2018', '10 December 2018'),\n ('2008-04', '2010-11'),\n ('2006-09', '2012-12'),\n ('2004-09', '2004-09'),\n ('2007-01', '2011-01'),\n ('17 January 2017', '30 January 2027'),\n ('25 February 2020', '30 September 2024'),\n ('01 January 2016', '2018-03'),\n ('2003-03', '2004-01'),\n ('2014-01', '2016-03'),\n ('01 September 2010', '01 March 2019'),\n ('2006-01', '2010-06'),\n ('16 November 2020', '31 January 2022'),\n ('2010-07', '2012-09'),\n ('13 August 2020', '2025-02'),\n ('01 October 2022', '01 December 2024'),\n ('27 June 2022', '2024-04'),\n ('25 March 2022', '2022-09'),\n ('01 September 2022', '31 May 2024'),\n ('2010-09', '2014-08'),\n ('01 February 2020', '20 June 2024'),\n ('09 January 2020', '01 October 2020'),\n ('2009-08', '2013-05'),\n ('2005-09', '2005-11'),\n ('2020-01', '2020-08'),\n ('2010-08', '2012-08'),\n ('06 February 2019', '01 August 2024'),\n ('17 June 2022', '01 December 2027'),\n ('2001-06', '2004-07'),\n ('2008-01', '2008-06'),\n ('20 November 2020', '01 February 2022'),\n ('05 May 2021', '2022-12'),\n ('08 October 2008', '06 April 2009'),\n ('16 January 2015', '14 March 2016'),\n ('2014-12', '2019-10'),\n ('13 March 2019', '15 April 2019'),\n ('13 May 2019', '30 June 2020'),\n ('01 August 2009', '31 December 2023'),\n ('01 June 2023', '01 June 2026'),\n ('2012-09', '2013-08'),\n ('29 March 2023', '29 March 2024'),\n ('16 August 2017', '11 April 2019'),\n ('01 September 2024', '01 June 2027'),\n ('07 October 2019', '13 June 2023'),\n ('10 February 2023', '15 August 2025'),\n ('19 December 2019', '2024-06'),\n ('2015-07', '2016-07'),\n ('21 July 2021', '2024-06'),\n ('30 September 2017', '30 September 2018'),\n ('01 February 2021', '01 December 2025'),\n ('2011-01', '2021-12'),\n ('01 January 2019', '01 January 2025'),\n ('13 March 2018', '03 September 2019'),\n ('24 January 2018', '30 June 2019'),\n ('18 March 2020', '01 September 2022'),\n ('01 May 2023', '2024-03'),\n ('2016-07', '2016-11'),\n ('2011-01', '2015-01'),\n ('2014-03', '2020-04'),\n ('2009-02', '2010-08'),\n ('2007-12', '31 December 2019'),\n ('13 March 2020', '2025-11'),\n ('05 February 2022', '30 December 2023'),\n ('15 November 2019', '2020-09'),\n ('2013-07', '2014-03'),\n ('01 October 2020', '01 October 2022'),\n ('2011-11', '2013-06'),\n ('11 October 2016', '24 June 2020'),\n ('03 March 2013', '20 March 2015'),\n ('01 October 2023', '01 June 2027'),\n ('2014-11', '2017-12'),\n ('2004-01', ''),\n ('2012-05', '2016-12'),\n ('01 January 2020', '01 November 2020'),\n ('14 December 2018', '17 May 2023'),\n ('07 December 2017', '21 July 2021'),\n ('25 July 2023', '31 December 2030'),\n ('2011-11', '2018-08'),\n ('2006-03', '2007-07'),\n ('18 February 2020', '2025-09'),\n ('2014-09', '2015-07'),\n ('03 January 2019', '03 January 2030'),\n ('01 March 2023', '03 April 2024'),\n ('15 October 2020', '08 November 2021'),\n ('2023-12', '2024-08'),\n ('01 May 2016', '01 October 2017'),\n ('', ''),\n ('1999-09', '2002-06'),\n ('24 October 2019', '2024-12'),\n ('2013-01', '2016-02'),\n ('2006-12', '2008-05'),\n ('15 October 2022', '2025-09'),\n ('2003-01', '2005-07'),\n ('29 June 2022', '2024-07'),\n ('2013-10', '2016-01'),\n ('01 September 2023', '31 December 2023'),\n ('2011-04', '2013-01'),\n ('14 December 2018', '26 March 2021'),\n ('2008-10', '2011-06'),\n ('13 September 2020', '04 October 2025'),\n ('01 May 2020', '01 June 2021'),\n ('07 June 2021', '24 March 2022'),\n ('2009-01', '2009-11'),\n ('08 February 2023', '30 September 2025'),\n ('19 June 2020', '31 January 2023'),\n ('2011-09', '2017-09'),\n ('09 December 2021', '2024-12'),\n ('28 March 2017', '13 September 2018'),\n ...]"
     ]
    }
   ],
   "source": [
    "# Extract Start Date and Completion Date\n",
    "\n",
    "rdd3 = rdd2.map(lambda row: (row[-2], row[-1]))\n",
    "\n",
    "rdd3.collect()  #show all data in rdd to examine date format that exist"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0ab98aca-e099-4d51-b5d0-93be8cd8bfa5",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('Start Date', 'Completion Date')\n"
     ]
    }
   ],
   "source": [
    "#Create date without the Header\n",
    "\n",
    "#create Date Header\n",
    "\n",
    "Date_Header = rdd3.first()\n",
    "\n",
    "print(Date_Header)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a541f2b0-d9ea-44b7-b90d-f164d53caae4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[20]: [('Start Date', 'Completion Date'),\n ('20 August 2018', '28 February 2019'),\n ('25 October 2023', '2024-08')]"
     ]
    }
   ],
   "source": [
    "rdd4 = rdd3.map(lambda x: x[:2])\n",
    "\n",
    "rdd4.take(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d6a4ab8c-bea5-4b1c-9082-4a86f0979abb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('Start Date', 'Completion Date')\n('20 August 2018', '28 February 2019')\n('25 October 2023', '01 August 2024')\n('01 August 2013', '01 December 2014')\n('01 October 2020', '01 October 2023')\n('01 July 2010', '30 October 2019')\n('05 May 2017', '09 October 2020')\n('01 September 2022', '15 June 2023')\n('01 February 2024', '01 March 2026')\n('11 May 2016', '13 December 2017')\n('01 February 2016', '01 May 2017')\n('13 July 2017', '30 June 2026')\n('01 January 2004', '01 January 2005')\n('09 February 2023', '17 November 2024')\n('01 March 2015', '01 December 2016')\n('13 June 2013', '02 November 2021')\n('13 June 2018', '24 December 2018')\n('01 January 2009', '01 December 2009')\n('01 August 2009', '01 July 2011')\n('01 September 2009', '01 March 2010')\n('02 December 2021', '31 December 2023')\n('01 March 2003', '01 April 2004')\n('30 May 2023', '30 May 2025')\n('15 July 2019', '01 September 2020')\n('15 April 2020', '31 May 2020')\n('01 September 2014', '01 February 2019')\n('01 July 2023', '01 December 2024')\n('01 January 2018', '31 December 2024')\n('06 May 2022', '06 November 2025')\n('01 December 2005', '')\n('01 May 2011', '01 March 2018')\n('01 November 2012', '01 August 2015')\n('01 May 2010', '01 June 2012')\n('01 April 2007', '01 October 2010')\n('01 February 2011', '01 March 2013')\n('01 April 2006', '')\n('01 September 2013', '01 October 2015')\n('', '')\n('01 November 2017', '28 February 2018')\n('25 October 2016', '01 December 2023')\n('25 January 2021', '18 February 2022')\n('19 April 2021', '19 May 2021')\n('14 February 2017', '30 June 2024')\n('11 February 2021', '22 December 2021')\n('01 September 2014', '01 June 2016')\n('03 September 2020', '31 January 2021')\n('15 November 2022', '31 October 2026')\n('01 July 2004', '01 August 2006')\n('01 February 1986', '')\n('01 January 2010', '01 May 2010')\n('09 June 2015', '17 November 2019')\n('01 August 2024', '01 August 2027')\n('01 March 2022', '01 February 2025')\n('01 July 2015', '01 July 2017')\n('05 July 2019', '30 June 2022')\n('08 January 2022', '30 June 2023')\n('01 October 2015', '')\n('30 November 2010', '01 June 2024')\n('01 September 2020', '01 February 2022')\n('01 July 2016', '')\n('13 March 2020', '31 December 2022')\n('15 December 2021', '31 December 2025')\n('01 September 2015', '01 October 2015')\n('01 December 2014', '01 September 2016')\n('01 April 2019', '31 December 2022')\n('23 February 2022', '31 July 2024')\n('10 November 2019', '25 August 2020')\n('25 August 2023', '31 March 2024')\n('01 September 2005', '01 August 2008')\n('01 December 2016', '01 June 2018')\n('01 April 2016', '01 January 2017')\n('26 April 2018', '01 May 2025')\n('01 April 2014', '01 December 2018')\n('15 September 2021', '29 August 2022')\n('01 January 2003', '01 October 2004')\n('08 November 2015', '15 October 2019')\n('12 February 2023', '31 December 2024')\n('01 July 2002', '01 May 2010')\n('01 November 2020', '01 May 2021')\n('01 January 2024', '31 December 2026')\n('01 August 2006', '01 May 2007')\n('01 October 2008', '')\n('01 April 2009', '01 December 2011')\n('15 May 2022', '30 May 2025')\n('', '01 November 2004')\n('15 July 2023', '15 January 2025')\n('01 December 2023', '01 November 2026')\n('01 January 2024', '01 January 2025')\n('01 February 2013', '01 December 2018')\n('31 March 2022', '30 June 2023')\n('01 November 2014', '01 January 2020')\n('29 April 2020', '01 July 2020')\n('01 May 2015', '13 May 2017')\n('15 January 2024', '30 June 2024')\n('01 November 2013', '01 November 2017')\n('29 April 2019', '30 December 2020')\n('01 February 2014', '30 April 2015')\n('01 October 2010', '01 June 2013')\n('01 September 2010', '01 September 2014')\n('05 April 2019', '31 August 2021')\n('01 October 2009', '01 July 2011')\n('01 November 2014', '01 April 2015')\n('01 May 2016', '')\n('21 August 2023', '21 August 2025')\n('01 February 2015', '01 December 2016')\n('21 July 2021', '31 December 2022')\n('02 December 2022', '01 December 2023')\n('21 April 2016', '01 May 2021')\n('01 January 2009', '01 June 2010')\n('01 July 2012', '01 October 2013')\n('01 June 2008', '01 March 2009')\n('04 March 2019', '06 January 2023')\n('12 April 2023', '11 October 2023')\n('18 March 2020', '31 July 2023')\n('01 December 2015', '01 December 2022')\n('29 September 2014', '28 October 2020')\n('01 March 2005', '01 December 2007')\n('01 October 2014', '01 October 2015')\n('01 May 2013', '01 December 2027')\n('01 July 2008', '01 October 2011')\n('30 April 2019', '26 March 2021')\n('01 January 2016', '01 December 2024')\n('10 December 2020', '09 December 2025')\n('26 September 2013', '28 August 2015')\n('01 February 2009', '01 April 2022')\n('24 April 2017', '30 January 2026')\n('01 February 2013', '01 October 2014')\n('01 April 2021', '01 December 2022')\n('01 October 2005', '01 January 2007')\n('21 February 2017', '19 July 2017')\n('01 July 2004', '01 February 2010')\n('01 September 2002', '01 March 2012')\n('03 April 2017', '31 December 2023')\n('01 November 2013', '01 September 2015')\n('01 January 2009', '01 October 2010')\n('01 October 2012', '01 December 2017')\n('24 April 2023', '21 February 2025')\n('15 April 2021', '31 December 2036')\n('08 December 2016', '01 December 2022')\n('01 January 2017', '01 December 2019')\n('01 June 2008', '01 September 2008')\n('01 October 2010', '01 October 2015')\n('01 May 2011', '01 December 2011')\n('06 July 2023', '01 June 2025')\n('30 July 2018', '31 December 2024')\n('01 August 2020', '31 August 2029')\n('01 August 2013', '31 December 2017')\n('26 October 2022', '01 September 2026')\n('01 December 2011', '01 July 2012')\n('20 October 2023', '20 February 2024')\n('14 March 2022', '21 December 2022')\n('01 June 2017', '31 July 2018')\n('06 December 2021', '01 December 2032')\n('25 July 2022', '30 August 2023')\n('14 December 2022', '01 December 2024')\n('31 July 2018', '20 April 2023')\n('21 August 2023', '24 April 2025')\n('01 July 2014', '01 October 2018')\n('03 November 2020', '01 January 2030')\n('01 January 2010', '01 June 2011')\n('17 April 2023', '08 December 2023')\n('28 March 2018', '30 November 2019')\n('01 November 2016', '24 March 2020')\n('05 January 2023', '01 January 2025')\n('25 July 2014', '11 June 2016')\n('03 November 2008', '30 November 2024')\n('04 April 2022', '01 October 2023')\n('01 February 2014', '01 July 2015')\n('20 August 2020', '20 November 2021')\n('25 April 2020', '02 October 2021')\n('01 July 2005', '')\n('21 December 2016', '01 April 2019')\n('01 November 2005', '01 January 2008')\n('01 December 2003', '01 February 2007')\n('29 January 2023', '17 March 2023')\n('01 January 2006', '01 July 2010')\n('01 July 2009', '01 September 2014')\n('22 January 2020', '22 January 2021')\n('01 January 2018', '05 April 2018')\n('15 April 2021', '07 May 2022')\n('15 August 2017', '28 January 2024')\n('01 January 2019', '31 December 2019')\n('01 April 2007', '01 May 2010')\n('01 December 2012', '01 September 2015')\n('01 November 2022', '01 July 2023')\n('01 February 2023', '01 December 2023')\n('27 July 2017', '27 July 2017')\n('01 November 2009', '01 October 2010')\n('01 January 2012', '01 January 2012')\n('01 October 2015', '10 May 2017')\n('13 September 2021', '01 December 2023')\n('01 July 2022', '01 January 2028')\n('21 November 2014', '14 February 2020')\n('01 July 2021', '01 January 2023')\n('14 February 2011', '29 November 2017')\n('10 March 2022', '01 December 2023')\n('14 January 2021', '01 January 2028')\n('01 February 2019', '31 May 2019')\n('01 June 2009', '01 July 2011')\n('01 January 2014', '01 March 2017')\n('28 June 2019', '28 June 2022')\n('01 April 2011', '01 December 2011')\n('01 December 2009', '01 March 2010')\n('25 November 2014', '26 November 2019')\n('12 August 2019', '31 March 2021')\n('11 June 2021', '31 December 2027')\n('01 January 2022', '01 November 2023')\n('01 March 2018', '18 December 2020')\n('01 February 2011', '01 May 2012')\n('01 October 2007', '01 November 2012')\n('01 June 2021', '31 October 2023')\n('01 January 2011', '01 September 2016')\n('01 April 2009', '01 September 2009')\n('08 January 2024', '01 July 2027')\n('01 August 2016', '01 October 2017')\n('25 April 2018', '14 March 2019')\n('22 October 2018', '13 November 2019')\n('05 December 2017', '30 January 2019')\n('18 February 2014', '29 December 2023')\n('20 April 2017', '27 March 2019')\n('01 June 1996', '01 December 1997')\n('20 July 2005', '24 September 2010')\n('01 May 2022', '01 November 2022')\n('01 March 2010', '01 October 2010')\n('01 January 2011', '23 December 2016')\n('01 February 2009', '01 April 2009')\n('01 April 2013', '28 November 2017')\n('07 December 2018', '29 April 2020')\n('01 October 2016', '01 November 2017')\n('01 February 2009', '')\n('15 August 2022', '20 January 2023')\n('10 March 2015', '21 October 2020')\n('26 April 2023', '30 October 2025')\n('01 September 2016', '01 November 2017')\n('03 August 2018', '21 February 2021')\n('02 November 2020', '30 September 2024')\n('01 November 2007', '01 December 2008')\n('01 December 2012', '01 December 2013')\n('23 November 2021', '31 December 2022')\n('01 December 2007', '01 February 2009')\n('01 December 2011', '01 October 2013')\n('01 July 2022', '01 December 2022')\n('01 September 2022', '01 September 2024')\n('08 October 2019', '19 December 2019')\n('07 September 2023', '25 September 2025')\n('01 June 2004', '01 August 2005')\n('30 May 2018', '01 March 2025')\n('01 September 2012', '01 June 2014')\n('01 March 2001', '01 February 2006')\n('19 December 2016', '01 November 2018')\n('01 January 2008', '01 January 2012')\n('01 October 2007', '30 April 2008')\n('01 January 2020', '01 January 2021')\n('01 January 2025', '01 December 2026')\n('01 March 2012', '01 October 2012')\n('01 March 2016', '01 September 2018')\n('01 November 2022', '01 December 2024')\n('01 October 2014', '01 May 2015')\n('01 December 2014', '01 September 2015')\n('01 January 2017', '')\n('16 April 2021', '01 April 2022')\n('04 February 2022', '01 June 2023')\n('01 July 2010', '01 August 2012')\n('01 April 2014', '04 June 2021')\n('07 December 2016', '16 November 2017')\n('01 February 2024', '01 August 2028')\n('09 July 2020', '29 March 2025')\n('01 July 2007', '01 June 2011')\n('27 September 2021', '21 June 2022')\n('19 March 2014', '23 March 2019')\n('01 September 2005', '01 October 2008')\n('01 April 2012', '01 December 2017')\n('01 October 2020', '01 January 2021')\n('01 March 2017', '12 July 2018')\n('01 March 2016', '01 September 2016')\n('01 June 2004', '01 February 2011')\n('30 April 2015', '05 August 2019')\n('03 February 2017', '01 October 2018')\n('01 June 2018', '15 June 2019')\n('01 February 2012', '01 December 2024')\n('01 June 2013', '01 December 2016')\n('01 October 2019', '01 December 2020')\n('01 January 2005', '')\n('01 February 2015', '28 February 2017')\n('01 October 2016', '01 July 2017')\n('01 August 2012', '01 January 2015')\n('01 October 2020', '21 December 2022')\n('01 November 2012', '01 June 2014')\n('01 July 2012', '01 October 2014')\n('01 March 2024', '01 September 2025')\n('18 February 2021', '31 December 2024')\n('23 December 2017', '08 April 2036')\n('10 June 2009', '')\n('01 May 2011', '01 January 2012')\n('01 July 2014', '01 December 2016')\n('01 November 2012', '01 September 2020')\n('10 March 2022', '15 September 2023')\n('01 March 2013', '01 July 2014')\n('01 May 2005', '01 December 2016')\n('01 October 2015', '18 October 2017')\n('16 January 2015', '12 January 2017')\n('01 October 2011', '01 April 2014')\n('01 February 2016', '01 March 2017')\n('11 November 2016', '01 February 2019')\n('31 July 2017', '15 August 2025')\n('', '')\n('23 December 2019', '02 June 2026')\n('25 October 2019', '30 December 2023')\n('31 August 2018', '11 December 2019')\n('01 July 2015', '25 February 2020')\n('30 March 2022', '12 December 2022')\n('01 July 2013', '01 April 2017')\n('01 June 2019', '30 June 2021')\n('28 April 2019', '31 December 2024')\n('01 September 2021', '11 October 2022')\n('01 December 2022', '31 December 2023')\n('01 August 2023', '01 November 2023')\n('11 December 2023', '30 June 2024')\n('10 March 2019', '10 February 2020')\n('01 December 2008', '01 February 2010')\n('01 January 2019', '31 December 2023')\n('01 November 2004', '01 January 2011')\n('27 October 2020', '08 August 2023')\n('23 May 2022', '01 December 2024')\n('21 February 2018', '07 September 2018')\n('01 January 2011', '01 January 2016')\n('01 April 2014', '01 August 2014')\n('30 March 2023', '30 January 2024')\n('01 March 2011', '23 September 2011')\n('13 June 2019', '31 December 2023')\n('01 June 2023', '01 June 2026')\n('12 August 2010', '16 December 2011')\n('01 January 2012', '01 April 2014')\n('22 November 2018', '01 November 2022')\n('01 January 2008', '01 October 2013')\n('01 December 2010', '01 March 2016')\n('30 May 2023', '31 May 2027')\n('01 January 2017', '23 August 2018')\n('08 November 2017', '01 February 2019')\n('01 June 2013', '01 July 2013')\n('02 October 2023', '01 May 2024')\n('01 October 2008', '01 August 2009')\n('18 March 2020', '17 April 2020')\n('01 June 2014', '01 January 2016')\n('01 January 2013', '02 May 2023')\n('01 December 2016', '25 November 2019')\n('24 November 2009', '06 December 2009')\n('01 September 2007', '01 May 2009')\n('01 October 2023', '01 March 2024')\n('01 July 2015', '01 October 2016')\n('01 May 2013', '')\n('01 June 2013', '30 July 2020')\n('01 December 2015', '01 December 2022')\n('29 January 2018', '27 September 2019')\n('08 November 2021', '01 June 2026')\n('03 January 2018', '01 July 2020')\n('01 August 2016', '01 January 2017')\n('11 January 2022', '29 September 2023')\n('01 August 2002', '01 September 2004')\n('01 September 2017', '01 September 2019')\n('01 May 2004', '01 May 2025')\n('01 April 2007', '01 April 2010')\n('01 July 2009', '01 November 2009')\n('01 May 2008', '01 June 2012')\n('01 August 2013', '01 July 2014')\n('01 April 2022', '01 October 2023')\n('01 December 2010', '01 April 2011')\n('01 June 2020', '01 September 2020')\n('01 December 2023', '31 December 2028')\n('10 February 2019', '15 February 2019')\n('21 February 2023', '01 June 2024')\n('15 September 2010', '01 September 2025')\n('12 December 2017', '26 November 2019')\n('18 September 2018', '08 September 2022')\n('01 August 2014', '01 December 2016')\n('01 June 1999', '01 May 2007')\n('01 January 2006', '01 December 2014')\n('01 April 2004', '01 September 2006')\n('01 November 2007', '01 September 2008')\n('31 October 2019', '01 July 2021')\n('01 August 2023', '31 December 2025')\n('17 May 2016', '03 August 2016')\n('01 January 2004', '01 December 2006')\n('29 March 2023', '01 January 2026')\n('20 March 2018', '19 November 2018')\n('10 August 2021', '31 December 2022')\n('31 January 2023', '31 August 2025')\n('01 June 2021', '01 October 2021')\n('01 September 2021', '14 October 2021')\n('13 December 2022', '30 June 2026')\n('01 November 2012', '01 October 2013')\n('01 May 2017', '30 March 2018')\n('01 January 2024', '01 December 2025')\n('01 June 2009', '01 September 2011')\n('01 November 2002', '01 August 2005')\n('21 April 2016', '03 July 2017')\n('01 December 2008', '01 June 2009')\n('01 January 2015', '01 May 2016')\n('01 August 2018', '01 November 2019')\n('01 April 2021', '01 November 2021')\n('01 April 2015', '01 September 2015')\n('01 March 2012', '01 March 2015')\n('26 February 2020', '01 October 2021')\n('01 July 2014', '01 November 2016')\n('26 December 2013', '15 January 2015')\n('01 August 2008', '01 September 2009')\n('06 December 2023', '01 October 2026')\n('11 June 2007', '08 October 2007')\n('30 April 2019', '06 June 2021')\n('07 January 2021', '07 January 2024')\n('01 January 2017', '01 March 2021')\n('01 April 1996', '01 June 1997')\n('01 November 2018', '30 June 2022')\n('01 January 2006', '01 November 2013')\n('01 June 2018', '01 July 2020')\n('01 December 1999', '01 February 2009')\n('01 May 2002', '01 March 2005')\n('01 July 2010', '01 November 2013')\n('15 February 2022', '15 December 2022')\n('01 December 2010', '01 October 2011')\n('01 July 2019', '31 January 2026')\n('01 May 2007', '01 March 2013')\n('10 October 2017', '25 September 2019')\n('01 January 2008', '')\n('02 March 2021', '30 June 2024')\n('01 March 2017', '30 December 2019')\n('21 June 2017', '29 September 2020')\n('01 March 2008', '01 May 2012')\n('05 July 2022', '01 December 2023')\n('01 July 2013', '01 September 2014')\n('01 August 2015', '01 August 2025')\n('01 December 2023', '01 March 2025')\n('01 June 2015', '01 November 2017')\n('01 November 2010', '01 December 2014')\n('01 December 2005', '01 December 2007')\n('01 March 2011', '19 August 2016')\n('01 July 2014', '01 July 2015')\n('01 July 2007', '01 March 2014')\n('01 February 2007', '01 December 2011')\n('01 August 2011', '01 December 2012')\n('01 July 2022', '06 June 2023')\n('13 January 2023', '01 November 2027')\n('12 March 2019', '31 January 2020')\n('01 November 2001', '01 May 2002')\n('27 October 2021', '01 December 2021')\n('01 January 2016', '01 June 2019')\n('01 April 2007', '01 December 2008')\n('01 February 2016', '31 August 2018')\n('01 March 2011', '01 January 2012')\n('12 December 2018', '14 June 2019')\n('04 April 2023', '01 August 2027')\n('01 January 2001', '01 March 2002')\n('01 May 2005', '01 June 2009')\n('09 February 2021', '15 February 2024')\n('01 December 2016', '01 March 2019')\n('01 March 2015', '01 July 2018')\n('01 August 2016', '01 July 2018')\n('01 September 2020', '31 March 2021')\n('01 February 2006', '01 August 2008')\n('01 August 2008', '01 December 2013')\n('01 January 2013', '01 July 2013')\n('20 July 2014', '11 August 2015')\n('01 January 2014', '01 December 2015')\n('27 May 2021', '31 December 2023')\n('01 May 2007', '01 April 2015')\n('01 July 2020', '01 December 2021')\n('03 December 2018', '01 November 2019')\n('01 October 2023', '01 December 2027')\n('01 October 2009', '01 April 2010')\n('02 June 2021', '22 July 2021')\n('23 August 2023', '30 June 2027')\n('01 November 2009', '01 May 2011')\n('01 June 2012', '12 August 2014')\n('01 November 1998', '')\n('01 May 2010', '18 April 2016')\n('21 January 2020', '01 June 2022')\n('01 January 2021', '01 June 2021')\n('01 August 2019', '30 December 2021')\n('01 January 2018', '31 December 2019')\n('01 July 2011', '01 January 2015')\n('01 February 2019', '01 March 2023')\n('01 February 2001', '01 August 2002')\n('18 July 2018', '24 June 2019')\n('01 May 2013', '01 July 2015')\n('05 October 2020', '27 July 2021')\n('22 September 2020', '04 May 2023')\n('01 January 2015', '01 June 2015')\n('22 December 2019', '30 December 2021')\n('27 February 2018', '30 March 2020')\n('01 May 2013', '01 April 2017')\n('01 January 2006', '01 January 2009')\n('10 October 2022', '31 December 2024')\n('25 June 2016', '01 September 2016')\n('01 October 2008', '19 November 2015')\n('04 June 2018', '04 June 2019')\n('01 July 2012', '01 July 2013')\n('01 August 2022', '01 May 2025')\n('01 August 2005', '')\n('01 November 2006', '01 May 2011')\n('01 October 2012', '01 October 2016')\n('01 February 2019', '31 December 2027')\n('01 July 2019', '31 December 2024')\n('16 February 2020', '01 October 2020')\n('29 September 2008', '29 June 2017')\n('01 January 2015', '22 June 2021')\n('01 August 2019', '20 August 2021')\n('01 April 2015', '01 May 2021')\n('07 November 2011', '08 March 2012')\n('13 July 2023', '25 June 2025')\n('13 November 2017', '22 June 2021')\n('01 November 2019', '01 December 2021')\n('30 May 2011', '30 September 2011')\n('01 June 2005', '01 June 2009')\n('01 September 2021', '16 August 2022')\n('17 December 2018', '01 September 2021')\n('01 January 2005', '01 December 2009')\n('01 July 2006', '01 September 2009')\n('15 June 2023', '24 December 2024')\n('15 January 2018', '30 May 2018')\n('07 January 2016', '24 July 2019')\n('01 October 2020', '30 September 2022')\n('01 December 2023', '01 September 2032')\n('01 November 2008', '01 December 2015')\n('01 October 2017', '22 February 2023')\n('28 October 2021', '03 December 2021')\n('01 December 2010', '01 December 2012')\n('09 May 2023', '20 January 2024')\n('23 August 2006', '')\n('01 April 2015', '01 July 2015')\n('01 April 2007', '01 January 2010')\n('02 March 2023', '01 March 2026')\n('21 November 2018', '31 December 2022')\n('22 May 2017', '24 June 2020')\n('01 December 2014', '')\n('01 June 2013', '01 November 2018')\n('01 May 2009', '01 July 2009')\n('15 May 2022', '01 December 2023')\n('01 March 2012', '01 April 2013')\n('01 March 2020', '01 January 2021')\n('11 November 2019', '31 December 2022')\n('01 February 2014', '01 April 2014')\n('01 May 2018', '01 March 2019')\n('01 June 2013', '01 July 2013')\n('09 May 2022', '01 September 2022')\n('01 October 2008', '01 October 2009')\n('01 March 2022', '01 January 2023')\n('01 February 2007', '')\n('18 March 2019', '18 March 2024')\n('01 January 2011', '01 March 2011')\n('01 August 2014', '06 May 2015')\n('01 August 2003', '')\n('18 October 2019', '10 August 2021')\n('01 August 2010', '01 December 2014')\n('01 February 2006', '01 December 2012')\n('01 March 2009', '01 November 2013')\n('05 December 2023', '05 December 2026')\n('15 June 2021', '31 December 2023')\n('01 January 2023', '01 December 2027')\n('01 April 2005', '01 June 2007')\n('14 October 2017', '15 February 2019')\n('01 May 2013', '01 June 2013')\n('01 December 2013', '01 December 2015')\n('01 July 2018', '12 December 2021')\n('01 December 2023', '01 August 2024')\n('21 June 2021', '24 September 2021')\n('01 January 2013', '01 December 2019')\n('01 March 2008', '01 January 2009')\n('01 January 2021', '01 June 2022')\n('07 June 2018', '01 March 2025')\n('01 March 2012', '01 August 2015')\n('21 March 2018', '29 November 2023')\n('27 June 2017', '30 July 2018')\n('01 September 2023', '29 February 2024')\n('01 March 2006', '01 December 2008')\n('01 April 2014', '01 June 2017')\n('01 September 2021', '28 February 2024')\n('14 June 2022', '01 October 2024')\n('12 November 2018', '20 August 2020')\n('25 April 2014', '31 December 2015')\n('01 October 2005', '01 December 2007')\n('01 September 2019', '31 August 2020')\n('18 October 2018', '30 December 2023')\n('02 July 2018', '28 May 2020')\n('02 May 2018', '24 October 2018')\n('01 August 2008', '01 December 2010')\n('01 December 2015', '01 May 2018')\n('01 June 2001', '01 October 2004')\n('01 March 2020', '01 July 2020')\n('01 July 2012', '01 June 2014')\n('01 January 2004', '01 July 2004')\n('01 July 2023', '01 July 2028')\n('01 July 2015', '01 April 2016')\n('12 July 2018', '31 December 2023')\n('01 January 2023', '01 December 2025')\n('25 January 2012', '29 January 2015')\n('01 January 2008', '01 September 2013')\n('01 February 2015', '01 July 2015')\n('01 April 2015', '26 June 2020')\n('01 March 2010', '01 May 2013')\n('24 April 2023', '03 December 2024')\n('01 July 2015', '01 November 2016')\n('01 January 2022', '01 December 2022')\n('01 January 2015', '01 April 2015')\n('04 February 2019', '31 August 2019')\n('01 August 2012', '01 January 2013')\n('01 September 2017', '31 August 2018')\n('15 August 2021', '30 June 2022')\n('01 January 2010', '01 December 2017')\n('01 May 2008', '01 February 2014')\n('08 October 2019', '17 July 2021')\n('15 December 2018', '30 March 2019')\n('15 May 2018', '28 February 2023')\n('28 August 2017', '06 July 2019')\n('', '01 January 2007')\n('01 October 2022', '22 December 2022')\n('06 May 2021', '01 March 2026')\n('13 December 2001', '24 March 2009')\n('01 June 2019', '31 December 2024')\n('01 July 2017', '01 July 2020')\n('26 July 2013', '12 August 2014')\n('01 September 2013', '01 December 2015')\n('01 April 2022', '01 December 2022')\n('28 February 2016', '31 December 2016')\n('01 April 2015', '01 December 2015')\n('01 December 2017', '01 April 2019')\n('01 October 2020', '01 December 2023')\n('29 January 2021', '02 December 2025')\n('01 June 2006', '01 April 2008')\n('11 May 2021', '08 July 2022')\n('01 January 2012', '01 April 2015')\n('18 August 2020', '31 October 2020')\n('01 September 2004', '01 December 2006')\n('08 November 2018', '19 April 2019')\n('01 October 2005', '01 September 2008')\n('01 January 2012', '')\n('12 February 2018', '30 March 2020')\n('01 January 2008', '01 October 2013')\n('06 May 2020', '20 September 2021')\n('01 January 2011', '01 May 2012')\n('27 February 2023', '31 October 2024')\n('01 June 2003', '01 October 2006')\n('01 January 2017', '01 January 2023')\n('07 September 2018', '01 September 2021')\n('01 May 2009', '01 February 2013')\n('01 October 2009', '01 December 2009')\n('01 January 2024', '31 December 2027')\n('01 January 2013', '')\n('26 April 2019', '01 September 2021')\n('01 January 2000', '01 April 2006')\n('01 January 2011', '01 December 2016')\n('01 May 2004', '01 August 2005')\n('09 May 2019', '28 February 2024')\n('01 May 2021', '31 December 2024')\n('01 May 2012', '15 May 2020')\n('01 August 2017', '01 December 2017')\n('01 March 2014', '01 July 2014')\n('13 October 2022', '30 March 2023')\n('01 July 2016', '01 February 2019')\n('01 October 2018', '01 December 2019')\n('06 January 2020', '31 January 2024')\n('01 February 2007', '01 July 2011')\n('23 March 2020', '16 June 2020')\n('22 July 2022', '19 August 2025')\n('01 January 2015', '01 January 2016')\n('01 April 2016', '01 December 2021')\n('01 April 2016', '01 December 2016')\n('01 July 2012', '01 October 2014')\n('05 November 2022', '05 June 2023')\n('28 October 2021', '26 July 2023')\n('01 April 2014', '01 July 2015')\n('01 July 1991', '01 April 2001')\n('01 January 2012', '01 December 2012')\n('01 May 2021', '01 December 2023')\n('15 November 2018', '30 June 2022')\n('01 June 2003', '01 February 2006')\n('18 September 2017', '30 November 2019')\n('02 \n\n*** WARNING: max output size exceeded, skipping output. ***\n\n '01 October 2024')\n('01 February 2006', '01 June 2010')\n('01 July 2008', '01 July 2012')\n('01 November 2013', '30 September 2019')\n('01 October 2016', '01 December 2020')\n('15 January 2019', '01 December 2019')\n('01 April 2014', '01 December 2015')\n('01 November 2012', '01 June 2013')\n('01 November 2005', '01 November 2007')\n('01 February 2023', '01 December 2023')\n('01 December 2021', '01 June 2026')\n('01 April 2015', '01 August 2018')\n('16 November 2022', '10 May 2023')\n('20 September 2021', '31 August 2026')\n('01 August 2005', '01 December 2017')\n('23 June 2021', '30 June 2022')\n('01 April 2023', '10 May 2023')\n('01 March 2010', '01 November 2015')\n('29 September 2016', '13 June 2018')\n('11 November 2020', '31 March 2024')\n('10 July 2020', '07 August 2020')\n('01 March 2012', '01 May 2013')\n('05 January 2019', '01 June 2022')\n('01 March 2005', '01 October 2006')\n('', '01 October 1999')\n('25 May 2018', '11 April 2022')\n('16 December 2014', '27 January 2023')\n('01 March 2019', '01 May 2021')\n('01 March 2021', '30 November 2021')\n('01 August 2013', '01 October 2015')\n('01 December 2023', '15 March 2024')\n('01 January 2012', '31 December 2032')\n('13 November 2015', '05 April 2017')\n('01 May 2011', '01 December 2014')\n('01 February 2009', '01 October 2009')\n('01 February 2014', '01 August 2014')\n('01 January 2008', '01 September 2015')\n('20 January 2019', '30 December 2020')\n('18 December 2015', '31 August 2021')\n('01 January 2013', '01 December 2019')\n('01 December 2022', '30 December 2023')\n('01 February 2013', '01 December 2016')\n('01 November 2022', '30 May 2023')\n('23 April 2013', '17 November 2020')\n('01 May 2013', '01 August 2013')\n('01 April 2020', '01 August 2020')\n('17 November 2023', '01 July 2025')\n('19 June 2020', '31 December 2020')\n('01 May 2010', '01 May 2015')\n('01 February 2016', '01 December 2021')\n('01 March 2010', '01 February 2014')\n('01 July 2019', '30 June 2022')\n('01 February 2015', '07 November 2017')\n('27 April 2016', '21 July 2020')\n('14 August 2023', '30 September 2026')\n('01 August 2005', '01 August 2006')\n('01 October 2011', '01 January 2020')\n('09 January 2024', '02 May 2024')\n('', '')\n('01 January 2012', '01 February 2019')\n('23 October 2023', '01 January 2025')\n('01 May 2018', '31 December 2018')\n('28 September 2017', '17 April 2018')\n('03 August 2020', '31 May 2025')\n('01 July 2020', '31 December 2020')\n('01 July 2014', '01 December 2020')\n('01 November 2017', '30 September 2021')\n('01 June 2022', '31 December 2024')\n('16 July 2015', '13 February 2020')\n('01 August 2013', '01 July 2014')\n('31 March 2016', '31 December 2016')\n('01 October 2011', '01 November 2011')\n('20 July 2019', '01 December 2023')\n('01 October 2008', '01 December 2011')\n('01 March 2015', '01 June 2019')\n('01 November 2009', '01 January 2014')\n('01 February 2015', '01 August 2015')\n('19 October 2020', '01 September 2021')\n('19 August 2019', '01 January 2021')\n('01 December 1994', '')\n('02 March 2023', '01 March 2029')\n('27 July 2022', '30 June 2023')\n('16 November 2023', '01 November 2024')\n('01 July 2020', '09 July 2021')\n('01 October 2019', '30 September 2020')\n('01 January 2020', '01 June 2022')\n('01 January 2010', '01 April 2019')\n('14 December 2018', '14 December 2018')\n('15 July 2019', '01 December 2023')\n('01 December 2009', '01 August 2013')\n('07 February 2008', '01 March 2015')\n('01 January 2015', '20 May 2020')\n('01 March 2017', '03 October 2017')\n('01 May 2015', '01 December 2015')\n('01 January 2002', '01 December 2012')\n('01 February 2013', '01 April 2014')\n('20 February 2017', '31 December 2023')\n('01 May 2005', '01 June 2008')\n('25 August 2017', '06 April 2020')\n('02 October 2023', '31 August 2024')\n('01 May 2023', '01 October 2024')\n('01 November 2023', '01 May 2024')\n('15 April 2015', '29 December 2016')\n('02 June 2023', '30 December 2024')\n('01 April 2017', '31 March 2019')\n('01 March 2022', '31 May 2023')\n('15 November 2018', '25 October 2020')\n('07 June 2018', '10 April 2020')\n('30 September 2021', '09 September 2022')\n('01 April 2016', '01 August 2017')\n('01 October 2023', '01 December 2025')\n('01 December 1997', '01 November 2000')\n('15 April 2022', '24 May 2022')\n('01 May 2007', '01 March 2015')\n('01 April 2000', '16 December 2014')\n('01 September 2008', '01 June 2009')\n('12 August 2020', '01 November 2021')\n('01 October 2007', '01 October 2010')\n('01 February 2013', '01 February 2014')\n('01 April 2021', '31 December 2022')\n('28 March 2013', '12 February 2019')\n('01 February 2001', '')\n('01 January 2002', '15 September 2003')\n('19 June 2018', '07 September 2018')\n('01 November 2010', '01 November 2013')\n('31 January 2015', '31 January 2018')\n('01 January 2008', '01 November 2015')\n('01 January 2012', '01 November 2013')\n('01 August 2000', '01 July 2006')\n('26 September 2019', '15 January 2020')\n('06 September 2023', '31 January 2024')\n('01 September 2014', '22 October 2017')\n('01 August 2016', '15 September 2020')\n('01 January 2006', '01 November 2011')\n('01 September 2005', '01 June 2008')\n('01 April 2017', '01 November 2018')\n('31 May 2019', '01 August 2024')\n('28 March 2015', '01 December 2024')\n('01 February 2022', '01 December 2022')\n('20 November 2013', '01 January 2018')\n('19 June 2018', '19 February 2021')\n('01 January 2012', '01 January 2032')\n('01 January 2016', '01 February 2017')\n('01 November 2005', '')\n('01 April 2010', '01 May 2011')\n('01 January 2023', '01 June 2023')\n('01 October 2007', '01 April 2010')\n('01 November 2014', '01 August 2016')\n('01 July 2010', '01 August 2012')\n('01 December 2004', '01 October 2010')\n('01 January 2005', '01 December 2022')\n('01 March 2012', '30 August 2015')\n('01 August 2011', '29 December 2017')\n('01 October 2012', '01 October 2013')\n('07 June 2016', '10 December 2020')\n('15 June 2010', '31 May 2013')\n('01 June 2020', '01 September 2025')\n('04 August 2023', '01 November 2025')\n('01 May 2004', '01 January 2009')\n('08 March 2021', '16 December 2021')\n('01 August 2007', '01 April 2011')\n('27 February 2023', '18 October 2023')\n('01 June 2022', '01 June 2024')\n('01 September 2023', '30 December 2024')\n('29 January 2014', '26 June 2019')\n('01 September 2010', '01 November 2011')\n('10 March 2023', '31 December 2025')\n('28 May 2015', '04 December 2017')\n('01 March 2007', '01 February 2010')\n('01 August 2018', '30 March 2020')\n('18 August 2020', '30 June 2021')\n('01 January 2006', '01 January 2006')\n('24 January 2022', '30 November 2024')\n('01 March 2014', '01 February 2020')\n('01 April 2008', '01 September 2008')\n('01 February 2023', '01 February 2024')\n('03 June 2022', '21 September 2023')\n('10 September 2021', '19 November 2021')\n('01 June 2009', '01 May 2010')\n('01 December 2001', '01 December 2001')\n('01 September 2007', '01 January 2009')\n('01 October 2020', '01 May 2022')\n('01 October 2009', '01 September 2010')\n('29 March 2017', '30 December 2018')\n('01 August 2016', '01 August 2024')\n('01 February 2008', '01 June 2009')\n('01 January 2003', '01 December 2008')\n('01 February 2018', '01 May 2021')\n('01 May 2002', '')\n('10 May 2021', '30 April 2023')\n('01 March 2018', '31 May 2020')\n('01 May 2010', '01 July 2014')\n('01 January 2006', '01 December 2011')\n('02 February 2017', '20 July 2021')\n('07 July 2017', '12 February 2020')\n('15 June 2009', '15 October 2017')\n('25 June 2018', '01 December 2022')\n('01 April 2014', '17 October 2017')\n('01 June 2010', '01 November 2010')\n('01 May 2019', '15 October 2020')\n('01 June 2017', '01 December 2017')\n('01 December 2014', '01 October 2016')\n('01 March 2021', '06 August 2021')\n('01 July 2007', '')\n('01 May 2012', '01 May 2017')\n('', '')\n('01 July 2017', '31 December 2018')\n('22 January 2007', '19 February 2007')\n('01 June 2013', '01 December 2013')\n('27 June 2017', '01 December 2065')\n('08 July 2016', '01 December 2017')\n('07 October 2021', '01 December 2023')\n('29 March 2018', '30 June 2022')\n('01 June 2021', '15 October 2021')\n('05 September 2023', '07 November 2024')\n('18 December 2015', '15 April 2019')\n('01 October 2023', '25 February 2024')\n('', '')\n('28 June 2022', '17 October 2022')\n('13 November 2018', '12 December 2018')\n('01 June 2012', '01 December 2013')\n('01 March 2004', '01 November 2007')\n('01 February 2014', '01 December 2019')\n('01 October 2018', '30 March 2019')\n('01 May 2009', '01 July 2010')\n('19 November 2020', '01 April 2027')\n('26 June 2017', '01 September 2020')\n('01 December 2021', '31 December 2024')\n('01 January 2024', '01 December 2026')\n('14 February 2018', '01 January 2022')\n('25 June 2019', '03 December 2020')\n('01 June 2022', '01 November 2023')\n('01 April 2012', '01 June 2016')\n('29 August 2017', '30 December 2018')\n('01 February 2015', '01 April 2016')\n('19 September 2019', '26 March 2020')\n('10 June 2018', '01 June 2024')\n('09 February 2022', '01 September 2022')\n('31 October 2020', '30 June 2021')\n('01 January 2017', '30 November 2020')\n('01 June 2019', '01 December 2023')\n('01 January 2013', '01 December 2013')\n('26 November 2017', '31 December 2025')\n('01 December 2014', '01 December 2026')\n('29 May 2022', '10 November 2022')\n('01 May 2023', '07 July 2023')\n('30 July 2022', '15 February 2023')\n('10 September 2018', '01 May 2024')\n('01 June 2009', '14 December 2015')\n('01 October 2007', '01 December 2008')\n('01 December 2010', '01 June 2018')\n('01 January 2001', '31 July 2021')\n('20 November 2018', '31 March 2020')\n('01 January 2022', '01 April 2023')\n('02 May 2017', '16 July 2018')\n('01 February 2020', '15 June 2020')\n('01 December 2020', '10 January 2022')\n('02 March 2020', '05 February 2021')\n('01 August 2016', '30 March 2018')\n('01 December 2021', '30 June 2022')\n('01 December 2014', '14 February 2022')\n('01 March 2022', '01 July 2022')\n('01 February 2003', '01 March 2005')\n('01 September 1999', '')\n('04 January 2021', '04 January 2025')\n('01 December 2020', '30 June 2023')\n('25 January 2021', '29 October 2021')\n('01 March 2003', '01 November 2015')\n('29 September 2020', '30 June 2021')\n('01 August 2015', '01 December 2015')\n('16 June 2022', '01 June 2025')\n('01 April 2003', '01 May 2007')\n('01 May 2011', '28 May 2012')\n('01 June 2016', '01 August 2017')\n('20 March 2017', '14 January 2023')\n('01 August 2023', '01 December 2024')\n('01 September 2019', '31 December 2021')\n('01 May 2011', '01 October 2015')\n('', '')\n('07 April 2008', '04 February 2009')\n('21 February 2017', '16 March 2018')\n('10 January 2019', '28 February 2023')\n('01 February 2003', '01 November 2007')\n('07 May 2018', '08 August 2018')\n('01 October 2014', '01 January 2018')\n('01 August 2013', '01 August 2018')\n('01 April 2008', '01 January 2009')\n('01 February 2020', '01 June 2023')\n('02 August 2018', '02 August 2018')\n('01 October 2009', '01 June 2012')\n('09 December 2019', '30 September 2020')\n('22 June 2017', '01 December 2030')\n('01 December 2019', '01 January 2022')\n('02 July 2021', '01 June 2026')\n('03 March 2022', '05 May 2022')\n('02 September 2020', '30 July 2030')\n('01 May 2002', '')\n('01 December 2008', '01 December 2012')\n('04 December 2017', '28 February 2022')\n('12 March 2019', '15 June 2024')\n('26 June 2020', '06 May 2021')\n('24 April 2020', '02 April 2021')\n('07 August 2017', '07 August 2021')\n('01 December 2022', '23 June 2023')\n('01 July 2011', '01 October 2015')\n('22 March 2023', '01 August 2024')\n('01 August 2016', '01 February 2017')\n('01 January 2017', '01 December 2019')\n('08 June 2004', '19 December 2017')\n('26 September 2018', '30 April 2019')\n('01 May 2007', '01 September 2010')\n('27 October 2017', '08 March 2019')\n('30 December 2015', '31 December 2020')\n('01 August 2016', '01 December 2016')\n('01 August 2011', '01 December 2012')\n('05 February 2021', '01 May 2022')\n('01 August 2006', '01 April 2008')\n('11 April 2022', '01 November 2023')\n('01 January 2008', '31 December 2014')\n('01 September 2003', '')\n('04 April 2020', '05 June 2020')\n('06 April 2017', '26 February 2018')\n('01 May 2003', '01 January 2012')\n('22 November 2021', '06 May 2022')\n('09 July 2018', '01 January 2021')\n('23 January 2009', '27 August 2014')\n('01 September 2015', '01 October 2015')\n('01 December 2020', '30 December 2022')\n('01 March 2015', '01 August 2021')\n('05 May 2017', '31 May 2022')\n('01 June 2009', '01 October 2011')\n('05 September 2017', '18 January 2018')\n('01 July 2016', '07 November 2017')\n('01 February 2008', '01 December 2009')\n('22 November 2020', '22 November 2022')\n('', '')\n('01 March 2013', '01 April 2014')\n('19 February 2016', '26 May 2017')\n('01 February 2008', '')\n('04 October 2021', '28 December 2022')\n('09 September 2019', '01 February 2024')\n('03 July 2019', '01 May 2020')\n('02 October 2017', '30 September 2018')\n('01 August 2019', '01 March 2025')\n('01 July 2010', '01 April 2023')\n('01 February 2024', '01 July 2027')\n('17 September 2022', '10 February 2023')\n('06 October 2021', '20 October 2022')\n('01 June 2000', '01 December 2001')\n('01 November 2017', '01 November 2020')\n('', '')\n('01 June 2013', '01 February 2015')\n('01 May 2009', '01 February 2014')\n('15 June 2022', '30 September 2025')\n('06 April 2006', '31 October 2016')\n('19 April 2018', '30 April 2020')\n('14 March 2022', '01 December 2022')\n('01 January 2023', '01 January 2029')\n('01 June 2015', '01 May 2018')\n('01 October 2010', '01 April 2012')\n('07 April 2020', '01 September 2021')\n('21 February 2018', '28 February 2019')\n('01 September 2013', '01 December 2021')\n('07 June 2023', '11 November 2023')\n('01 November 2010', '18 January 2018')\n('22 December 2021', '22 December 2023')\n('01 September 2002', '01 November 2025')\n('19 June 2015', '01 September 2023')\n('01 May 2013', '01 May 2019')\n('01 October 2012', '01 October 2020')\n('01 January 2005', '01 June 2008')\n('31 May 2022', '30 January 2025')\n('01 March 2011', '01 April 2011')\n('01 June 2014', '01 April 2016')\n('27 November 2022', '01 December 2025')\n('13 June 2016', '19 December 2019')\n('05 November 2020', '18 December 2020')\n('01 January 2017', '01 June 2022')\n('07 August 2018', '23 August 2019')\n('01 September 2016', '01 September 2019')\n('01 June 2022', '15 April 2023')\n('10 December 2018', '20 July 2019')\n('01 August 2013', '01 June 2015')\n('01 August 2012', '01 October 2013')\n('01 November 2023', '01 February 2025')\n('15 June 2016', '10 July 2018')\n('01 October 2013', '01 September 2014')\n('01 March 2024', '30 June 2025')\n('13 January 2021', '01 November 2022')\n('10 December 2018', '16 May 2019')\n('01 August 2012', '01 July 2015')\n('01 February 2012', '01 September 2012')\n('01 February 2003', '01 February 2005')\n('10 February 2020', '31 December 2023')\n('01 July 2021', '01 December 2022')\n('28 November 2011', '01 May 2012')\n('01 January 2015', '01 December 2018')\n('01 January 2014', '01 April 2014')\n('07 November 2019', '31 May 2021')\n('31 October 2017', '10 May 2018')\n('22 May 2023', '31 December 2025')\n('01 April 2021', '01 March 2024')\n('02 June 2020', '14 December 2020')\n('04 April 2016', '07 October 2016')\n('01 February 1997', '01 April 2011')\n('01 April 2008', '01 January 2012')\n('01 September 2007', '01 February 2011')\n('01 January 2013', '01 August 2015')\n('01 November 2013', '01 November 2016')\n('02 July 2014', '20 March 2018')\n('01 July 2014', '31 December 2020')\n('31 January 2023', '04 April 2023')\n('27 November 2018', '01 November 2023')\n('23 September 2022', '12 December 2022')\n('01 July 2007', '01 December 2019')\n('06 August 2009', '03 September 2010')\n('01 January 2011', '01 April 2013')\n('03 September 2018', '18 December 2018')\n('01 November 2013', '26 October 2017')\n('01 March 2022', '30 January 2023')\n('02 November 2023', '02 January 2024')\n('01 March 2021', '31 July 2022')\n('20 November 2020', '30 September 2021')\n('01 March 2013', '01 August 2015')\n('01 December 2018', '01 February 2023')\n('05 July 2019', '29 December 2020')\n('01 December 2018', '30 December 2023')\n('21 December 2021', '01 March 2023')\n('05 April 2017', '05 April 2019')\n('01 August 2015', '01 April 2016')\n('01 February 2009', '01 July 2010')\n('01 September 2001', '')\n('20 January 2019', '31 August 2021')\n('01 August 2014', '01 November 2015')\n('01 March 2016', '01 May 2017')\n('01 May 2012', '01 September 2013')\n('19 August 2021', '01 July 2024')\n('01 April 2020', '01 December 2022')\n('05 January 2017', '25 May 2019')\n('01 July 2017', '01 March 2020')\n('01 January 2010', '01 August 2010')\n('25 February 2013', '13 July 2017')\n('01 August 2014', '01 December 2015')\n('01 March 2010', '01 December 2018')\n('23 October 2013', '03 July 2014')\n('01 June 2010', '01 August 2011')\n('01 September 2018', '01 September 2020')\n('15 June 2021', '15 June 2023')\n('25 November 2019', '03 October 2022')\n('01 December 2006', '01 July 2009')\n('01 September 2014', '01 October 2014')\n('01 May 2015', '01 June 2022')\n('01 October 2017', '30 August 2018')\n('01 September 2016', '01 September 2017')\n('11 June 2003', '20 June 2006')\n('01 October 2016', '01 August 2020')\n('15 June 2020', '15 April 2021')\n('15 September 2023', '25 November 2023')\n('01 February 2007', '01 September 2012')\n('31 August 2019', '31 March 2022')\n('01 December 2021', '01 July 2023')\n('25 November 2014', '11 March 2021')\n('19 May 2020', '31 December 2021')\n('01 September 2022', '31 January 2025')\n('01 May 2015', '01 June 2021')\n('01 June 2022', '01 February 2023')\n('15 May 2021', '25 January 2022')\n('01 August 2010', '01 March 2013')\n('19 May 2014', '31 May 2026')\n('01 March 2017', '01 February 2018')\n('', '01 February 1990')\n('28 January 2020', '31 October 2024')\n('15 December 2018', '30 December 2019')\n('01 January 2012', '01 December 2025')\n('17 March 2021', '01 August 2022')\n('21 March 2019', '26 February 2025')\n('20 March 2019', '20 June 2024')\n('01 April 2010', '01 April 2017')\n('01 January 2018', '31 March 2022')\n('12 June 2017', '24 June 2021')\n('03 February 2020', '01 February 2021')\n('16 March 2021', '15 November 2022')\n('01 June 2020', '01 February 2021')\n('21 November 2022', '01 January 2027')\n('01 March 2011', '01 January 2012')\n('16 April 2019', '01 August 2023')\n('01 July 2010', '01 September 2011')\n('28 October 2012', '11 February 2019')\n('01 April 2010', '01 October 2010')\n('01 March 2015', '01 January 2016')\n('01 February 2011', '01 September 2016')\n('01 December 2011', '01 April 2016')\n('01 May 2022', '01 May 2024')\n('01 September 2010', '01 January 2013')\n('01 May 2023', '01 September 2024')\n('01 May 2015', '01 May 2015')\n('01 October 2006', '01 December 2007')\n('01 August 2012', '23 May 2018')\n('01 August 2004', '01 June 2009')\n('17 November 2021', '08 December 2025')\n('01 March 2014', '01 December 2019')\n('25 October 2023', '01 October 2025')\n('20 October 2015', '01 October 2017')\n('01 October 2004', '01 February 2006')\n('01 February 2015', '01 February 2016')\n('11 May 2007', '31 December 2008')\n('01 January 2014', '01 December 2017')\n('01 June 2002', '01 April 2008')\n('01 September 2018', '01 July 2023')\n('01 July 2015', '30 December 2016')\n('06 May 2014', '01 March 2019')\n('20 March 2019', '24 April 2019')\n('01 February 2018', '01 January 2020')\n('01 January 2010', '01 June 2013')\n('01 November 2023', '30 December 2025')\n('07 December 2020', '01 July 2022')\n('01 May 2010', '01 June 2013')\n('28 October 2017', '21 December 2018')\n('01 October 2008', '01 December 2008')\n('01 July 2000', '01 October 2000')\n('10 February 2020', '10 February 2022')\n('23 March 2021', '04 February 2022')\n('01 May 2010', '01 January 2020')\n('01 January 2004', '01 August 2004')\n('01 April 2013', '01 November 2014')\n('01 April 2014', '01 September 2014')\n('01 April 2022', '01 March 2023')\n('17 May 2022', '01 June 2023')\n('01 November 2012', '19 September 2019')\n('01 March 2019', '01 June 2028')\n('01 September 2001', '01 July 2020')\n('01 January 1997', '01 March 1999')\n('31 January 2024', '01 June 2025')\n('01 March 2008', '01 October 2010')\n('18 January 2022', '31 March 2023')\n('01 November 2018', '05 June 2019')\n('01 November 2023', '01 December 2025')\n('01 September 2009', '01 December 2011')\n('01 December 2003', '01 May 2010')\n('08 August 2018', '01 February 2021')\n('11 May 2022', '31 August 2025')\n('01 June 2011', '01 January 2022')\n('11 April 2022', '11 July 2024')\n('01 April 2014', '05 August 2016')\n('01 December 2016', '31 October 2020')\n('26 January 2016', '31 August 2016')\n('01 June 2014', '01 September 2015')\n('27 January 2021', '17 June 2021')\n('01 July 2011', '01 April 2013')\n('01 July 2011', '01 July 2012')\n('11 February 2020', '15 September 2020')\n('01 June 2006', '01 December 2009')\n('01 February 2017', '07 May 2018')\n('01 July 2015', '30 December 2019')\n('01 December 2021', '15 May 2028')\n('18 January 2022', '18 October 2023')\n('01 January 2014', '01 January 2016')\n('01 October 2013', '')\n('04 April 2022', '01 December 2024')\n('01 July 2012', '01 April 2018')\n('01 January 2016', '01 March 2035')\n('01 September 2020', '01 April 2021')\n('01 July 1998', '01 June 1999')\n('01 January 2016', '01 December 2017')\n('21 January 2016', '31 August 2017')\n('', '')\n('01 January 2012', '01 March 2014')\n('01 September 2007', '01 September 2013')\n('01 May 2016', '01 December 2018')\n('01 August 2020', '09 April 2023')\n('03 February 2020', '22 June 2023')\n('20 April 2015', '30 December 2020')\n('01 December 2023', '01 February 2027')\n('20 March 2017', '25 November 2019')\n('01 January 2012', '31 December 2020')\n('19 November 2015', '09 August 2017')\n('09 June 2015', '09 November 2022')\n('01 December 2009', '01 January 2011')\n('01 March 2016', '01 June 2017')\n('01 September 2009', '01 September 2013')\n('11 August 2016', '22 December 2017')\n('20 November 2015', '20 December 2018')\n('01 July 2003', '01 May 2004')\n('01 March 2012', '01 April 2013')\n('07 February 2017', '08 June 2018')\n('07 June 2021', '21 February 2022')\n('06 November 2021', '30 December 2023')\n('31 January 2022', '24 February 2023')\n('01 August 2016', '01 April 2024')\n('06 November 2017', '01 September 2020')\n('20 April 2021', '30 September 2022')\n('20 December 2022', '30 October 2023')\n('01 January 2021', '01 November 2021')\n('01 August 2006', '01 December 2008')\n('01 September 2014', '01 September 2016')\n('29 January 2021', '29 January 2024')\n('01 October 2015', '28 February 2021')\n('12 July 2018', '01 December 2021')\n('01 September 2009', '01 September 2009')\n('01 February 2009', '01 March 2012')\n('19 June 2018', '30 June 2022')\n('30 April 2019', '12 November 2021')\n('01 March 2019', '24 April 2019')\n('01 April 2006', '01 August 2006')\n('01 April 2013', '01 March 2014')\n('01 November 2012', '01 December 2020')\n('01 February 2009', '29 November 2016')\n('04 December 2023', '29 March 2024')\n('01 August 2014', '01 December 2019')\n('01 January 2008', '01 November 2008')\n('01 November 2003', '01 November 2007')\n('12 May 2021', '10 August 2022')\n('01 July 2010', '01 June 2012')\n('26 July 2018', '30 June 2023')\n('01 March 2015', '01 April 2017')\n('24 May 2022', '01 March 2027')\n('08 August 2020', '06 August 2021')\n('22 July 2018', '01 December 2023')\n('22 July 2023', '31 December 2024')\n('24 October 2018', '31 December 2021')\n('01 September 2013', '01 December 2013')\n('26 August 1996', '25 June 2019')\n('01 September 2010', '01 October 2013')\n('30 March 2020', '30 June 2021')\n('01 May 2009', '01 November 2009')\n('22 January 2024', '31 December 2024')\n('28 July 2022', '01 June 2024')\n('01 January 2004', '01 July 2008')\n('01 January 2007', '01 January 2008')\n('11 October 2021', '11 October 2023')\n('11 April 2019', '22 March 2021')\n('01 March 2011', '01 March 2014')\n('01 January 2016', '01 January 2019')\n('01 July 2011', '01 December 2012')\n('01 May 2014', '01 March 2018')\n('01 January 2015', '01 March 2016')\n('11 January 2020', '30 March 2021')\n('12 June 2023', '20 March 2024')\n('01 April 2010', '01 September 2017')\n('01 January 2009', '01 July 2009')\n('10 January 2022', '30 October 2028')\n('01 January 2024', '01 January 2027')\n('10 December 2019', '28 February 2020')\n('01 March 2006', '01 September 2008')\n('01 February 2017', '01 April 2018')\n('01 June 2023', '01 January 2024')\n('13 April 2022', '23 June 2022')\n('25 September 2017', '10 December 2017')\n('14 January 2019', '31 March 2021')\n('01 February 2014', '01 February 2015')\n('20 November 2021', '01 August 2022')\n('15 September 2016', '12 May 2022')\n('01 April 2021', '30 June 2023')\n('01 April 2017', '28 February 2020')\n('01 November 2008', '01 June 2011')\n('01 March 2009', '01 December 2009')\n('22 April 2022', '01 December 2022')\n('01 April 2004', '01 December 2009')\n('01 January 2024', '01 March 2027')\n('01 September 2019', '01 December 2020')\n('15 October 2019', '01 January 2022')\n('08 October 2010', '13 June 2011')\n('06 December 2022', '01 October 2023')\n('07 September 2022', '31 December 2024')\n('07 March 2023', '01 December 2025')\n('01 August 2015', '01 October 2015')\n('01 March 2008', '01 August 2010')\n('02 July 2018', '25 May 2022')\n('01 May 2003', '01 May 2004')\n('01 January 2016', '04 May 2017')\n('18 October 2022', '30 December 2024')\n('11 September 2017', '31 March 2019')\n('01 March 2021', '01 June 2021')\n('17 May 2023', '01 September 2026')\n('22 February 2018', '30 September 2020')\n('01 November 2005', '01 July 2017')\n"
     ]
    }
   ],
   "source": [
    "#Function to clean the date and convert to a consistent date format\n",
    "\n",
    "from datetime import datetime\n",
    "\n",
    "# Define a function to clean date data\n",
    "def clean_date(date_str):\n",
    "    if not date_str:\n",
    "        return \"\"\n",
    "        \n",
    "    formats = ['%d %B %Y', '%Y %m %d', '%d %m %Y', '%Y-%m']\n",
    "    for fmt in formats:\n",
    "        try:\n",
    "            return datetime.strptime(date_str, fmt).strftime('%d %B %Y')\n",
    "        except ValueError:\n",
    "            pass\n",
    "    return date_str\n",
    "\n",
    "# Clean the date data in the RDD\n",
    "cleaned_dates = rdd3.map(lambda x: (clean_date(x[0]), clean_date(x[1])))\n",
    "\n",
    "# Collect and print the cleaned date data\n",
    "for date_pair in cleaned_dates.collect():\n",
    "    print(date_pair)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4c018a95-cacf-4215-8901-c99327875327",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[41]: [['NCT Number ',\n  ' Study Title ',\n  ' Acronym ',\n  ' Study Status ',\n  ' Conditions ',\n  ' Interventions ',\n  ' Sponsor ',\n  ' Collaborators ',\n  ' Enrollment ',\n  ' Funder Type ',\n  ' Study Type ',\n  ' Study Design',\n  'Start Date',\n  'Completion Date'],\n ['\"NCT03630471 ',\n  ' Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India ',\n  ' PRIDE ',\n  ' COMPLETED ',\n  ' Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) ',\n  \" BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care \",\n  ' Sangath ',\n  ' Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine ',\n  ' 250 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR',\n  ' OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\"',\n  '20 August 2018',\n  '28 February 2019'],\n ['\"NCT05992571 ',\n  ' Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity ',\n  ' RECRUITING ',\n  ' Cerebrovascular Function|Cognition ',\n  ' OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB ',\n  ' McMaster University ',\n  \" Alzheimer's Society of Brant, Haldimand Norfolk, Hamilton Halton \",\n  ' 30 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT',\n  ' INVESTIGATOR',\n  ' OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\"',\n  '25 October 2023',\n  '2024-08'],\n ['NCT01854671 ',\n  ' Investigating the Effect of a Prenatal Family Planning Counseling Intervention Led by Community Health Workers on Postpartum Contraceptive Use Among Women in the West Bank ',\n  ' COMPLETED ',\n  ' Focus: Contraceptive Counseling|Focus: Postpartum Contraception ',\n  ' OTHER: family planning counseling let by community health workers ',\n  ' Planned Parenthood League of Massachusetts ',\n  ' Society for Family Planning Research Fund ',\n  ' 176 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: ',\n  '2013-08',\n  '2014-12'],\n ['NCT03820271 ',\n  ' New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation ',\n  ' SUPERMELD ',\n  ' RECRUITING ',\n  ' Decompensated Cirrhosis|Liver Transplantation ',\n  ' OTHER: SuperMELD ',\n  ' Assistance Publique - Hôpitaux de Paris ',\n  ' 500 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER',\n  '01 October 2020',\n  '01 October 2023'],\n ['NCT01160471 ',\n  ' Noninvasive Imaging of Heart Failure: A Pilot Study ',\n  ' COMPLETED ',\n  ' MRI|Acquired Heart Disease|Myocardial Fibrosis ',\n  ' National Institutes of Health Clinical Center (CC) ',\n  ' 62 ',\n  ' NIH ',\n  ' OBSERVATIONAL ',\n  ' Observational Model: |Time Perspective: p',\n  '01 July 2010',\n  '30 October 2019'],\n ['\"NCT04338971 ',\n  ' Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes ',\n  ' COMPLETED ',\n  ' Stroke ',\n  ' DEVICE: IpsiHand Therapy ',\n  ' Neurolutions, Inc. ',\n  ' 24 ',\n  ' INDUSTRY ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\"',\n  '05 May 2017',\n  '09 October 2020'],\n ['\"NCT05843071 ',\n  ' PMCF Study to Evaluate Performance and Safety of \"\"NASAL SPRAYS \"\" Used to Relieve Nasal Congestion and Dryness ',\n  ' RECRUITING ',\n  ' Nasal Congestion|Nasal Dryness ',\n  ' DEVICE: Nasal sprays with sea salts ',\n  ' C.O.C. Farmaceutici S.r.l. ',\n  ' 105 ',\n  ' INDUSTRY ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\"',\n  '01 September 2022',\n  '15 June 2023'],\n ['NCT06174571 ',\n  ' Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer. ',\n  ' NOT_YET_RECRUITING ',\n  ' Breast Cancer ',\n  ' Assiut University ',\n  ' 90 ',\n  ' OTHER ',\n  ' OBSERVATIONAL ',\n  ' Observational Model: |Time Perspective: p',\n  '01 February 2024',\n  '01 March 2026'],\n ['NCT03700671 ',\n  ' High Intensity Interval Training Versus Circuit Training ',\n  ' COMPLETED ',\n  ' High Intensity Interval Training ',\n  ' OTHER: High intensity interval training|OTHER: Circuit training ',\n  ' University of Central Lancashire ',\n  ' University of Hull ',\n  ' 42 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE',\n  '11 May 2016',\n  '13 December 2017']]"
     ]
    }
   ],
   "source": [
    "## Create an rdd excluding the 'Start\" and 'Completion\" date\n",
    "\n",
    "rdd5 = rdd2.map(lambda x: x[:11])\n",
    "\n",
    "rdd2.take(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "67fb011a-abc5-42ca-9ebc-032ba3ffe1a1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[23]: [['NCT Number ',\n  ' Study Title ',\n  ' Acronym ',\n  ' Study Status ',\n  ' Conditions ',\n  ' Interventions ',\n  ' Sponsor ',\n  ' Collaborators ',\n  ' Enrollment ',\n  ' Funder Type ',\n  ' Study Type ',\n  ' Study Design',\n  'Start Date',\n  'Completion Date'],\n ['\"NCT03630471 ',\n  ' Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India ',\n  ' PRIDE ',\n  ' COMPLETED ',\n  ' Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) ',\n  \" BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care \",\n  ' Sangath ',\n  ' Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine ',\n  ' 250 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR',\n  '20 August 2018',\n  '28 February 2019'],\n ['\"NCT05992571 ',\n  ' Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity ',\n  ' RECRUITING ',\n  ' Cerebrovascular Function|Cognition ',\n  ' OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB ',\n  ' McMaster University ',\n  \" Alzheimer's Society of Brant, Haldimand Norfolk, Hamilton Halton \",\n  ' 30 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT',\n  ' INVESTIGATOR',\n  '25 October 2023',\n  '01 August 2024'],\n ['NCT01854671 ',\n  ' Investigating the Effect of a Prenatal Family Planning Counseling Intervention Led by Community Health Workers on Postpartum Contraceptive Use Among Women in the West Bank ',\n  ' COMPLETED ',\n  ' Focus: Contraceptive Counseling|Focus: Postpartum Contraception ',\n  ' OTHER: family planning counseling let by community health workers ',\n  ' Planned Parenthood League of Massachusetts ',\n  ' Society for Family Planning Research Fund ',\n  ' 176 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: ',\n  '2013-08',\n  '01 August 2013',\n  '01 December 2014'],\n ['NCT03820271 ',\n  ' New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation ',\n  ' SUPERMELD ',\n  ' RECRUITING ',\n  ' Decompensated Cirrhosis|Liver Transplantation ',\n  ' OTHER: SuperMELD ',\n  ' Assistance Publique - Hôpitaux de Paris ',\n  ' 500 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER',\n  '01 October 2020',\n  '01 October 2020',\n  '01 October 2023'],\n ['NCT01160471 ',\n  ' Noninvasive Imaging of Heart Failure: A Pilot Study ',\n  ' COMPLETED ',\n  ' MRI|Acquired Heart Disease|Myocardial Fibrosis ',\n  ' National Institutes of Health Clinical Center (CC) ',\n  ' 62 ',\n  ' NIH ',\n  ' OBSERVATIONAL ',\n  ' Observational Model: |Time Perspective: p',\n  '01 July 2010',\n  '30 October 2019',\n  '01 July 2010',\n  '30 October 2019'],\n ['\"NCT04338971 ',\n  ' Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes ',\n  ' COMPLETED ',\n  ' Stroke ',\n  ' DEVICE: IpsiHand Therapy ',\n  ' Neurolutions, Inc. ',\n  ' 24 ',\n  ' INDUSTRY ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\"',\n  '05 May 2017',\n  '09 October 2020',\n  '05 May 2017',\n  '09 October 2020'],\n ['\"NCT05843071 ',\n  ' PMCF Study to Evaluate Performance and Safety of \"\"NASAL SPRAYS \"\" Used to Relieve Nasal Congestion and Dryness ',\n  ' RECRUITING ',\n  ' Nasal Congestion|Nasal Dryness ',\n  ' DEVICE: Nasal sprays with sea salts ',\n  ' C.O.C. Farmaceutici S.r.l. ',\n  ' 105 ',\n  ' INDUSTRY ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\"',\n  '01 September 2022',\n  '15 June 2023',\n  '01 September 2022',\n  '15 June 2023'],\n ['NCT06174571 ',\n  ' Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer. ',\n  ' NOT_YET_RECRUITING ',\n  ' Breast Cancer ',\n  ' Assiut University ',\n  ' 90 ',\n  ' OTHER ',\n  ' OBSERVATIONAL ',\n  ' Observational Model: |Time Perspective: p',\n  '01 February 2024',\n  '01 March 2026',\n  '01 February 2024',\n  '01 March 2026'],\n ['NCT03700671 ',\n  ' High Intensity Interval Training Versus Circuit Training ',\n  ' COMPLETED ',\n  ' High Intensity Interval Training ',\n  ' OTHER: High intensity interval training|OTHER: Circuit training ',\n  ' University of Central Lancashire ',\n  ' University of Hull ',\n  ' 42 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE',\n  '11 May 2016',\n  '11 May 2016',\n  '13 December 2017'],\n ['\"NCT02633371 ',\n  ' A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults ',\n  ' COMPLETED ',\n  ' Hyperhidrosis ',\n  ' DRUG: Oxybutynin 3% gel ',\n  ' University of Colorado, Denver ',\n  ' Society for Pediatric Dermatology ',\n  ' 10 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\"',\n  '2016-02',\n  '01 February 2016',\n  '01 May 2017'],\n ['\"NCT03400371 ',\n  ' Biology of Juvenile Myoclonic Epilepsy ',\n  ' BIOJUME ',\n  ' RECRUITING ',\n  ' Juvenile Myoclonic Epilepsy ',\n  ' OTHER: Blood draw|OTHER: Existing samples ',\n  \" King's College London \",\n  \" King's College Hospital NHS Trust|Charles University, Czech Republic|Hopital Universitaire Robert-Debre|Vestre Viken Hospital Trust|The Hospital for Sick Children|Cardiff University|Odense University Hospital \",\n  ' 1000 ',\n  ' OTHER ',\n  ' OBSERVATIONAL ',\n  ' Observational Model: |Time Perspective: p\"',\n  '13 July 2017',\n  '30 June 2026'],\n ['\"NCT00221871 ',\n  ' Proper Dosage of Ketamine in Intravenous Regional Anesthesia ',\n  ' UNKNOWN ',\n  ' Pain. ',\n  ' DRUG: Different dosages of Ketamine ',\n  ' University Health Network, Toronto ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT\"',\n  '2004-01',\n  '2005-01',\n  '01 January 2004',\n  '01 January 2005'],\n ['\"NCT05664971 ',\n  ' JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer ',\n  ' RECRUITING ',\n  ' Advanced Lung Cancer ',\n  ' BIOLOGICAL: Recombinant humanized anti-BTLA monoclonal antibody (JS004) injection|BIOLOGICAL: Toripalimab|DRUG: Docetaxel|DRUG: Pemetrexed|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Etoposide ',\n  ' Shanghai Junshi Bioscience Co., Ltd. ',\n  ' 240 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\"',\n  '09 February 2023',\n  '17 November 2024',\n  '09 February 2023',\n  '17 November 2024'],\n ['NCT02383771 ',\n  ' Reversal of the Anti-platelet Effects of Ticagrelor ',\n  ' REVERSAL ',\n  ' COMPLETED ',\n  ' Coronary Artery Disease ',\n  ' DRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor ',\n  ' The First Affiliated Hospital with Nanjing Medical University ',\n  ' National Natural Science Foundation of China ',\n  ' 64 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT',\n  '01 March 2015',\n  '01 December 2016'],\n ['\"NCT01897571 ',\n  ' Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL ',\n  ' COMPLETED ',\n  ' B-cell Lymphomas (Phase 1)|Advanced Solid Tumors (Phase 1)|Diffuse Large B-cell Lymphoma (Phase 2)|Follicular Lymphoma (Phase 2)|Transformed Follicular Lymphoma|Primary Mediastinal Large B-Cell Lymphoma ',\n  ' DRUG: Tazemetostat|DRUG: Prednisolone|DRUG: Tazemetostat ',\n  ' Epizyme, Inc. ',\n  ' 400 ',\n  ' INDUSTRY ',\n  ' INTERVENTIONAL ',\n  ' Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\"',\n  '13 June 2013',\n  '02 November 2021',\n  '13 June 2013',\n  '02 November 2021'],\n ['\"NCT03928171 ',\n  ' The Effect of Intra-abdominal Pressure on Peritoneal Perfusion During Laparoscopic Colorectal Surgery ',\n  ' PERFUSION ',\n  ' COMPLETED ',\n  ' Laparoscopic Surgery|Pneumoperitoneum ',\n  ' OTHER: Intra-abdominal pressure during laparoscopy ',\n  ' Radboud University Medical Center ',\n  ' 30 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT',\n  ' CARE_PROVIDER',\n  '13 June 2018',\n  '24 December 2018'],\n ['NCT00848471 ',\n  ' Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems) ',\n  ' Protocol Quark ',\n  ' UNKNOWN ',\n  ' Healthy|Obesity ',\n  ' DEVICE: Quark RMR|DEVICE: Deltatrac II ',\n  ' Hospices Civils de Lyon ',\n  ' Centre de Recherche en Nutrition Humaine Rhone-Alpe ',\n  ' 30 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH',\n  '01 January 2009',\n  '01 December 2009'],\n ['\"NCT01189071 ',\n  ' Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain ',\n  ' TERMINATED ',\n  ' Overactive Bladder|Renal Colic|Pain, Postoperative ',\n  ' DRUG: Darifenacin ',\n  ' University of Missouri-Columbia ',\n  ' 3 ',\n  ' OTHER ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT',\n  ' INVESTIGATOR)|Primary Purpose: TREATMENT\"',\n  '2009-08',\n  '01 August 2009',\n  '01 July 2011'],\n ['\"NCT01005771 ',\n  ' Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions ',\n  ' COMPLETED ',\n  ' Secondarily Infected Traumatic Lesions ',\n  ' DRUG: GF-001001-00|DRUG: Placebo ',\n  ' Ferrer Internacional S.A. ',\n  ' 200 ',\n  ' INDUSTRY ',\n  ' INTERVENTIONAL ',\n  ' Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT',\n  ' INVESTIGATOR)|Primary Purpose: TREATMENT\"',\n  '2009-09',\n  '01 September 2009',\n  '01 March 2010']]"
     ]
    }
   ],
   "source": [
    "#Zip RDDs together and flatten the rdd\n",
    "\n",
    "# Zip the RDDs together column-wise\n",
    "zipped_rdd = rdd5.zip(cleaned_dates)\n",
    "\n",
    "# Add start and completion date columns to each tuple in the zipped RDD as a tuple\n",
    "flattened_rdd = zipped_rdd.map(lambda x: x[0] + list(x[1]))\n",
    "\n",
    "# Output the result\n",
    "flattened_rdd.take(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "28fa12a4-8c57-42ee-aea0-d8fea24a093d",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "Exploratory data analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "cc8f3262-e45e-4b4d-96b0-1845b85ee0df",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Column 'NCT Number ': 478698\nColumn ' Interventions ': 477801\nColumn ' Sponsor ': 477801\nColumn ' Collaborators ': 477775\nColumn ' Study Design': 467588\nColumn ' Study Title ': 478698\nColumn ' Study Status ': 478698\nColumn ' Funder Type ': 475705\nColumn ' Study Type ': 472627\nColumn 'Completion Date': 438184\nColumn ' Acronym ': 478697\nColumn ' Conditions ': 477815\nColumn ' Enrollment ': 477049\nColumn 'Start Date': 471145\n"
     ]
    }
   ],
   "source": [
    "#Check the count of values by column header\n",
    "\n",
    "# Extract the header row\n",
    "header_row = flattened_rdd.first()\n",
    "\n",
    "# Count the total number of non-empty values for each column\n",
    "column_counts = flattened_rdd.flatMap(lambda row: zip(header_row, row)) \\\n",
    "                   .filter(lambda x: x[1] != '') \\\n",
    "                   .map(lambda x: (x[0], 1)) \\\n",
    "                   .reduceByKey(lambda a, b: a + b) \\\n",
    "                   .collect()\n",
    "\n",
    "# Output the column counts\n",
    "for column, count in column_counts:\n",
    "    print(f\"Column '{column}': {count}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "bc49a405-2b5e-4097-bcb3-a7e99adba974",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Column ' Study Design': 10187\nColumn ' Interventions ': 882\nColumn ' Sponsor ': 882\nColumn ' Collaborators ': 908\nColumn ' Study Type ': 5174\nColumn 'Completion Date': 12204\nColumn ' Funder Type ': 2096\nColumn 'Start Date': 5182\nColumn ' Enrollment ': 752\nColumn ' Conditions ': 883\nColumn ' Acronym ': 1\n"
     ]
    }
   ],
   "source": [
    "#Likewise, Check missing values by column headers\n",
    "\n",
    "# Extract the header row\n",
    "header_row = flattened_rdd.first()\n",
    "\n",
    "# Count the total number of empty values for each column\n",
    "empty_counts = flattened_rdd.flatMap(lambda row: zip(header_row, row)) \\\n",
    "                  .filter(lambda x: x[1] == '') \\\n",
    "                  .map(lambda x: (x[0], 1)) \\\n",
    "                  .reduceByKey(lambda a, b: a + b) \\\n",
    "                  .collect()\n",
    "\n",
    "# Output the column counts\n",
    "for column, count in empty_counts:\n",
    "    print(f\"Column '{column}': {count}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "31ff65ce-fd70-4ce3-aef6-4e4d7a4e52e8",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[135]: ['NCT01160471 \\\\t Noninvasive Imaging of Heart Failure: A Pilot Study \\\\t COMPLETED \\\\t MRI|Acquired Heart Disease|Myocardial Fibrosis \\\\t National Institutes of Health Clinical Center (CC) \\\\t 62 \\\\t NIH \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 July 2010,30 October 2019',\n '\"NCT04338971 \\\\t Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes \\\\t COMPLETED \\\\t Stroke \\\\t DEVICE: IpsiHand Therapy \\\\t Neurolutions, Inc. \\\\t 24 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",05 May 2017,09 October 2020',\n '\"NCT05843071 \\\\t PMCF Study to Evaluate Performance and Safety of \"\"NASAL SPRAYS \"\" Used to Relieve Nasal Congestion and Dryness \\\\t RECRUITING \\\\t Nasal Congestion|Nasal Dryness \\\\t DEVICE: Nasal sprays with sea salts \\\\t C.O.C. Farmaceutici S.r.l. \\\\t 105 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",01 September 2022,15 June 2023',\n 'NCT06174571 \\\\t Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer. \\\\t NOT_YET_RECRUITING \\\\t Breast Cancer \\\\t Assiut University \\\\t 90 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 February 2024,01 March 2026',\n '\"NCT00221871 \\\\t Proper Dosage of Ketamine in Intravenous Regional Anesthesia \\\\t UNKNOWN \\\\t Pain. \\\\t DRUG: Different dosages of Ketamine \\\\t University Health Network, Toronto \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT\",2004-01,2005-01',\n '\"NCT05664971 \\\\t JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer \\\\t RECRUITING \\\\t Advanced Lung Cancer \\\\t BIOLOGICAL: Recombinant humanized anti-BTLA monoclonal antibody (JS004) injection|BIOLOGICAL: Toripalimab|DRUG: Docetaxel|DRUG: Pemetrexed|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Etoposide \\\\t Shanghai Junshi Bioscience Co., Ltd. \\\\t 240 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",09 February 2023,17 November 2024',\n '\"NCT01897571 \\\\t Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL \\\\t COMPLETED \\\\t B-cell Lymphomas (Phase 1)|Advanced Solid Tumors (Phase 1)|Diffuse Large B-cell Lymphoma (Phase 2)|Follicular Lymphoma (Phase 2)|Transformed Follicular Lymphoma|Primary Mediastinal Large B-Cell Lymphoma \\\\t DRUG: Tazemetostat|DRUG: Prednisolone|DRUG: Tazemetostat \\\\t Epizyme, Inc. \\\\t 400 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",13 June 2013,02 November 2021',\n '\"NCT01189071 \\\\t Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain \\\\t TERMINATED \\\\t Overactive Bladder|Renal Colic|Pain, Postoperative \\\\t DRUG: Darifenacin \\\\t University of Missouri-Columbia \\\\t 3 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2009-08,2011-07',\n '\"NCT01005771 \\\\t Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions \\\\t COMPLETED \\\\t Secondarily Infected Traumatic Lesions \\\\t DRUG: GF-001001-00|DRUG: Placebo \\\\t Ferrer Internacional S.A. \\\\t 200 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2009-09,2010-03',\n 'NCT05913271 \\\\t Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure \\\\t RECRUITING \\\\t Heart Failure|Levosimendan|Efficacy|Safety \\\\t Yi Han \\\\t Qianfoshan Hospital \\\\t 352 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,30 May 2023,30 May 2025',\n '\"NCT04340271 \\\\t The Clinical Utility of Extracorporeal Shock Wave Therapy on Burns \\\\t COMPLETED \\\\t Burn Scar \\\\t OTHER: Extracorporeal shock wave therapy|OTHER: conventional occupational therapy \\\\t Hangang Sacred Heart Hospital \\\\t 48 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",15 April 2020,31 May 2020',\n 'NCT05966571 \\\\t Ovarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS) \\\\t RECRUITING \\\\t Polycystic Ovary Syndrome \\\\t PROCEDURE: Ovary Biopsie \\\\t Albanian University \\\\t 50 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 July 2023,01 December 2024',\n 'NCT03490071 \\\\t Long-term Follow up of Patients With Longstanding Hip and Groin Pain \\\\t Lund LHGP \\\\t RECRUITING \\\\t Hip Pain Chronic \\\\t Lund University \\\\t 81 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 January 2018,31 December 2024',\n 'NCT05801471 \\\\t Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression \\\\t RECRUITING \\\\t Glaucoma \\\\t Centervue SpA \\\\t 200 \\\\t INDUSTRY \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,06 May 2022,06 November 2025',\n '\"NCT00266071 \\\\t Study of the Cutaneous Microcirculation in Elderly People \\\\t UNKNOWN \\\\t Elderly People \\\\t BEHAVIORAL: Cutaneous response \\\\t University Hospital, Angers \\\\t OTHER_GOV \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",2005-12,',\n 'NCT03097471 \\\\t BPK-S Integration (Ceramic) Post Market Clinical Follow-Up \\\\t UNKNOWN \\\\t Restoration if Knee Joint Function \\\\t DEVICE: BPK-S Integration (Ceramic) \\\\t Klemens Trieb \\\\t 40 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2011-05,2018-03',\n 'NCT01334671 \\\\t The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI \\\\t UNKNOWN \\\\t ST-elevation Myocardial Infarction|(STEMI) \\\\t DRUG: Atorvastatin \\\\t General Hospital of Chinese Armed Police Forces \\\\t 150 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2011-02,2013-03',\n 'NCT00553371 \\\\t Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer \\\\t UNKNOWN \\\\t Testicular Germ Cell Tumor \\\\t OTHER: biomarker analysis|PROCEDURE: computed tomography \\\\t Royal Marsden NHS Foundation Trust \\\\t 300 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2006-04,',\n 'NCT01993771 \\\\t Monitoring of Anaesthesic Depth in the Cerebral Cortex Using Bispectral Bilateral System. \\\\t COMPLETED \\\\t Breast Surgery \\\\t PROCEDURE: Surgery with general anaesthesia.|PROCEDURE: Raw EEG \\\\t Parc de Salut Mar \\\\t 25 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2013-09,2015-10',\n 'NCT02804971 \\\\t Cardiovascular Comorbidities and Bronchiectasis \\\\t BRONCOCA \\\\t ACTIVE_NOT_RECRUITING \\\\t Bronchiectasis \\\\t Centre Hospitalier Intercommunal Creteil \\\\t 200 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,25 October 2016,2023-12',\n '\"NCT04814771 \\\\t Mass Balance Study of TS-142 in Healthy Adult Subjects. \\\\t COMPLETED \\\\t Healthy Male Subjects \\\\t DRUG: [14C] TS-142 \\\\t Taisho Pharmaceutical Co., Ltd. \\\\t 6 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\",19 April 2021,19 May 2021',\n 'NCT02920671 \\\\t Muscle OXPHOS and Nutrient Homeostasis \\\\t ACTIVE_NOT_RECRUITING \\\\t Mitochondrial Diseases|Obesity \\\\t OTHER: Tracer-enhanced oral glucose tolerance test (OGTT*)|OTHER: Muscle MRI|OTHER: Dual energy x-ray absorptiometry (DXA)|OTHER: Questionnaires \\\\t University of Pennsylvania \\\\t 45 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,14 February 2017,30 June 2024',\n 'NCT04756271 \\\\t Safety and Immunogenicity of Oxford AstraZeneca Vaccine Against COVID-19 Infection \\\\t COMPLETED \\\\t Vaccine Adverse Reaction|Seroconversion \\\\t BIOLOGICAL: SARS-Cov-2 neutralizing antibody titer \\\\t Zagazig University \\\\t 246 \\\\t OTHER_GOV \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,11 February 2021,22 December 2021',\n 'NCT00103571 \\\\t Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia \\\\t COMPLETED \\\\t Schizophrenia \\\\t DRUG: Olanzapine|DRUG: Aripiprazole \\\\t Eli Lilly and Company \\\\t 600 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,2004-07,2006-08',\n '\"NCT00000571 \\\\t Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease \\\\t COMPLETED \\\\t Lung Diseases|Lung Diseases, Obstructive|Chronic Obstructive Pulmonary Disease \\\\t DEVICE: ventilators, negative pressure \\\\t McGill University \\\\t National Heart, Lung, and Blood Institute (NHLBI) \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT\",1986-02,',\n '\"NCT01053871 \\\\t Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy \\\\t COMPLETED \\\\t Gastritis|Functional Dyspepsia \\\\t DRUG: propofol|DRUG: midazolam with fentanyl \\\\t Shandong University \\\\t 104 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: \",2010-01,2010-05',\n 'NCT05974371 \\\\t Episodic Memory Integration and Interference \\\\t NOT_YET_RECRUITING \\\\t Episodic Memory \\\\t OTHER: emotional context similarity \\\\t Boston College \\\\t 150 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,2024-08,2027-08',\n '\"NCT01425671 \\\\t Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States \\\\t ACTIVE_NOT_RECRUITING \\\\t Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder \\\\t University of Maryland, Baltimore \\\\t National Institute of Mental Health (NIMH) \\\\t 800 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",30 November 2010,2024-06',\n '\"NCT02827071 \\\\t Ocular Imaging Study Using Advanced OCT \\\\t UNKNOWN \\\\t Retinal Vascular Disorder|Macular Degeneration \\\\t University of California, Los Angeles \\\\t 1000 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",2016-07,',\n 'NCT02529371 \\\\t Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients \\\\t UNKNOWN \\\\t Urinary Incontinence \\\\t DEVICE: UriCap-RM \\\\t G.R. Dome Medical Ltd. \\\\t 30 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2015-09,2015-10',\n 'NCT02309671 \\\\t A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment \\\\t COMPLETED \\\\t Infertility \\\\t DRUG: FE 999049|DRUG: follitropin beta \\\\t Ferring Pharmaceuticals \\\\t 159 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,2014-12,2016-09',\n 'NCT05009771 \\\\t Postoperative Pain Management of Caesarean Section \\\\t RECRUITING \\\\t Postoperative Pain|Caesarean Section|Analgesia \\\\t DRUG: Intravenous patient-control analgesia|DRUG: Dinalbuphine sebacate \\\\t Mackay Memorial Hospital \\\\t 150 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,23 February 2022,31 July 2024',\n 'NCT04769271 \\\\t Intra-pocket Application of Tea Tree Oil Gel in the Treatment of Stage-2 Periodontitis \\\\t COMPLETED \\\\t Periodontitis \\\\t PROCEDURE: Scaling and Root Planing|DRUG: Scaling and Root Planing with tea tree oil \\\\t Alexandria University \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,10 November 2019,25 August 2020',\n 'NCT00596271 \\\\t Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 \\\\t COMPLETED \\\\t Japanese Encephalitis \\\\t BIOLOGICAL: IC51|BIOLOGICAL: HAVRIX|OTHER: Placebo \\\\t Valneva Austria GmbH \\\\t 192 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION,2005-09,2008-08',\n 'NCT03077971 \\\\t Effectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis \\\\t UNKNOWN \\\\t Carer Stress Syndrome \\\\t BEHAVIORAL: ACT Self-Help|BEHAVIORAL: ACT Self-Help with Telephone Support \\\\t University of Nottingham \\\\t 24 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE,01 December 2016,2018-06',\n 'NCT02130271 \\\\t PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients \\\\t COMPLETED \\\\t Sciatica \\\\t DRUG: Radioactive dye|RADIATION: PET/MRI|OTHER: Blood draw \\\\t Massachusetts General Hospital \\\\t 42 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2014-04,2018-12',\n 'NCT03419871 \\\\t Associations of Socioeconomic Adversity and Sleep With Allostatic Load Among Toddlers \\\\t COMPLETED \\\\t Sleep Disorder \\\\t OTHER: Monitoring Sleep|OTHER: stress biomarkers \\\\t Yale University \\\\t 100 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,08 November 2015,15 October 2019',\n '\"NCT05544071 \\\\t the Safety and Effectiveness of Precise rTMS Based on Neuroimaging in the Treatment of Adolescent Depression With Anhedoniadepression With Anhedonia \\\\t RECRUITING \\\\t Major Depressive Disorder|Repetitive Transcranial Magnetic Stimulation \\\\t DEVICE: Transcranial Magnetic Stimulation (TMS) \\\\t Xijing Hospital \\\\t 88 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",12 February 2023,31 December 2024',\n '\"NCT04117971 \\\\t Knowledge, Attitude and Practice of Child Abuse Diagnosis and Reporting Among a Group of Egyptian Dentists \\\\t COMPLETED \\\\t Child Abuse \\\\t OTHER: Questionnaire \\\\t Cairo University \\\\t 196 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",01 November 2020,01 May 2021',\n 'NCT06199271 \\\\t Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma \\\\t NOT_YET_RECRUITING \\\\t Head and Neck Squamous Cell Carcinoma \\\\t DRUG: Adebrelimab and dalpiciclib \\\\t Zhongzheng Xiang \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,01 January 2024,31 December 2026',\n '\"NCT00363571 \\\\t The Effect of Glyceryl Trinitate and Diamox on Cerebral Haemodynamics. \\\\t UNKNOWN \\\\t Migraine \\\\t DRUG: GTN, Diamox \\\\t Danish Headache Center \\\\t 12 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: ECT\",2006-08,2007-05',\n '\"NCT00805571 \\\\t Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients \\\\t COMPLETED \\\\t Kidney Transplant Dysfunction \\\\t Northwell Health \\\\t Astellas Pharma US, Inc. \\\\t 120 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",2008-10,',\n 'NCT06182371 \\\\t Effectiveness of Detachment of the Breathing Circuit on the Rate of DLT Malposition After Postural Change \\\\t NOT_YET_RECRUITING \\\\t Intratracheal Intubation|Patient Positioning \\\\t BEHAVIORAL: Disengage the breathing circuit \\\\t Shandong Provincial Hospital \\\\t 256 \\\\t OTHER_GOV \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION,2024-01,2025-01',\n 'NCT01776671 \\\\t Once Daily Gabapentin in the Treatment of Post Amputation Pain \\\\t UNKNOWN \\\\t Pain|Quality of Life \\\\t DRUG: Gralise \\\\t Chicago Anesthesia Pain Specialists \\\\t 16 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-02,2018-12',\n '\"NCT04970771 \\\\t Solving Wellness: An Initiative to Enhance Canadian Healthcare Provider Wellness \\\\t COMPLETED \\\\t Stress|Burnout, Professional|Burnout \\\\t BEHAVIORAL: Solving Wellness platform \\\\t Hopital Montfort \\\\t 53 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",31 March 2022,30 June 2023',\n 'NCT06096571 \\\\t Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers \\\\t NOT_YET_RECRUITING \\\\t Viral Infection COVID-19 \\\\t DRUG: Aterixen \\\\t Valenta Pharm JSC \\\\t 36 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER,15 January 2024,30 June 2024',\n '\"NCT03694171 \\\\t Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study) \\\\t COMPLETED \\\\t Cancer \\\\t Institut Bergonié \\\\t Institut National de la Santé Et de la Recherche Médicale, France|University of Bordeaux \\\\t 450 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",2013-11,2017-11',\n '\"NCT03457571 \\\\t Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome \\\\t COMPLETED \\\\t Inflammatory Bowel Diseases|Restless Legs Syndrome|Iron-deficiency \\\\t Charite University, Berlin, Germany \\\\t 353 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",01 February 2014,30 April 2015',\n '\"NCT01088971 \\\\t Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome \\\\t COMPLETED \\\\t Irritable Bowel Syndrome \\\\t DIETARY_SUPPLEMENT: Duolac7S|DIETARY_SUPPLEMENT: starch \\\\t Cell Biotech Co., Ltd. \\\\t 60 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2009-10,2011-07',\n 'NCT04793971 \\\\t Minimal Invasive Treatment of Achilles Tendinopathy: Focus on Percutaneous Release (Maffulli) \\\\t COMPLETED \\\\t Tendinopathy \\\\t PROCEDURE: percutaneous paratenon release \\\\t Universitaire Ziekenhuizen KU Leuven \\\\t 8 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2014-11,2015-04']"
     ]
    }
   ],
   "source": [
    "rdd1_splitline = rdd1 \\\n",
    "    .flatMap(lambda x: x.split('\\n')) \\\n",
    "    .filter(lambda line: line.count(\"\\\\t\") < 10)\n",
    "\n",
    "rdd1_splitline.take(50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4d9ec836-3b94-4ec9-87f7-7b7d4ef5c464",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[31]: ['NCT Number \\\\t Study Title \\\\t Acronym \\\\t Study Status \\\\t Conditions \\\\t Interventions \\\\t Sponsor \\\\t Collaborators \\\\t Enrollment \\\\t Funder Type \\\\t Study Type \\\\t Study Design,Start Date,Completion Date',\n '\"NCT03630471 \\\\t Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India \\\\t PRIDE \\\\t COMPLETED \\\\t Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) \\\\t BEHAVIORAL: PRIDE \\'Step 1\\' problem-solving intervention|BEHAVIORAL: Enhanced usual care \\\\t Sangath \\\\t Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine \\\\t 250 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",20 August 2018,28 February 2019',\n '\"NCT05992571 \\\\t Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity \\\\t RECRUITING \\\\t Cerebrovascular Function|Cognition \\\\t OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB \\\\t McMaster University \\\\t Alzheimer\\'s Society of Brant, Haldimand Norfolk, Hamilton Halton \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\",25 October 2023,2024-08',\n 'NCT01854671 \\\\t Investigating the Effect of a Prenatal Family Planning Counseling Intervention Led by Community Health Workers on Postpartum Contraceptive Use Among Women in the West Bank \\\\t COMPLETED \\\\t Focus: Contraceptive Counseling|Focus: Postpartum Contraception \\\\t OTHER: family planning counseling let by community health workers \\\\t Planned Parenthood League of Massachusetts \\\\t Society for Family Planning Research Fund \\\\t 176 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: ,2013-08,2014-12',\n 'NCT03820271 \\\\t New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation \\\\t SUPERMELD \\\\t RECRUITING \\\\t Decompensated Cirrhosis|Liver Transplantation \\\\t OTHER: SuperMELD \\\\t Assistance Publique - Hôpitaux de Paris \\\\t 500 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,01 October 2020,01 October 2023',\n 'NCT01160471 \\\\t Noninvasive Imaging of Heart Failure: A Pilot Study \\\\t COMPLETED \\\\t MRI|Acquired Heart Disease|Myocardial Fibrosis \\\\t National Institutes of Health Clinical Center (CC) \\\\t 62 \\\\t NIH \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 July 2010,30 October 2019',\n '\"NCT04338971 \\\\t Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes \\\\t COMPLETED \\\\t Stroke \\\\t DEVICE: IpsiHand Therapy \\\\t Neurolutions, Inc. \\\\t 24 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",05 May 2017,09 October 2020',\n '\"NCT05843071 \\\\t PMCF Study to Evaluate Performance and Safety of \"\"NASAL SPRAYS \"\" Used to Relieve Nasal Congestion and Dryness \\\\t RECRUITING \\\\t Nasal Congestion|Nasal Dryness \\\\t DEVICE: Nasal sprays with sea salts \\\\t C.O.C. Farmaceutici S.r.l. \\\\t 105 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",01 September 2022,15 June 2023',\n 'NCT06174571 \\\\t Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer. \\\\t NOT_YET_RECRUITING \\\\t Breast Cancer \\\\t Assiut University \\\\t 90 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,01 February 2024,01 March 2026',\n 'NCT03700671 \\\\t High Intensity Interval Training Versus Circuit Training \\\\t COMPLETED \\\\t High Intensity Interval Training \\\\t OTHER: High intensity interval training|OTHER: Circuit training \\\\t University of Central Lancashire \\\\t University of Hull \\\\t 42 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,11 May 2016,13 December 2017',\n '\"NCT02633371 \\\\t A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults \\\\t COMPLETED \\\\t Hyperhidrosis \\\\t DRUG: Oxybutynin 3% gel \\\\t University of Colorado, Denver \\\\t Society for Pediatric Dermatology \\\\t 10 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",2016-02,2017-05',\n '\"NCT03400371 \\\\t Biology of Juvenile Myoclonic Epilepsy \\\\t BIOJUME \\\\t RECRUITING \\\\t Juvenile Myoclonic Epilepsy \\\\t OTHER: Blood draw|OTHER: Existing samples \\\\t King\\'s College London \\\\t King\\'s College Hospital NHS Trust|Charles University, Czech Republic|Hopital Universitaire Robert-Debre|Vestre Viken Hospital Trust|The Hospital for Sick Children|Cardiff University|Odense University Hospital \\\\t 1000 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",13 July 2017,30 June 2026',\n '\"NCT00221871 \\\\t Proper Dosage of Ketamine in Intravenous Regional Anesthesia \\\\t UNKNOWN \\\\t Pain. \\\\t DRUG: Different dosages of Ketamine \\\\t University Health Network, Toronto \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: TREATMENT\",2004-01,2005-01',\n '\"NCT05664971 \\\\t JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer \\\\t RECRUITING \\\\t Advanced Lung Cancer \\\\t BIOLOGICAL: Recombinant humanized anti-BTLA monoclonal antibody (JS004) injection|BIOLOGICAL: Toripalimab|DRUG: Docetaxel|DRUG: Pemetrexed|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Etoposide \\\\t Shanghai Junshi Bioscience Co., Ltd. \\\\t 240 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",09 February 2023,17 November 2024',\n 'NCT02383771 \\\\t Reversal of the Anti-platelet Effects of Ticagrelor \\\\t REVERSAL \\\\t COMPLETED \\\\t Coronary Artery Disease \\\\t DRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor \\\\t The First Affiliated Hospital with Nanjing Medical University \\\\t National Natural Science Foundation of China \\\\t 64 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2015-03,2016-12',\n '\"NCT01897571 \\\\t Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL \\\\t COMPLETED \\\\t B-cell Lymphomas (Phase 1)|Advanced Solid Tumors (Phase 1)|Diffuse Large B-cell Lymphoma (Phase 2)|Follicular Lymphoma (Phase 2)|Transformed Follicular Lymphoma|Primary Mediastinal Large B-Cell Lymphoma \\\\t DRUG: Tazemetostat|DRUG: Prednisolone|DRUG: Tazemetostat \\\\t Epizyme, Inc. \\\\t 400 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\",13 June 2013,02 November 2021',\n '\"NCT03928171 \\\\t The Effect of Intra-abdominal Pressure on Peritoneal Perfusion During Laparoscopic Colorectal Surgery \\\\t PERFUSION \\\\t COMPLETED \\\\t Laparoscopic Surgery|Pneumoperitoneum \\\\t OTHER: Intra-abdominal pressure during laparoscopy \\\\t Radboud University Medical Center \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",13 June 2018,24 December 2018',\n 'NCT00848471 \\\\t Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems) \\\\t Protocol Quark \\\\t UNKNOWN \\\\t Healthy|Obesity \\\\t DEVICE: Quark RMR|DEVICE: Deltatrac II \\\\t Hospices Civils de Lyon \\\\t Centre de Recherche en Nutrition Humaine Rhone-Alpe \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,2009-01,2009-12',\n '\"NCT01189071 \\\\t Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain \\\\t TERMINATED \\\\t Overactive Bladder|Renal Colic|Pain, Postoperative \\\\t DRUG: Darifenacin \\\\t University of Missouri-Columbia \\\\t 3 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2009-08,2011-07',\n '\"NCT01005771 \\\\t Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions \\\\t COMPLETED \\\\t Secondarily Infected Traumatic Lesions \\\\t DRUG: GF-001001-00|DRUG: Placebo \\\\t Ferrer Internacional S.A. \\\\t 200 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT\",2009-09,2010-03']"
     ]
    }
   ],
   "source": [
    "# Apply a FlatMap operation to extract all conditions\n",
    "\n",
    "rdd_condition = rdd1 \\\n",
    "    .flatMap(lambda x: x.split('\\n'))\n",
    "rdd_condition.take(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3e392fc4-04d4-4532-acc4-bbb33f83e42e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[32]: ['NCT Number \\\\t Study Title \\\\t Acronym \\\\t Study Status \\\\t Conditions \\\\t Interventions \\\\t Sponsor \\\\t Collaborators \\\\t Enrollment \\\\t Funder Type \\\\t Study Type \\\\t Study Design,Start Date,Completion Date',\n '\"NCT03630471 \\\\t Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India \\\\t PRIDE \\\\t COMPLETED \\\\t Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse) \\\\t BEHAVIORAL: PRIDE \\'Step 1\\' problem-solving intervention|BEHAVIORAL: Enhanced usual care \\\\t Sangath \\\\t Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine \\\\t 250 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\",20 August 2018,28 February 2019',\n '\"NCT03400371 \\\\t Biology of Juvenile Myoclonic Epilepsy \\\\t BIOJUME \\\\t RECRUITING \\\\t Juvenile Myoclonic Epilepsy \\\\t OTHER: Blood draw|OTHER: Existing samples \\\\t King\\'s College London \\\\t King\\'s College Hospital NHS Trust|Charles University, Czech Republic|Hopital Universitaire Robert-Debre|Vestre Viken Hospital Trust|The Hospital for Sick Children|Cardiff University|Odense University Hospital \\\\t 1000 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p\",13 July 2017,30 June 2026',\n 'NCT02383771 \\\\t Reversal of the Anti-platelet Effects of Ticagrelor \\\\t REVERSAL \\\\t COMPLETED \\\\t Coronary Artery Disease \\\\t DRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor \\\\t The First Affiliated Hospital with Nanjing Medical University \\\\t National Natural Science Foundation of China \\\\t 64 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT,2015-03,2016-12',\n 'NCT00848471 \\\\t Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems) \\\\t Protocol Quark \\\\t UNKNOWN \\\\t Healthy|Obesity \\\\t DEVICE: Quark RMR|DEVICE: Deltatrac II \\\\t Hospices Civils de Lyon \\\\t Centre de Recherche en Nutrition Humaine Rhone-Alpe \\\\t 30 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,2009-01,2009-12',\n 'NCT04236271 \\\\t TELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE \\\\t TELE-PEACE \\\\t COMPLETED \\\\t Coronary Artery Bypass \\\\t DEVICE: connected objects \\\\t Assistance Publique - Hôpitaux de Paris \\\\t GFI \\\\t 33 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,13 March 2020,31 December 2022',\n '\"NCT01226771 \\\\t Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 \\\\t RibaC \\\\t COMPLETED \\\\t Hepatitis C \\\\t DRUG: Ribavirin \"\"loading\"\" dose given|DRUG: \"\"Priming\"\" dose of ribavirin given|DRUG: Group C (\"\"Standard-of-Care\"\") \\\\t Göteborg University \\\\t The Swedish Research Council|Roche Pharma AG \\\\t 105 \\\\t OTHER \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\",2010-09,2014-09',\n \"NCT03673371 \\\\t Women's-Specific Footwear With Prosthetic Feet \\\\t WSF \\\\t COMPLETED \\\\t Lower Limb Amputation Below Knee (Injury)|Lower Limb Amputation Above Knee (Injury) \\\\t OTHER: Questionnaire \\\\t Minneapolis Veterans Affairs Medical Center \\\\t United States Department of Defense \\\\t 100 \\\\t FED \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,04 March 2019,06 January 2023\",\n 'NCT01866371 \\\\t High Resolution Retinal Imaging \\\\t AOSLO \\\\t RECRUITING \\\\t Stargardts|Retinitis Pigmentosa|Age-related Macular Degeneration|Choroideremia|Geographic Atrophy \\\\t PROCEDURE: Retinal imaging \\\\t University of Pennsylvania \\\\t National Eye Institute (NEI) \\\\t 600 \\\\t OTHER \\\\t OBSERVATIONAL \\\\t Observational Model: |Time Perspective: p,2013-05,2027-12',\n '\"NCT01729871 \\\\t A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation Therapy \\\\t VENTURE-AF \\\\t COMPLETED \\\\t Atrial Fibrillation \\\\t DRUG: rivaroxaban|DRUG: uninterrupted vitamin K antagonist (VKA) \\\\t Janssen Scientific Affairs, LLC \\\\t Bayer \\\\t 253 \\\\t INDUSTRY \\\\t INTERVENTIONAL \\\\t Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\",2013-02,2014-10']"
     ]
    }
   ],
   "source": [
    "rdd_condition = rdd1 \\\n",
    "    .flatMap(lambda x: x.split('\\n')) \\\n",
    "    .filter(lambda line: line.count(\"\\\\t\") > 10)\n",
    "\n",
    "rdd_condition.take(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4e25b14e-7712-48ab-9e68-0562d83ebdd2",
     "showTitle": true,
     "title": "Question 1 : What is the Number of Distinct Studies in the Dataset"
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of distinct studies: 476396\n"
     ]
    }
   ],
   "source": [
    "# Extract the header row\n",
    "header_row = flattened_rdd.first()\n",
    "\n",
    "# Find the index of the 'Study Title' column\n",
    "study_title_index = header_row.index(' Study Title ')\n",
    "\n",
    "# Count the number of distinct studies\n",
    "distinct_study_count = flattened_rdd.map(lambda row: row[study_title_index]) \\\n",
    "                          .distinct() \\\n",
    "                          .count()\n",
    "\n",
    "# Output the number of distinct studies\n",
    "print(\"Number of distinct studies:\", distinct_study_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "10555a29-cf50-4879-8b97-8d7e767d4642",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Line 1: Length = 12\nLine 2: Length = 12\nLine 3: Length = 11\nLine 4: Length = 11\nLine 5: Length = 11\nLine 6: Length = 9\nLine 7: Length = 10\nLine 8: Length = 10\nLine 9: Length = 9\nLine 10: Length = 11\nLine 11: Length = 11\nLine 12: Length = 12\nLine 13: Length = 9\nLine 14: Length = 10\nLine 15: Length = 12\nLine 16: Length = 10\nLine 17: Length = 11\nLine 18: Length = 12\nLine 19: Length = 10\nLine 20: Length = 10\nLine 21: Length = 11\nLine 22: Length = 11\nLine 23: Length = 10\nLine 24: Length = 11\nLine 25: Length = 10\nLine 26: Length = 11\nLine 27: Length = 10\nLine 28: Length = 10\nLine 29: Length = 9\nLine 30: Length = 9\nLine 31: Length = 10\nLine 32: Length = 11\nLine 33: Length = 11\nLine 34: Length = 11\nLine 35: Length = 10\nLine 36: Length = 10\nLine 37: Length = 10\nLine 38: Length = 11\nLine 39: Length = 11\nLine 40: Length = 10\nLine 41: Length = 11\nLine 42: Length = 10\nLine 43: Length = 10\nLine 44: Length = 10\nLine 45: Length = 11\nLine 46: Length = 11\nLine 47: Length = 11\nLine 48: Length = 10\nLine 49: Length = 10\nLine 50: Length = 10\nLine 51: Length = 11\nLine 52: Length = 10\nLine 53: Length = 11\nLine 54: Length = 11\nLine 55: Length = 11\nLine 56: Length = 11\nLine 57: Length = 11\nLine 58: Length = 10\nLine 59: Length = 11\nLine 60: Length = 9\nLine 61: Length = 12\nLine 62: Length = 11\nLine 63: Length = 10\nLine 64: Length = 10\nLine 65: Length = 11\nLine 66: Length = 10\nLine 67: Length = 10\nLine 68: Length = 11\nLine 69: Length = 10\nLine 70: Length = 10\nLine 71: Length = 11\nLine 72: Length = 11\nLine 73: Length = 10\nLine 74: Length = 11\nLine 75: Length = 11\nLine 76: Length = 10\nLine 77: Length = 10\nLine 78: Length = 11\nLine 79: Length = 10\nLine 80: Length = 10\nLine 81: Length = 10\nLine 82: Length = 10\nLine 83: Length = 11\nLine 84: Length = 11\nLine 85: Length = 11\nLine 86: Length = 11\nLine 87: Length = 11\nLine 88: Length = 10\nLine 89: Length = 10\nLine 90: Length = 10\nLine 91: Length = 11\nLine 92: Length = 11\nLine 93: Length = 11\nLine 94: Length = 10\nLine 95: Length = 10\nLine 96: Length = 11\nLine 97: Length = 9\nLine 98: Length = 11\nLine 99: Length = 12\nLine 100: Length = 11\nLine 101: Length = 10\nLine 102: Length = 10\nLine 103: Length = 10\nLine 104: Length = 10\nLine 105: Length = 11\nLine 106: Length = 9\nLine 107: Length = 10\nLine 108: Length = 10\nLine 109: Length = 11\nLine 110: Length = 10\nLine 111: Length = 11\nLine 112: Length = 12\nLine 113: Length = 11\nLine 114: Length = 11\nLine 115: Length = 10\nLine 116: Length = 11\nLine 117: Length = 10\nLine 118: Length = 10\nLine 119: Length = 12\nLine 120: Length = 10\nLine 121: Length = 10\nLine 122: Length = 11\nLine 123: Length = 11\nLine 124: Length = 10\nLine 125: Length = 10\nLine 126: Length = 11\nLine 127: Length = 12\nLine 128: Length = 10\nLine 129: Length = 11\nLine 130: Length = 10\nLine 131: Length = 10\nLine 132: Length = 12\nLine 133: Length = 12\nLine 134: Length = 12\nLine 135: Length = 11\nLine 136: Length = 12\nLine 137: Length = 9\nLine 138: Length = 11\nLine 139: Length = 11\nLine 140: Length = 10\nLine 141: Length = 10\nLine 142: Length = 12\nLine 143: Length = 10\nLine 144: Length = 11\nLine 145: Length = 10\nLine 146: Length = 11\nLine 147: Length = 12\nLine 148: Length = 11\nLine 149: Length = 10\nLine 150: Length = 10\nLine 151: Length = 12\nLine 152: Length = 11\nLine 153: Length = 11\nLine 154: Length = 10\nLine 155: Length = 11\nLine 156: Length = 12\nLine 157: Length = 10\nLine 158: Length = 11\nLine 159: Length = 11\nLine 160: Length = 12\nLine 161: Length = 10\nLine 162: Length = 12\nLine 163: Length = 10\nLine 164: Length = 10\nLine 165: Length = 11\nLine 166: Length = 11\nLine 167: Length = 11\nLine 168: Length = 11\nLine 169: Length = 10\nLine 170: Length = 10\nLine 171: Length = 10\nLine 172: Length = 10\nLine 173: Length = 10\nLine 174: Length = 11\nLine 175: Length = 11\nLine 176: Length = 10\nLine 177: Length = 11\nLine 178: Length = 10\nLine 179: Length = 10\nLine 180: Length = 10\nLine 181: Length = 12\nLine 182: Length = 11\nLine 183: Length = 11\nLine 184: Length = 11\nLine 185: Length = 11\nLine 186: Length = 10\nLine 187: Length = 11\nLine 188: Length = 10\nLine 189: Length = 11\nLine 190: Length = 10\nLine 191: Length = 12\nLine 192: Length = 9\nLine 193: Length = 10\nLine 194: Length = 10\nLine 195: Length = 12\nLine 196: Length = 10\nLine 197: Length = 10\nLine 198: Length = 10\nLine 199: Length = 10\nLine 200: Length = 11\nLine 201: Length = 10\nLine 202: Length = 10\nLine 203: Length = 10\nLine 204: Length = 12\nLine 205: Length = 12\nLine 206: Length = 12\nLine 207: Length = 10\nLine 208: Length = 11\nLine 209: Length = 10\nLine 210: Length = 11\nLine 211: Length = 9\nLine 212: Length = 12\nLine 213: Length = 9\nLine 214: Length = 11\nLine 215: Length = 10\nLine 216: Length = 10\nLine 217: Length = 11\nLine 218: Length = 11\nLine 219: Length = 10\nLine 220: Length = 11\nLine 221: Length = 10\nLine 222: Length = 10\nLine 223: Length = 11\nLine 224: Length = 10\nLine 225: Length = 11\nLine 226: Length = 10\nLine 227: Length = 11\nLine 228: Length = 10\nLine 229: Length = 10\nLine 230: Length = 10\nLine 231: Length = 11\nLine 232: Length = 10\nLine 233: Length = 11\nLine 234: Length = 9\nLine 235: Length = 11\nLine 236: Length = 10\nLine 237: Length = 11\nLine 238: Length = 10\nLine 239: Length = 11\nLine 240: Length = 11\nLine 241: Length = 9\nLine 242: Length = 11\nLine 243: Length = 11\nLine 244: Length = 10\nLine 245: Length = 11\nLine 246: Length = 11\nLine 247: Length = 12\nLine 248: Length = 11\nLine 249: Length = 10\nLine 250: Length = 10\nLine 251: Length = 11\nLine 252: Length = 10\nLine 253: Length = 10\nLine 254: Length = 10\nLine 255: Length = 10\nLine 256: Length = 12\nLine 257: Length = 11\nLine 258: Length = 11\nLine 259: Length = 11\nLine 260: Length = 11\nLine 261: Length = 10\nLine 262: Length = 11\nLine 263: Length = 10\nLine 264: Length = 10\nLine 265: Length = 11\nLine 266: Length = 12\nLine 267: Length = 11\nLine 268: Length = 10\nLine 269: Length = 11\nLine 270: Length = 10\nLine 271: Length = 11\nLine 272: Length = 11\nLine 273: Length = 11\nLine 274: Length = 10\nLine 275: Length = 10\nLine 276: Length = 10\nLine 277: Length = 10\nLine 278: Length = 10\nLine 279: Length = 11\nLine 280: Length = 10\nLine 281: Length = 10\nLine 282: Length = 10\nLine 283: Length = 11\nLine 284: Length = 11\nLine 285: Length = 11\nLine 286: Length = 12\nLine 287: Length = 9\nLine 288: Length = 9\nLine 289: Length = 9\nLine 290: Length = 12\nLine 291: Length = 10\nLine 292: Length = 10\nLine 293: Length = 9\nLine 294: Length = 10\nLine 295: Length = 11\nLine 296: Length = 10\nLine 297: Length = 11\nLine 298: Length = 10\nLine 299: Length = 10\nLine 300: Length = 10\nLine 301: Length = 11\nLine 302: Length = 10\nLine 303: Length = 11\nLine 304: Length = 12\nLine 305: Length = 12\nLine 306: Length = 9\nLine 307: Length = 11\nLine 308: Length = 10\nLine 309: Length = 10\nLine 310: Length = 11\nLine 311: Length = 11\nLine 312: Length = 11\nLine 313: Length = 10\nLine 314: Length = 10\nLine 315: Length = 10\nLine 316: Length = 10\nLine 317: Length = 10\nLine 318: Length = 11\nLine 319: Length = 9\nLine 320: Length = 11\nLine 321: Length = 10\nLine 322: Length = 11\nLine 323: Length = 10\nLine 324: Length = 10\nLine 325: Length = 10\nLine 326: Length = 11\nLine 327: Length = 11\nLine 328: Length = 11\nLine 329: Length = 11\nLine 330: Length = 11\nLine 331: Length = 12\nLine 332: Length = 12\nLine 333: Length = 10\nLine 334: Length = 11\nLine 335: Length = 10\nLine 336: Length = 10\nLine 337: Length = 11\nLine 338: Length = 10\nLine 339: Length = 11\nLine 340: Length = 11\nLine 341: Length = 10\nLine 342: Length = 9\nLine 343: Length = 10\nLine 344: Length = 11\nLine 345: Length = 11\nLine 346: Length = 11\nLine 347: Length = 10\nLine 348: Length = 10\nLine 349: Length = 10\nLine 350: Length = 10\nLine 351: Length = 10\nLine 352: Length = 10\nLine 353: Length = 10\nLine 354: Length = 9\nLine 355: Length = 10\nLine 356: Length = 11\nLine 357: Length = 10\nLine 358: Length = 10\nLine 359: Length = 10\nLine 360: Length = 11\nLine 361: Length = 11\nLine 362: Length = 11\nLine 363: Length = 10\nLine 364: Length = 11\nLine 365: Length = 11\nLine 366: Length = 10\nLine 367: Length = 11\nLine 368: Length = 12\nLine 369: Length = 12\nLine 370: Length = 10\nLine 371: Length = 11\nLine 372: Length = 9\nLine 373: Length = 10\nLine 374: Length = 11\nLine 375: Length = 12\nLine 376: Length = 12\nLine 377: Length = 12\nLine 378: Length = 10\nLine 379: Length = 10\nLine 380: Length = 10\nLine 381: Length = 10\nLine 382: Length = 11\nLine 383: Length = 11\nLine 384: Length = 12\nLine 385: Length = 11\nLine 386: Length = 9\nLine 387: Length = 10\nLine 388: Length = 11\nLine 389: Length = 10\nLine 390: Length = 11\nLine 391: Length = 10\nLine 392: Length = 10\nLine 393: Length = 10\nLine 394: Length = 10\nLine 395: Length = 9\nLine 396: Length = 10\nLine 397: Length = 10\nLine 398: Length = 11\nLine 399: Length = 11\nLine 400: Length = 10\nLine 401: Length = 11\nLine 402: Length = 10\nLine 403: Length = 11\nLine 404: Length = 11\nLine 405: Length = 11\nLine 406: Length = 10\nLine 407: Length = 12\nLine 408: Length = 10\nLine 409: Length = 12\nLine 410: Length = 11\nLine 411: Length = 10\nLine 412: Length = 11\nLine 413: Length = 11\nLine 414: Length = 12\nLine 415: Length = 10\nLine 416: Length = 11\nLine 417: Length = 11\nLine 418: Length = 10\nLine 419: Length = 10\nLine 420: Length = 11\nLine 421: Length = 11\nLine 422: Length = 11\nLine 423: Length = 10\nLine 424: Length = 10\nLine 425: Length = 11\nLine 426: Length = 12\nLine 427: Length = 10\nLine 428: Length = 11\nLine 429: Length = 11\nLine 430: Length = 10\nLine 431: Length = 11\nLine 432: Length = 10\nLine 433: Length = 11\nLine 434: Length = 12\nLine 435: Length = 9\nLine 436: Length = 10\nLine 437: Length = 10\nLine 438: Length = 11\nLine 439: Length = 11\nLine 440: Length = 11\nLine 441: Length = 10\nLine 442: Length = 11\nLine 443: Length = 11\nLine 444: Length = 10\nLine 445: Length = 10\nLine 446: Length = 10\nLine 447: Length = 9\nLine 448: Length = 12\nLine 449: Length = 11\nLine 450: Length = 11\nLine 451: Length = 10\nLine 452: Length = 10\nLine 453: Length = 11\nLine 454: Length = 10\nLine 455: Length = 11\nLine 456: Length = 12\nLine 457: Length = 11\nLine 458: Length = 10\nLine 459: Length = 10\nLine 460: Length = 11\nLine 461: Length = 9\nLine 462: Length = 10\nLine 463: Length = 12\nLine 464: Length = 12\nLine 465: Length = 10\nLine 466: Length = 10\nLine 467: Length = 10\nLine 468: Length = 12\nLine 469: Length = 11\nLine 470: Length = 10\nLine 471: Length = 12\nLine 472: Length = 10\nLine 473: Length = 10\nLine 474: Length = 9\nLine 475: Length = 11\nLine 476: Length = 10\nLine 477: Length = 10\nLine 478: Length = 10\nLine 479: Length = 11\nLine 480: Length = 12\nLine 481: Length = 10\nLine 482: Length = 10\nLine 483: Length = 11\nLine 484: Length = 10\nLine 485: Length = 11\nLine 486: Length = 11\nLine 487: Length = 9\nLine 488: Length = 10\nLine 489: Length = 11\nLine 490: Length = 11\nLine 491: Length = 10\nLine 492: Length = 10\nLine 493: Length = 10\nLine 494: Length = 12\nLine 495: Length = 11\nLine 496: Length = 10\nLine 497: Length = 9\nLine 498: Length = 10\nLine 499: Length = 10\nLine 500: Length = 11\nLine 501: Length = 12\nLine 502: Length = 11\nLine 503: Length = 11\nLine 504: Length = 9\nLine 505: Length = 11\nLine 506: Length = 10\nLine 507: Length = 11\nLine 508: Length = 10\nLine 509: Length = 10\nLine 510: Length = 11\nLine 511: Length = 11\nLine 512: Length = 10\nLine 513: Length = 10\nLine 514: Length = 11\nLine 515: Length = 12\nLine 516: Length = 12\nLine 517: Length = 10\nLine 518: Length = 12\nLine 519: Length = 10\nLine 520: Length = 10\nLine 521: Length = 11\nLine 522: Length = 10\nLine 523: Length = 11\nLine 524: Length = 11\nLine 525: Length = 11\nLine 526: Length = 10\nLine 527: Length = 11\nLine 528: Length = 9\nLine 529: Length = 11\nLine 530: Length = 11\nLine 531: Length = 12\nLine 532: Length = 11\nLine 533: Length = 11\nLine 534: Length = 10\nLine 535: Length = 11\nLine 536: Length = 10\nLine 537: Length = 11\nLine 538: Length = 10\nLine 539: Length = 10\nLine 540: Length = 12\nLine 541: Length = 11\nLine 542: Length = 11\nLine 543: Length = 12\nLine 544: Length = 11\nLine 545: Length = 10\nLine 546: Length = 10\nLine 547: Length = 10\nLine 548: Length = 11\nLine 549: Length = 10\nLine 550: Length = 11\nLine 551: Length = 10\nLine 552: Length = 11\nLine 553: Length = 11\nLine 554: Length = 11\nLine 555: Length = 11\nLine 556: Length = 12\nLine 557: Length = 11\nLine 558: Length = 12\nLine 559: Length = 10\nLine 560: Length = 11\nLine 561: Length = 11\nLine 562: Length = 10\nLine 563: Length = 11\nLine 564: Length = 11\nLine 565: Length = 10\nLine 566: Length = 12\nLine 567: Length = 9\nLine 568: Length = 10\nLine 569: Length = 10\nLine 570: Length = 10\nLine 571: Length = 12\nLine 572: Length = 10\nLine 573: Length = 10\nLine 574: Length = 11\nLine 575: Length = 11\nLine 576: Length = 12\nLine 577: Length = 11\nLine 578: Length = 11\nLine 579: Length = 10\nLine 580: Length = 10\nLine 581: Length = 10\nLine 582: Length = 11\nLine 583: Length = 11\nLine 584: Length = 10\nLine 585: Length = 9\nLine 586: Length = 9\nLine 587: Length = 9\nLine 588: Length = 10\nLine 589: Length = 11\nLine 590: Length = 11\nLine 591: Length = 10\nLine 592: Length = 10\nLine 593: Length = 11\nLine 594: Length = 11\nLine 595: Length = 10\nLine 596: Length = 11\nLine 597: Length = 11\nLine 598: Length = 11\nLine 599: Length = 12\nLine 600: Length = 10\nLine 601: Length = 11\nLine 602: Length = 9\nLine 603: Length = 10\nLine 604: Length = 11\nLine 605: Length = 11\nLine 606: Length = 11\nLine 607: Length = 10\nLine 608: Length = 11\nLine 609: Length = 11\nLine 610: Length = 11\nLine 611: Length = 10\nLine 612: Length = 11\nLine 613: Length = 10\nLine 614: Length = 11\nLine 615: Length = 12\nLine 616: Length = 11\nLine 617: Length = 10\nLine 618: Length = 12\nLine 619: Length = 10\nLine 620: Length = 10\nLine 621: Length = 10\nLine 622: Length = 12\nLine 623: Length = 11\nLine 624: Length = 11\nLine 625: Length = 10\nLine 626: Length = 10\nLine 627: Length = 11\nLine 628: Length = 10\nLine 629: Length = 11\nLine 630: Length = 12\nLine 631: Length = 9\nLine 632: Length = 11\nLine 633: Length = 11\nLine 634: Length = 10\nLine 635: Length = 11\nLine 636: Length = 10\nLine 637: Length = 12\nLine 638: Length = 11\nLine 639: Length = 11\nLine 640: Length = 10\nLine 641: Length = 11\nLine 642: Length = 10\nLine 643: Length = 10\nLine 644: Length = 11\nLine 645: Length = 10\nLine 646: Length = 11\nLine 647: Length = 10\nLine 648: Length = 10\nLine 649: Length = 11\nLine 650: Length = 10\nLine 651: Length = 10\nLine 652: Length = 10\nLine 653: Length = 10\nLine 654: Length = 9\nLine 655: Length = 10\nLine 656: Length = 10\nLine 657: Length = 10\nLine 658: Length = 11\nLine 659: Length = 10\nLine 660: Length = 11\nLine 661: Length = 11\nLine 662: Length = 10\nLine 663: Length = 10\nLine 664: Length = 11\nLine 665: Length = 11\nLine 666: Length = 11\nLine 667: Length = 11\nLine 668: Length = 10\nLine 669: Length = 10\nLine 670: Length = 11\nLine 671: Length = 10\nLine 672: Length = 10\nLine 673: Length = 10\nLine 674: Length = 12\nLine 675: Length = 11\nLine 676: Length = 10\nLine 677: Length = 11\nLine 678: Length = 10\nLine 679: Length = 10\nLine 680: Length = 10\nLine 681: Length = 10\nLine 682: Length = 10\nLine 683: Length = 11\nLine 684: Length = 10\nLine 685: Length = 12\nLine 686: Length = 10\nLine 687: Length = 11\nLine 688: Length = 11\nLine 689: Length = 10\nLine 690: Length = 10\nLine 691: Length = 10\nLine 692: Length = 10\nLine 693: Length = 10\nLine 694: Length = 10\nLine 695: Length = 10\nLine 696: Length = 10\nLine 697: Length = 12\nLine 698: Length = 12\nLine 699: Length = 10\nLine 700: Length = 12\nLine 701: Length = 10\nLine 702: Length = 11\nLine 703: Length = 11\nLine 704: Length = 10\nLine 705: Length = 10\nLine 706: Length = 11\nLine 707: Length = 9\nLine 708: Length = 11\nLine 709: Length = 10\nLine 710: Length = 10\nLine 711: Length = 11\nLine 712: Length = 11\nLine 713: Length = 10\nLine 714: Length = 11\nLine 715: Length = 11\nLine 716: Length = 10\nLine 717: Length = 10\nLine 718: Length = 12\nLine 719: Length = 11\nLine 720: Length = 10\nLine 721: Length = 12\nLine 722: Length = 10\nLine 723: Length = 10\nLine 724: Length = 10\nLine 725: Length = 10\nLine 726: Length = 10\nLine 727: Length = 10\nLine 728: Length = 10\nLine 729: Length = 10\nLine 730: Length = 9\nLine 731: Length = 10\nLine 732: Length = 10\nLine 733: Length = 10\nLine 734: Length = 11\nLine 735: Length = 10\nLine 736: Length = 12\nLine 737: Length = 11\nLine 738: Length = 11\nLine 739: Length = 11\nLine 740: Length = 11\nLine 741: Length = 10\nLine 742: Length = 9\nLine 743: Length = 10\nLine 744: Length = 10\nLine 745: Length = 10\nLine 746: Length = 11\nLine 747: Length = 11\nLine 748: Length = 10\nLine 749: Length = 12\nLine 750: Length = 10\nLine 751: Length = 10\nLine 752: Length = 10\nLine 753: Length = 11\nLine 754: Length = 11\nLine 755: Length = 11\nLine 756: Length = 10\nLine 757: Length = 11\nLine 758: Length = 10\nLine 759: Length = 10\nLine 760: Length = 12\nLine 761: Length = 10\nLine 762: Length = 10\nLine 763: Length = 10\nLine 764: Length = 12\nLine 765: Length = 11\nLine 766: Length = 9\nLine 767: Length = 10\nLine 768: Length = 11\nLine 769: Length = 9\nLine 770: Length = 10\nLine 771: Length = 11\nLine 772: Length = 10\nLine 773: Length = 11\nLine 774: Length = 9\nLine 775: Length = 11\nLine 776: Length = 11\nLine 777: Length = 11\nLine 778: Length = 10\nLine 779: Length = 12\nLine 780: Length = 10\nLine 781: Length = 12\nLine 782: Length = 11\nLine 783: Length = 10\nLine 784: Length = 11\nLine 785: Length = 10\nLine 786: Length = 10\nLine 787: Length = 10\nLine 788: Length = 10\nLine 789: Length = 10\nLine 790: Length = 11\nLine 791: Length = 11\nLine 792: Length = 11\nLine 793: Length = 11\nLine 794: Length = 12\nLine 795: Length = 10\nLine 796: Length = 11\nLine 797: Length = 10\nLine 798: Length = 9\nLine 799: Length = 9\nLine 800: Length = 11\nLine 801: Length = 11\nLine 802: Length = 12\nLine 803: Length = 10\nLine 804: Length = 11\nLine 805: Length = 12\nLine 806: Length = 12\nLine 807: Length = 10\nLine 808: Length = 11\nLine 809: Length = 9\nLine 810: Length = 10\nLine 811: Length = 10\nLine 812: Length = 10\nLine 813: Length = 9\nLine 814: Length = 10\nLine 815: Length = 10\nLine 816: Length = 10\nLine 817: Length = 10\nLine 818: Length = 10\nLine 819: Length = 9\nLine 820: Length = 10\nLine 821: Length = 10\nLine 822: Length = 11\nLine 823: Length = 10\nLine 824: Length = 10\nLine 825: Length = 11\nLine 826: Length = 11\nLine 827: Length = 12\nLine 828: Length = 9\nLine 829: Length = 10\nLine 830: Length = 10\nLine 831: Length = 11\nLine 832: Length = 10\nLine 833: Length = 10\nLine 834: Length = 10\nLine 835: Length = 10\nLine 836: Length = 9\nLine 837: Length = 10\nLine 838: Length = 12\nLine 839: Length = 11\nLine 840: Length = 11\nLine 841: Length = 11\nLine 842: Length = 10\nLine 843: Length = 10\nLine 844: Length = 10\nLine 845: Length = 11\nLine 846: Length = 10\nLine 847: Length = 10\nLine 848: Length = 11\nLine 849: Length = 11\nLine 850: Length = 10\nLine 851: Length = 10\nLine 852: Length = 10\nLine 853: Length = 12\nLine 854: Length = 10\nLine 855: Length = 11\nLine 856: Length = 11\nLine 857: Length = 11\nLine 858: Length = 11\nLine 859: Length = 10\nLine 860: Length = 12\nLine 861: Length = 12\nLine 862: Length = 11\nLine 863: Length = 10\nLine 864: Length = 11\nLine 865: Length = 11\nLine 866: Length = 10\nLine 867: Length = 10\nLine 868: Length = 11\nLine 869: Length = 10\nLine 870: Length = 10\nLine 871: Length = 11\nLine 872: Length = 10\nLine 873: Length = 11\nLine 874: Length = 9\nLine 875: Length = 11\nLine 876: Length = 10\nLine 877: Length = 10\nLine 878: Length = 10\nLine 879: Length = 10\nLine 880: Length = 10\nLine 881: Length = 11\nLine 882: Length = 11\nLine 883: Length = 12\nLine 884: Length = 11\nLine 885: Length = 10\nLine 886: Length = 10\nLine 887: Length = 10\nLine 888: Length = 10\nLine 889: Length = 10\nLine 890: Length = 10\nLine 891: Length = 10\nLine 892: Length = 11\nLine 893: Length = 10\nLine 894: Length = 11\nLine 895: Length = 12\nLine 896: Length = 10\nLine 897: Length = 11\nLine 898: Length = 9\nLine 899: Length = 12\nLine 900: Length = 10\nLine 901: Length = 10\nLine 902: Length = 11\nLine 903: Length = 10\nLine 904: Length = 11\nLine 905: Length = 10\nLine 906: Length = 10\nLine 907: Length = 12\nLine 908: Length = 11\nLine 909: Length = 11\nLine 910: Length = 10\nLine 911: Length = 11\nLine 912: Length = 11\nLine 913: Length = 11\nLine 914: Length = 10\nLine 915: Length = 11\nLine 916: Length = 11\nLine 917: Length = 10\nLine 918: Length = 11\nLine 919: Length = 11\nLine 920: Length = 12\nLine 921: Length = 9\nLine 922: Length = 11\nLine 923: Length = 12\nLine 924: Length = 10\nLine 925: Length = 10\nLine 926: Length = 11\nLine 927: Length = 12\nLine 928: Length = 10\nLine 929: Length = 10\nLine 930: Length = 10\nLine 931: Length = 10\nLine 932: Length = 10\nLine 933: Length = 11\nLine 934: Length = 11\nLine 935: Length = 11\nLine 936: Length = 10\nLine 937: Length = 11\nLine 938: Length = 12\nLine 939: Length = 9\nLine 940: Length = 12\nLine 941: Length = 10\nLine 942: Length = 10\nLine 943: Length = 10\nLine 944: Length = 11\nLine 945: Length = 10\nLine 946: Length = 11\nLine 947: Length = 10\nLine 948: Length = 11\nLine 949: Length = 11\nLine 950: Length = 11\nLine 951: Length = 10\nLine 952: Length = 11\nLine 953: Length = 11\nLine 954: Length = 10\nLine 955: Length = 10\nLine 956: Length = 11\nLine 957: Length = 10\nLine 958: Length = 10\nLine 959: Length = 10\nLine 960: Length = 11\nLine 961: Length = 10\nLine 962: Length = 10\nLine 963: Length = 11\nLine 964: Length = 11\nLine 965: Length = 11\nLine 966: Length = 10\nLine 967: Length = 10\nLine 968: Length = 11\nLine 969: Length = 10\nLine 970: Length = 11\nLine 971: Length = 10\nLine 972: Length = 11\nLine 973: Length = 12\nLine 974: Length = 10\nLine 975: Length = 10\nLine 976: Length = 12\nLine 977: Length = 12\nLine 978: Length = 10\nLine 979: Length = 8\nLine 980: Length = 11\nLine 981: Length = 10\nLine 982: Length = 12\nLine 983: Length = 10\nLine 984: Length = 11\nLine 985: Length = 11\nLine 986: Length = 11\nLine 987: Length = 12\nLine 988: Length = 11\nLine 989: Length = 11\nLine 990: Length = 10\nLine 991: Length = 10\nLine 992: Length = 10\nLine 993: Length = 10\nLine 994: Length = 12\nLine 995: Length = 9\nLine 996: Length = 10\nLine 997: Length = 10\nLine 998: Length = 11\nLine 999: Length = 11\nLine 1000: Length = 11\nLine 1001: Length = 11\nLine 1002: Length = 9\nLine 1003: Length = 10\nLine 1004: Length = 10\nLine 1005: Length = 10\nLine 1006: Length = 10\nLine 1007: Length = 11\nLine 1008: Length = 10\nLine 1009: Length = 10\nLine 1010: Length = 12\nLine 1011: Length = 9\nLine 1012: Length = 11\nLine 1013: Length = 10\nLine 1014: Length = 10\nLine 1015: Length = 10\nLine 1016: Length = 10\nLine 1017: Length = 10\nLine 1018: Length = 10\nLine 1019: Length = 10\nLine 1020: Length = 10\nLine 1021: Length = 11\nLine 1022: Length = 11\nLine 1023: Length = 10\nLine 1024: Length = 10\nLine 1025: Length = 10\nLine 1026: Length = 9\nLine 1027: Length = 10\nLine 1028: Length = 9\nLine 1029: Length = 10\nLine 1030: Length = 10\nLine 1031: Length = 10\nLine 1032: Length = 12\nLine 1033: Length = 10\nLine 1034: Length = 12\nLine 1035: Length = 10\nLine 1036: Length = 10\nLine 1037: Length = 11\nLine 1038: Length = 10\nLine 1039: Length = 10\nLine 1040: Length = 10\nLine 1041: Length = 10\nLine 1042: Length = 11\nLine 1043: Length = 10\nLine 1044: Length = 10\nLine 1045: Length = 11\nLine 1046: Length = 11\nLine 1047: Length = 10\nLine 1048: Length = 10\nLine 1049: Length = 10\nLine 1050: Length = 11\nLine 1051: Length = 10\nLine 1052: Length = 10\nLine 1053: Length = 10\nLine 1054: Length = 11\nLine 1055: Length = 11\nLine 1056: Length = 11\nLine 1057: Length = 9\nLine 1058: Length = 10\nLine 1059: Length = 11\nLine 1060: Length = 11\nLine 1061: Length = 12\nLine 1062: Length = 11\nLine 1063: Length = 10\nLine 1064: Length = 10\nLine 1065: Length = 10\nLine 1066: Length = 9\nLine 1067: Length = 10\nLine 1068: Length = 10\nLine 1069: Length = 11\nLine 1070: Length = 11\nLine 1071: Length = 11\nLine 1072: Length = 11\nLine 1073: Length = 12\nLine 1074: Length = 10\nLine 1075: Length = 10\nLine 1076: Length = 11\nLine 1077: Length = 11\nLine 1078: Length = 10\nLine 1079: Length = 11\nLine 1080: Length = 10\nLine 1081: Length = 10\nLine 1082: Length = 9\nLine 1083: Length = 11\nLine 1084: Length = 4\nLine 1085: Length = 10\nLine 1086: Length = 11\nLine 1087: Length = 10\nLine 1088: Length = 10\nLine 1089: Length = 10\nLine 1090: Length = 10\nLine 1091: Length = 11\nLine 1092: Length = 11\nLine 1093: Length = 10\nLine 1094: Length = 10\nLine 1095: Length = 11\nLine 1096: Length = 12\nLine 1097: Length = 10\nLine 1098: Length = 11\nLine 1099: Length = 12\nLine 1100: Length = 12\nLine 1101: Length = 10\nLine 1102: Length = 10\nLine 1103: Length = 11\nLine 1104: Length = 11\nLine 1105: Length = 9\nLine 1106: Length = 12\nLine 1107: Length = 11\nLine 1108: Length = 11\nLine 1109: Length = 12\nLine 1110: Length = 10\nLine 1111: Length = 11\nLine 1112: Length = 11\nLine 1113: Length = 11\nLine 1114: Length = 10\nLine 1115: Length = 10\nLine 1116: Length = 10\nLine 1117: Length = 11\nLine 1118: Length = 10\nLine 1119: Length = 12\nLine 1120: Length = 11\nLine 1121: Length = 10\nLine 1122: Length = 10\nLine 1123: Length = 10\nLine 1124: Length = 11\nLine 1125: Length = 10\nLine 1126: Length = 11\nLine 1127: Length = 11\nLine 1128: Length = 11\nLine 1129: Length = 10\nLine 1130: Length = 11\nLine 1131: Length = 11\nLine 1132: Length = 11\nLine 1133: Length = 10\nLine 1134: Length = 10\nLine 1135: Length = 11\nLine 1136: Length = 10\nLine 1137: Length = 11\nLine 1138: Length = 10\nL\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nength = 10\nLine 477704: Length = 10\nLine 477705: Length = 12\nLine 477706: Length = 9\nLine 477707: Length = 11\nLine 477708: Length = 11\nLine 477709: Length = 12\nLine 477710: Length = 11\nLine 477711: Length = 11\nLine 477712: Length = 10\nLine 477713: Length = 11\nLine 477714: Length = 11\nLine 477715: Length = 10\nLine 477716: Length = 9\nLine 477717: Length = 10\nLine 477718: Length = 11\nLine 477719: Length = 10\nLine 477720: Length = 12\nLine 477721: Length = 10\nLine 477722: Length = 12\nLine 477723: Length = 11\nLine 477724: Length = 11\nLine 477725: Length = 12\nLine 477726: Length = 10\nLine 477727: Length = 10\nLine 477728: Length = 10\nLine 477729: Length = 10\nLine 477730: Length = 9\nLine 477731: Length = 10\nLine 477732: Length = 12\nLine 477733: Length = 10\nLine 477734: Length = 11\nLine 477735: Length = 11\nLine 477736: Length = 11\nLine 477737: Length = 12\nLine 477738: Length = 10\nLine 477739: Length = 9\nLine 477740: Length = 10\nLine 477741: Length = 10\nLine 477742: Length = 11\nLine 477743: Length = 9\nLine 477744: Length = 10\nLine 477745: Length = 10\nLine 477746: Length = 11\nLine 477747: Length = 11\nLine 477748: Length = 11\nLine 477749: Length = 10\nLine 477750: Length = 11\nLine 477751: Length = 12\nLine 477752: Length = 11\nLine 477753: Length = 12\nLine 477754: Length = 10\nLine 477755: Length = 11\nLine 477756: Length = 11\nLine 477757: Length = 12\nLine 477758: Length = 11\nLine 477759: Length = 10\nLine 477760: Length = 10\nLine 477761: Length = 10\nLine 477762: Length = 11\nLine 477763: Length = 11\nLine 477764: Length = 10\nLine 477765: Length = 11\nLine 477766: Length = 9\nLine 477767: Length = 10\nLine 477768: Length = 11\nLine 477769: Length = 10\nLine 477770: Length = 11\nLine 477771: Length = 10\nLine 477772: Length = 10\nLine 477773: Length = 10\nLine 477774: Length = 12\nLine 477775: Length = 10\nLine 477776: Length = 10\nLine 477777: Length = 12\nLine 477778: Length = 10\nLine 477779: Length = 10\nLine 477780: Length = 10\nLine 477781: Length = 10\nLine 477782: Length = 10\nLine 477783: Length = 12\nLine 477784: Length = 11\nLine 477785: Length = 11\nLine 477786: Length = 11\nLine 477787: Length = 12\nLine 477788: Length = 10\nLine 477789: Length = 10\nLine 477790: Length = 10\nLine 477791: Length = 10\nLine 477792: Length = 10\nLine 477793: Length = 10\nLine 477794: Length = 10\nLine 477795: Length = 10\nLine 477796: Length = 10\nLine 477797: Length = 11\nLine 477798: Length = 11\nLine 477799: Length = 10\nLine 477800: Length = 10\nLine 477801: Length = 10\nLine 477802: Length = 12\nLine 477803: Length = 12\nLine 477804: Length = 12\nLine 477805: Length = 11\nLine 477806: Length = 12\nLine 477807: Length = 10\nLine 477808: Length = 10\nLine 477809: Length = 11\nLine 477810: Length = 10\nLine 477811: Length = 10\nLine 477812: Length = 10\nLine 477813: Length = 10\nLine 477814: Length = 10\nLine 477815: Length = 11\nLine 477816: Length = 11\nLine 477817: Length = 12\nLine 477818: Length = 10\nLine 477819: Length = 9\nLine 477820: Length = 10\nLine 477821: Length = 12\nLine 477822: Length = 10\nLine 477823: Length = 10\nLine 477824: Length = 10\nLine 477825: Length = 11\nLine 477826: Length = 11\nLine 477827: Length = 10\nLine 477828: Length = 10\nLine 477829: Length = 10\nLine 477830: Length = 12\nLine 477831: Length = 10\nLine 477832: Length = 10\nLine 477833: Length = 12\nLine 477834: Length = 10\nLine 477835: Length = 10\nLine 477836: Length = 11\nLine 477837: Length = 10\nLine 477838: Length = 10\nLine 477839: Length = 10\nLine 477840: Length = 10\nLine 477841: Length = 11\nLine 477842: Length = 11\nLine 477843: Length = 11\nLine 477844: Length = 10\nLine 477845: Length = 11\nLine 477846: Length = 10\nLine 477847: Length = 11\nLine 477848: Length = 10\nLine 477849: Length = 11\nLine 477850: Length = 11\nLine 477851: Length = 11\nLine 477852: Length = 11\nLine 477853: Length = 11\nLine 477854: Length = 12\nLine 477855: Length = 10\nLine 477856: Length = 9\nLine 477857: Length = 9\nLine 477858: Length = 10\nLine 477859: Length = 10\nLine 477860: Length = 10\nLine 477861: Length = 11\nLine 477862: Length = 11\nLine 477863: Length = 11\nLine 477864: Length = 11\nLine 477865: Length = 11\nLine 477866: Length = 11\nLine 477867: Length = 10\nLine 477868: Length = 10\nLine 477869: Length = 11\nLine 477870: Length = 10\nLine 477871: Length = 11\nLine 477872: Length = 10\nLine 477873: Length = 11\nLine 477874: Length = 9\nLine 477875: Length = 12\nLine 477876: Length = 10\nLine 477877: Length = 10\nLine 477878: Length = 10\nLine 477879: Length = 10\nLine 477880: Length = 12\nLine 477881: Length = 11\nLine 477882: Length = 11\nLine 477883: Length = 11\nLine 477884: Length = 11\nLine 477885: Length = 10\nLine 477886: Length = 10\nLine 477887: Length = 12\nLine 477888: Length = 10\nLine 477889: Length = 9\nLine 477890: Length = 11\nLine 477891: Length = 10\nLine 477892: Length = 11\nLine 477893: Length = 12\nLine 477894: Length = 10\nLine 477895: Length = 10\nLine 477896: Length = 11\nLine 477897: Length = 11\nLine 477898: Length = 11\nLine 477899: Length = 10\nLine 477900: Length = 10\nLine 477901: Length = 11\nLine 477902: Length = 9\nLine 477903: Length = 11\nLine 477904: Length = 10\nLine 477905: Length = 11\nLine 477906: Length = 12\nLine 477907: Length = 12\nLine 477908: Length = 9\nLine 477909: Length = 10\nLine 477910: Length = 10\nLine 477911: Length = 9\nLine 477912: Length = 10\nLine 477913: Length = 10\nLine 477914: Length = 10\nLine 477915: Length = 10\nLine 477916: Length = 10\nLine 477917: Length = 10\nLine 477918: Length = 11\nLine 477919: Length = 10\nLine 477920: Length = 10\nLine 477921: Length = 10\nLine 477922: Length = 12\nLine 477923: Length = 10\nLine 477924: Length = 10\nLine 477925: Length = 10\nLine 477926: Length = 11\nLine 477927: Length = 10\nLine 477928: Length = 10\nLine 477929: Length = 11\nLine 477930: Length = 10\nLine 477931: Length = 9\nLine 477932: Length = 12\nLine 477933: Length = 11\nLine 477934: Length = 10\nLine 477935: Length = 11\nLine 477936: Length = 10\nLine 477937: Length = 12\nLine 477938: Length = 11\nLine 477939: Length = 10\nLine 477940: Length = 11\nLine 477941: Length = 11\nLine 477942: Length = 9\nLine 477943: Length = 12\nLine 477944: Length = 10\nLine 477945: Length = 10\nLine 477946: Length = 10\nLine 477947: Length = 11\nLine 477948: Length = 10\nLine 477949: Length = 9\nLine 477950: Length = 10\nLine 477951: Length = 10\nLine 477952: Length = 11\nLine 477953: Length = 10\nLine 477954: Length = 11\nLine 477955: Length = 11\nLine 477956: Length = 10\nLine 477957: Length = 11\nLine 477958: Length = 11\nLine 477959: Length = 9\nLine 477960: Length = 10\nLine 477961: Length = 9\nLine 477962: Length = 10\nLine 477963: Length = 10\nLine 477964: Length = 10\nLine 477965: Length = 11\nLine 477966: Length = 1\nLine 477967: Length = 10\nLine 477968: Length = 12\nLine 477969: Length = 10\nLine 477970: Length = 11\nLine 477971: Length = 10\nLine 477972: Length = 10\nLine 477973: Length = 11\nLine 477974: Length = 9\nLine 477975: Length = 11\nLine 477976: Length = 11\nLine 477977: Length = 10\nLine 477978: Length = 10\nLine 477979: Length = 10\nLine 477980: Length = 9\nLine 477981: Length = 12\nLine 477982: Length = 11\nLine 477983: Length = 10\nLine 477984: Length = 10\nLine 477985: Length = 11\nLine 477986: Length = 11\nLine 477987: Length = 10\nLine 477988: Length = 11\nLine 477989: Length = 11\nLine 477990: Length = 12\nLine 477991: Length = 12\nLine 477992: Length = 10\nLine 477993: Length = 10\nLine 477994: Length = 10\nLine 477995: Length = 10\nLine 477996: Length = 10\nLine 477997: Length = 11\nLine 477998: Length = 11\nLine 477999: Length = 10\nLine 478000: Length = 12\nLine 478001: Length = 10\nLine 478002: Length = 10\nLine 478003: Length = 11\nLine 478004: Length = 12\nLine 478005: Length = 11\nLine 478006: Length = 10\nLine 478007: Length = 12\nLine 478008: Length = 10\nLine 478009: Length = 10\nLine 478010: Length = 10\nLine 478011: Length = 11\nLine 478012: Length = 11\nLine 478013: Length = 10\nLine 478014: Length = 11\nLine 478015: Length = 11\nLine 478016: Length = 11\nLine 478017: Length = 10\nLine 478018: Length = 10\nLine 478019: Length = 10\nLine 478020: Length = 11\nLine 478021: Length = 10\nLine 478022: Length = 10\nLine 478023: Length = 10\nLine 478024: Length = 10\nLine 478025: Length = 10\nLine 478026: Length = 11\nLine 478027: Length = 10\nLine 478028: Length = 10\nLine 478029: Length = 10\nLine 478030: Length = 10\nLine 478031: Length = 9\nLine 478032: Length = 10\nLine 478033: Length = 10\nLine 478034: Length = 10\nLine 478035: Length = 11\nLine 478036: Length = 12\nLine 478037: Length = 11\nLine 478038: Length = 11\nLine 478039: Length = 10\nLine 478040: Length = 10\nLine 478041: Length = 11\nLine 478042: Length = 11\nLine 478043: Length = 10\nLine 478044: Length = 11\nLine 478045: Length = 11\nLine 478046: Length = 10\nLine 478047: Length = 10\nLine 478048: Length = 11\nLine 478049: Length = 12\nLine 478050: Length = 12\nLine 478051: Length = 10\nLine 478052: Length = 10\nLine 478053: Length = 10\nLine 478054: Length = 10\nLine 478055: Length = 12\nLine 478056: Length = 10\nLine 478057: Length = 11\nLine 478058: Length = 11\nLine 478059: Length = 11\nLine 478060: Length = 9\nLine 478061: Length = 11\nLine 478062: Length = 10\nLine 478063: Length = 11\nLine 478064: Length = 12\nLine 478065: Length = 10\nLine 478066: Length = 11\nLine 478067: Length = 10\nLine 478068: Length = 10\nLine 478069: Length = 10\nLine 478070: Length = 10\nLine 478071: Length = 10\nLine 478072: Length = 9\nLine 478073: Length = 9\nLine 478074: Length = 11\nLine 478075: Length = 11\nLine 478076: Length = 11\nLine 478077: Length = 11\nLine 478078: Length = 11\nLine 478079: Length = 11\nLine 478080: Length = 10\nLine 478081: Length = 4\nLine 478082: Length = 11\nLine 478083: Length = 12\nLine 478084: Length = 11\nLine 478085: Length = 10\nLine 478086: Length = 10\nLine 478087: Length = 10\nLine 478088: Length = 10\nLine 478089: Length = 10\nLine 478090: Length = 12\nLine 478091: Length = 10\nLine 478092: Length = 9\nLine 478093: Length = 10\nLine 478094: Length = 10\nLine 478095: Length = 11\nLine 478096: Length = 10\nLine 478097: Length = 10\nLine 478098: Length = 12\nLine 478099: Length = 10\nLine 478100: Length = 10\nLine 478101: Length = 11\nLine 478102: Length = 9\nLine 478103: Length = 10\nLine 478104: Length = 10\nLine 478105: Length = 12\nLine 478106: Length = 10\nLine 478107: Length = 10\nLine 478108: Length = 10\nLine 478109: Length = 10\nLine 478110: Length = 11\nLine 478111: Length = 12\nLine 478112: Length = 10\nLine 478113: Length = 10\nLine 478114: Length = 10\nLine 478115: Length = 11\nLine 478116: Length = 10\nLine 478117: Length = 9\nLine 478118: Length = 10\nLine 478119: Length = 10\nLine 478120: Length = 11\nLine 478121: Length = 10\nLine 478122: Length = 11\nLine 478123: Length = 10\nLine 478124: Length = 11\nLine 478125: Length = 10\nLine 478126: Length = 11\nLine 478127: Length = 10\nLine 478128: Length = 12\nLine 478129: Length = 10\nLine 478130: Length = 10\nLine 478131: Length = 10\nLine 478132: Length = 10\nLine 478133: Length = 10\nLine 478134: Length = 10\nLine 478135: Length = 10\nLine 478136: Length = 10\nLine 478137: Length = 10\nLine 478138: Length = 11\nLine 478139: Length = 10\nLine 478140: Length = 11\nLine 478141: Length = 10\nLine 478142: Length = 10\nLine 478143: Length = 12\nLine 478144: Length = 10\nLine 478145: Length = 10\nLine 478146: Length = 11\nLine 478147: Length = 11\nLine 478148: Length = 11\nLine 478149: Length = 11\nLine 478150: Length = 10\nLine 478151: Length = 10\nLine 478152: Length = 10\nLine 478153: Length = 10\nLine 478154: Length = 12\nLine 478155: Length = 11\nLine 478156: Length = 10\nLine 478157: Length = 10\nLine 478158: Length = 10\nLine 478159: Length = 11\nLine 478160: Length = 11\nLine 478161: Length = 9\nLine 478162: Length = 10\nLine 478163: Length = 11\nLine 478164: Length = 9\nLine 478165: Length = 11\nLine 478166: Length = 10\nLine 478167: Length = 11\nLine 478168: Length = 10\nLine 478169: Length = 10\nLine 478170: Length = 10\nLine 478171: Length = 11\nLine 478172: Length = 10\nLine 478173: Length = 10\nLine 478174: Length = 11\nLine 478175: Length = 11\nLine 478176: Length = 9\nLine 478177: Length = 12\nLine 478178: Length = 10\nLine 478179: Length = 10\nLine 478180: Length = 12\nLine 478181: Length = 11\nLine 478182: Length = 10\nLine 478183: Length = 11\nLine 478184: Length = 10\nLine 478185: Length = 12\nLine 478186: Length = 11\nLine 478187: Length = 11\nLine 478188: Length = 12\nLine 478189: Length = 11\nLine 478190: Length = 12\nLine 478191: Length = 10\nLine 478192: Length = 11\nLine 478193: Length = 11\nLine 478194: Length = 10\nLine 478195: Length = 11\nLine 478196: Length = 10\nLine 478197: Length = 11\nLine 478198: Length = 10\nLine 478199: Length = 11\nLine 478200: Length = 10\nLine 478201: Length = 11\nLine 478202: Length = 10\nLine 478203: Length = 10\nLine 478204: Length = 10\nLine 478205: Length = 10\nLine 478206: Length = 11\nLine 478207: Length = 11\nLine 478208: Length = 10\nLine 478209: Length = 9\nLine 478210: Length = 11\nLine 478211: Length = 10\nLine 478212: Length = 12\nLine 478213: Length = 10\nLine 478214: Length = 12\nLine 478215: Length = 10\nLine 478216: Length = 11\nLine 478217: Length = 10\nLine 478218: Length = 11\nLine 478219: Length = 11\nLine 478220: Length = 11\nLine 478221: Length = 10\nLine 478222: Length = 10\nLine 478223: Length = 11\nLine 478224: Length = 11\nLine 478225: Length = 11\nLine 478226: Length = 10\nLine 478227: Length = 10\nLine 478228: Length = 9\nLine 478229: Length = 11\nLine 478230: Length = 10\nLine 478231: Length = 9\nLine 478232: Length = 9\nLine 478233: Length = 11\nLine 478234: Length = 11\nLine 478235: Length = 12\nLine 478236: Length = 10\nLine 478237: Length = 12\nLine 478238: Length = 10\nLine 478239: Length = 10\nLine 478240: Length = 9\nLine 478241: Length = 11\nLine 478242: Length = 10\nLine 478243: Length = 10\nLine 478244: Length = 11\nLine 478245: Length = 11\nLine 478246: Length = 11\nLine 478247: Length = 11\nLine 478248: Length = 11\nLine 478249: Length = 12\nLine 478250: Length = 11\nLine 478251: Length = 10\nLine 478252: Length = 12\nLine 478253: Length = 10\nLine 478254: Length = 11\nLine 478255: Length = 11\nLine 478256: Length = 10\nLine 478257: Length = 10\nLine 478258: Length = 10\nLine 478259: Length = 12\nLine 478260: Length = 10\nLine 478261: Length = 9\nLine 478262: Length = 9\nLine 478263: Length = 11\nLine 478264: Length = 10\nLine 478265: Length = 10\nLine 478266: Length = 11\nLine 478267: Length = 10\nLine 478268: Length = 10\nLine 478269: Length = 10\nLine 478270: Length = 12\nLine 478271: Length = 11\nLine 478272: Length = 10\nLine 478273: Length = 9\nLine 478274: Length = 10\nLine 478275: Length = 10\nLine 478276: Length = 10\nLine 478277: Length = 11\nLine 478278: Length = 10\nLine 478279: Length = 10\nLine 478280: Length = 10\nLine 478281: Length = 10\nLine 478282: Length = 11\nLine 478283: Length = 11\nLine 478284: Length = 10\nLine 478285: Length = 11\nLine 478286: Length = 10\nLine 478287: Length = 11\nLine 478288: Length = 10\nLine 478289: Length = 12\nLine 478290: Length = 12\nLine 478291: Length = 11\nLine 478292: Length = 11\nLine 478293: Length = 11\nLine 478294: Length = 10\nLine 478295: Length = 11\nLine 478296: Length = 10\nLine 478297: Length = 10\nLine 478298: Length = 11\nLine 478299: Length = 9\nLine 478300: Length = 11\nLine 478301: Length = 9\nLine 478302: Length = 10\nLine 478303: Length = 11\nLine 478304: Length = 12\nLine 478305: Length = 11\nLine 478306: Length = 12\nLine 478307: Length = 10\nLine 478308: Length = 10\nLine 478309: Length = 11\nLine 478310: Length = 10\nLine 478311: Length = 10\nLine 478312: Length = 11\nLine 478313: Length = 10\nLine 478314: Length = 10\nLine 478315: Length = 11\nLine 478316: Length = 11\nLine 478317: Length = 10\nLine 478318: Length = 11\nLine 478319: Length = 10\nLine 478320: Length = 11\nLine 478321: Length = 10\nLine 478322: Length = 11\nLine 478323: Length = 10\nLine 478324: Length = 10\nLine 478325: Length = 10\nLine 478326: Length = 10\nLine 478327: Length = 10\nLine 478328: Length = 11\nLine 478329: Length = 9\nLine 478330: Length = 11\nLine 478331: Length = 10\nLine 478332: Length = 10\nLine 478333: Length = 10\nLine 478334: Length = 11\nLine 478335: Length = 10\nLine 478336: Length = 10\nLine 478337: Length = 12\nLine 478338: Length = 10\nLine 478339: Length = 11\nLine 478340: Length = 10\nLine 478341: Length = 9\nLine 478342: Length = 10\nLine 478343: Length = 11\nLine 478344: Length = 11\nLine 478345: Length = 11\nLine 478346: Length = 10\nLine 478347: Length = 12\nLine 478348: Length = 11\nLine 478349: Length = 10\nLine 478350: Length = 12\nLine 478351: Length = 11\nLine 478352: Length = 12\nLine 478353: Length = 11\nLine 478354: Length = 10\nLine 478355: Length = 10\nLine 478356: Length = 10\nLine 478357: Length = 11\nLine 478358: Length = 10\nLine 478359: Length = 10\nLine 478360: Length = 10\nLine 478361: Length = 11\nLine 478362: Length = 10\nLine 478363: Length = 11\nLine 478364: Length = 10\nLine 478365: Length = 11\nLine 478366: Length = 11\nLine 478367: Length = 12\nLine 478368: Length = 11\nLine 478369: Length = 10\nLine 478370: Length = 10\nLine 478371: Length = 10\nLine 478372: Length = 10\nLine 478373: Length = 11\nLine 478374: Length = 10\nLine 478375: Length = 10\nLine 478376: Length = 11\nLine 478377: Length = 10\nLine 478378: Length = 10\nLine 478379: Length = 10\nLine 478380: Length = 11\nLine 478381: Length = 11\nLine 478382: Length = 10\nLine 478383: Length = 10\nLine 478384: Length = 12\nLine 478385: Length = 10\nLine 478386: Length = 12\nLine 478387: Length = 9\nLine 478388: Length = 10\nLine 478389: Length = 9\nLine 478390: Length = 11\nLine 478391: Length = 10\nLine 478392: Length = 10\nLine 478393: Length = 10\nLine 478394: Length = 11\nLine 478395: Length = 10\nLine 478396: Length = 11\nLine 478397: Length = 11\nLine 478398: Length = 11\nLine 478399: Length = 10\nLine 478400: Length = 10\nLine 478401: Length = 11\nLine 478402: Length = 10\nLine 478403: Length = 11\nLine 478404: Length = 11\nLine 478405: Length = 11\nLine 478406: Length = 11\nLine 478407: Length = 11\nLine 478408: Length = 10\nLine 478409: Length = 11\nLine 478410: Length = 11\nLine 478411: Length = 11\nLine 478412: Length = 10\nLine 478413: Length = 10\nLine 478414: Length = 11\nLine 478415: Length = 10\nLine 478416: Length = 11\nLine 478417: Length = 10\nLine 478418: Length = 10\nLine 478419: Length = 12\nLine 478420: Length = 10\nLine 478421: Length = 12\nLine 478422: Length = 10\nLine 478423: Length = 11\nLine 478424: Length = 10\nLine 478425: Length = 12\nLine 478426: Length = 11\nLine 478427: Length = 11\nLine 478428: Length = 10\nLine 478429: Length = 12\nLine 478430: Length = 10\nLine 478431: Length = 10\nLine 478432: Length = 11\nLine 478433: Length = 10\nLine 478434: Length = 10\nLine 478435: Length = 10\nLine 478436: Length = 10\nLine 478437: Length = 12\nLine 478438: Length = 10\nLine 478439: Length = 11\nLine 478440: Length = 11\nLine 478441: Length = 11\nLine 478442: Length = 10\nLine 478443: Length = 12\nLine 478444: Length = 10\nLine 478445: Length = 10\nLine 478446: Length = 10\nLine 478447: Length = 10\nLine 478448: Length = 11\nLine 478449: Length = 11\nLine 478450: Length = 10\nLine 478451: Length = 10\nLine 478452: Length = 10\nLine 478453: Length = 10\nLine 478454: Length = 9\nLine 478455: Length = 11\nLine 478456: Length = 10\nLine 478457: Length = 10\nLine 478458: Length = 10\nLine 478459: Length = 10\nLine 478460: Length = 11\nLine 478461: Length = 10\nLine 478462: Length = 10\nLine 478463: Length = 11\nLine 478464: Length = 11\nLine 478465: Length = 10\nLine 478466: Length = 11\nLine 478467: Length = 10\nLine 478468: Length = 11\nLine 478469: Length = 10\nLine 478470: Length = 12\nLine 478471: Length = 10\nLine 478472: Length = 11\nLine 478473: Length = 11\nLine 478474: Length = 11\nLine 478475: Length = 10\nLine 478476: Length = 11\nLine 478477: Length = 10\nLine 478478: Length = 10\nLine 478479: Length = 10\nLine 478480: Length = 10\nLine 478481: Length = 9\nLine 478482: Length = 11\nLine 478483: Length = 9\nLine 478484: Length = 9\nLine 478485: Length = 10\nLine 478486: Length = 12\nLine 478487: Length = 10\nLine 478488: Length = 10\nLine 478489: Length = 10\nLine 478490: Length = 10\nLine 478491: Length = 11\nLine 478492: Length = 10\nLine 478493: Length = 10\nLine 478494: Length = 9\nLine 478495: Length = 10\nLine 478496: Length = 10\nLine 478497: Length = 10\nLine 478498: Length = 11\nLine 478499: Length = 11\nLine 478500: Length = 11\nLine 478501: Length = 10\nLine 478502: Length = 10\nLine 478503: Length = 10\nLine 478504: Length = 12\nLine 478505: Length = 10\nLine 478506: Length = 12\nLine 478507: Length = 10\nLine 478508: Length = 11\nLine 478509: Length = 11\nLine 478510: Length = 10\nLine 478511: Length = 11\nLine 478512: Length = 11\nLine 478513: Length = 10\nLine 478514: Length = 11\nLine 478515: Length = 11\nLine 478516: Length = 12\nLine 478517: Length = 10\nLine 478518: Length = 10\nLine 478519: Length = 10\nLine 478520: Length = 11\nLine 478521: Length = 11\nLine 478522: Length = 11\nLine 478523: Length = 12\nLine 478524: Length = 11\nLine 478525: Length = 10\nLine 478526: Length = 9\nLine 478527: Length = 10\nLine 478528: Length = 11\nLine 478529: Length = 11\nLine 478530: Length = 10\nLine 478531: Length = 10\nLine 478532: Length = 11\nLine 478533: Length = 10\nLine 478534: Length = 10\nLine 478535: Length = 12\nLine 478536: Length = 12\nLine 478537: Length = 12\nLine 478538: Length = 11\nLine 478539: Length = 11\nLine 478540: Length = 11\nLine 478541: Length = 11\nLine 478542: Length = 10\nLine 478543: Length = 10\nLine 478544: Length = 10\nLine 478545: Length = 11\nLine 478546: Length = 10\nLine 478547: Length = 10\nLine 478548: Length = 10\nLine 478549: Length = 10\nLine 478550: Length = 10\nLine 478551: Length = 10\nLine 478552: Length = 10\nLine 478553: Length = 10\nLine 478554: Length = 10\nLine 478555: Length = 10\nLine 478556: Length = 11\nLine 478557: Length = 10\nLine 478558: Length = 10\nLine 478559: Length = 10\nLine 478560: Length = 9\nLine 478561: Length = 10\nLine 478562: Length = 11\nLine 478563: Length = 11\nLine 478564: Length = 11\nLine 478565: Length = 11\nLine 478566: Length = 10\nLine 478567: Length = 11\nLine 478568: Length = 10\nLine 478569: Length = 10\nLine 478570: Length = 10\nLine 478571: Length = 10\nLine 478572: Length = 10\nLine 478573: Length = 10\nLine 478574: Length = 11\nLine 478575: Length = 10\nLine 478576: Length = 11\nLine 478577: Length = 11\nLine 478578: Length = 10\nLine 478579: Length = 9\nLine 478580: Length = 11\nLine 478581: Length = 10\nLine 478582: Length = 12\nLine 478583: Length = 11\nLine 478584: Length = 10\nLine 478585: Length = 8\nLine 478586: Length = 9\nLine 478587: Length = 11\nLine 478588: Length = 10\nLine 478589: Length = 10\nLine 478590: Length = 10\nLine 478591: Length = 10\nLine 478592: Length = 12\nLine 478593: Length = 12\nLine 478594: Length = 11\nLine 478595: Length = 10\nLine 478596: Length = 11\nLine 478597: Length = 10\nLine 478598: Length = 11\nLine 478599: Length = 11\nLine 478600: Length = 11\nLine 478601: Length = 10\nLine 478602: Length = 10\nLine 478603: Length = 11\nLine 478604: Length = 11\nLine 478605: Length = 10\nLine 478606: Length = 9\nLine 478607: Length = 10\nLine 478608: Length = 10\nLine 478609: Length = 10\nLine 478610: Length = 10\nLine 478611: Length = 10\nLine 478612: Length = 11\nLine 478613: Length = 9\nLine 478614: Length = 10\nLine 478615: Length = 10\nLine 478616: Length = 11\nLine 478617: Length = 11\nLine 478618: Length = 12\nLine 478619: Length = 12\nLine 478620: Length = 10\nLine 478621: Length = 10\nLine 478622: Length = 11\nLine 478623: Length = 11\nLine 478624: Length = 11\nLine 478625: Length = 10\nLine 478626: Length = 10\nLine 478627: Length = 10\nLine 478628: Length = 11\nLine 478629: Length = 11\nLine 478630: Length = 11\nLine 478631: Length = 10\nLine 478632: Length = 11\nLine 478633: Length = 10\nLine 478634: Length = 10\nLine 478635: Length = 10\nLine 478636: Length = 12\nLine 478637: Length = 11\nLine 478638: Length = 10\nLine 478639: Length = 10\nLine 478640: Length = 12\nLine 478641: Length = 11\nLine 478642: Length = 10\nLine 478643: Length = 10\nLine 478644: Length = 9\nLine 478645: Length = 11\nLine 478646: Length = 10\nLine 478647: Length = 11\nLine 478648: Length = 10\nLine 478649: Length = 11\nLine 478650: Length = 10\nLine 478651: Length = 11\nLine 478652: Length = 12\nLine 478653: Length = 11\nLine 478654: Length = 10\nLine 478655: Length = 10\nLine 478656: Length = 9\nLine 478657: Length = 11\nLine 478658: Length = 11\nLine 478659: Length = 10\nLine 478660: Length = 10\nLine 478661: Length = 10\nLine 478662: Length = 10\nLine 478663: Length = 12\nLine 478664: Length = 11\nLine 478665: Length = 10\nLine 478666: Length = 10\nLine 478667: Length = 11\nLine 478668: Length = 10\nLine 478669: Length = 11\nLine 478670: Length = 10\nLine 478671: Length = 11\nLine 478672: Length = 10\nLine 478673: Length = 10\nLine 478674: Length = 10\nLine 478675: Length = 11\nLine 478676: Length = 11\nLine 478677: Length = 10\nLine 478678: Length = 11\nLine 478679: Length = 10\nLine 478680: Length = 11\nLine 478681: Length = 12\nLine 478682: Length = 12\nLine 478683: Length = 10\nLine 478684: Length = 10\nLine 478685: Length = 11\nLine 478686: Length = 10\nLine 478687: Length = 11\nLine 478688: Length = 9\nLine 478689: Length = 11\nLine 478690: Length = 10\nLine 478691: Length = 10\nLine 478692: Length = 10\nLine 478693: Length = 11\nLine 478694: Length = 10\nLine 478695: Length = 9\nLine 478696: Length = 12\nLine 478697: Length = 12\nLine 478698: Length = 10\nTotal number of lines with length 9: 25988\nTotal number of lines with length 10: 234595\nTotal number of lines with length 11: 167935\nTotal number of lines with length 12: 47809\n"
     ]
    }
   ],
   "source": [
    "#Checking the count of length of each line after split so that we don't lose on data\n",
    "types = rdd1 \\\n",
    "    .map(lambda x: x.split(\"\\\\t\")) \\\n",
    "\n",
    "# Initialize counters\n",
    "len_9_count = 0\n",
    "len_10_count = 0\n",
    "len_11_count = 0\n",
    "len_12_count = 0\n",
    "\n",
    "# Print the length of each line for 50 lines after the split\n",
    "for i, line in enumerate(types.collect(), 1):\n",
    "    print(f\"Line {i}: Length = {len(line)}\")\n",
    "    if len(line) == 9:\n",
    "        len_9_count += 1\n",
    "    elif len(line) == 10:\n",
    "        len_10_count += 1\n",
    "    elif len(line) == 11:\n",
    "        len_11_count += 1\n",
    "    elif len(line) == 12:\n",
    "        len_12_count += 1\n",
    "\n",
    "# Print total counts\n",
    "print(f\"Total number of lines with length 9: {len_9_count}\")\n",
    "print(f\"Total number of lines with length 10: {len_10_count}\")\n",
    "print(f\"Total number of lines with length 11: {len_11_count}\")\n",
    "print(f\"Total number of lines with length 12: {len_12_count}\")\n",
    "\n",
    "#It was found that after split, the lines have between 9-12 length. Majority of the lines have length 10 & 11"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4d3c2d8c-a107-4c69-b438-0d440a1fb61c",
     "showTitle": false,
     "title": "Question 2: Frequency of Types of studies in dataset"
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Study_Type: INTERVENTIONAL, Frequency: 186900\nStudy_Type: OBSERVATIONAL, Frequency: 47673\nStudy_Type: OTHER, Frequency: 14\n"
     ]
    }
   ],
   "source": [
    "#First Attempt 1 on Question 2 using only lines with length 10, study types index position in this case is 8\n",
    "\n",
    "types = rdd1_splitline \\\n",
    "    .map(lambda x: x.split(\"\\\\t\")) \\\n",
    "    .filter(lambda x: len(x) == 10) \\\n",
    "    .map(lambda x: x[8]) \\\n",
    "    .flatMap(lambda x: x.split(\"|\")) \\\n",
    "    .filter(lambda x: x.strip() != 'Allocated') \\\n",
    "    .filter(lambda x: x.strip() != 'INDUSTRY') \\\n",
    "    .filter(lambda x: x.strip() != 'FED') \\\n",
    "    .map(lambda x: (x.strip(), 1)) \\\n",
    "    .reduceByKey(lambda x, y: x + y) \\\n",
    "    .map(lambda x: (x[1], x[0])) \\\n",
    "    .sortByKey(ascending=False) \\\n",
    "    .map(lambda x: (x[1], x[0]))\n",
    "\n",
    "\n",
    "# Output the top 5\n",
    "study_types = types.take(5)\n",
    "\n",
    "for types, frequency in study_types:\n",
    "    print(f\"Study_Type: {types}, Frequency: {frequency}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "fd96f548-5059-432b-8ad0-a22c7aece71c",
     "showTitle": true,
     "title": "Question 2: Frequency of Types of studies in dataset"
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Study_Type: INTERVENTIONAL, Frequency: 189457\nStudy_Type: OBSERVATIONAL, Frequency: 70860\nStudy_Type: OTHER, Frequency: 132\n"
     ]
    }
   ],
   "source": [
    "#Using all lines in the dataset and adjusting the index position to capture study types.\n",
    "# At the end, I filter values that are not study types\n",
    "\n",
    "# For lines with length 10\n",
    "types_len_10 = rdd1_splitline \\\n",
    "    .map(lambda x: x.split(\"\\\\t\")) \\\n",
    "    .filter(lambda x: len(x) == 10) \\\n",
    "    .map(lambda x: x[8]) \\\n",
    "    .flatMap(lambda x: x.split(\"|\")) \\\n",
    "    .filter(lambda x: x.strip() != 'Allocated') \\\n",
    "    .map(lambda x: (x.strip(), 1)) \\\n",
    "    .reduceByKey(lambda x, y: x + y) \\\n",
    "    .map(lambda x: (x[1], x[0])) \\\n",
    "    .sortByKey(ascending=False) \\\n",
    "    .map(lambda x: (x[1], x[0]))\n",
    "\n",
    "# For lines with length 9\n",
    "types_len_9 = rdd1_splitline \\\n",
    "    .map(lambda x: x.split(\"\\\\t\")) \\\n",
    "    .filter(lambda x: len(x) == 9) \\\n",
    "    .map(lambda x: x[7]) \\\n",
    "    .flatMap(lambda x: x.split(\"|\")) \\\n",
    "    .filter(lambda x: x.strip() != 'Allocated') \\\n",
    "    .map(lambda x: (x.strip(), 1)) \\\n",
    "    .reduceByKey(lambda x, y: x + y) \\\n",
    "    .map(lambda x: (x[1], x[0])) \\\n",
    "    .sortByKey(ascending=False) \\\n",
    "    .map(lambda x: (x[1], x[0]))\n",
    "\n",
    "# For lines with length 11\n",
    "types_len_11 = rdd1_splitline \\\n",
    "    .map(lambda x: x.split(\"\\\\t\")) \\\n",
    "    .filter(lambda x: len(x) == 11) \\\n",
    "    .map(lambda x: x[9]) \\\n",
    "    .flatMap(lambda x: x.split(\"|\")) \\\n",
    "    .filter(lambda x: x.strip() != 'Allocated') \\\n",
    "    .map(lambda x: (x.strip(), 1)) \\\n",
    "    .reduceByKey(lambda x, y: x + y) \\\n",
    "    .map(lambda x: (x[1], x[0])) \\\n",
    "    .sortByKey(ascending=False) \\\n",
    "    .map(lambda x: (x[1], x[0]))\n",
    "\n",
    "# For lines with length 12\n",
    "types_len_12 = rdd1_splitline \\\n",
    "    .map(lambda x: x.split(\"\\\\t\")) \\\n",
    "    .filter(lambda x: len(x) == 12) \\\n",
    "    .map(lambda x: x[10]) \\\n",
    "    .flatMap(lambda x: x.split(\"|\")) \\\n",
    "    .filter(lambda x: x.strip() != 'Allocated') \\\n",
    "    .map(lambda x: (x.strip(), 1)) \\\n",
    "    .reduceByKey(lambda x, y: x + y) \\\n",
    "    .map(lambda x: (x[1], x[0])) \\\n",
    "    .sortByKey(ascending=False) \\\n",
    "    .map(lambda x: (x[1], x[0]))\n",
    "\n",
    "# Combine results for all lengths\n",
    "all_types = types_len_10.union(types_len_9).union(types_len_11).union(types_len_12)\n",
    "\n",
    "# Aggregate frequencies for each study type\n",
    "aggregated_types = all_types.reduceByKey(lambda x, y: x + y)\n",
    "\n",
    "# Sort aggregated types by frequency in ascending order\n",
    "sorted_types = aggregated_types.sortBy(lambda x: x[1], ascending=False)\n",
    "\n",
    "# Output the sorted results\n",
    "for study_type, frequency in sorted_types.take(3):\n",
    "    print(f\"Study_Type: {study_type}, Frequency: {frequency}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {},
     "inputWidgets": {},
     "nuid": "8dd7d283-7712-4556-a777-579a16b4a1d3",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "061cca8c-13c1-4b8a-af3d-9a71f8b54cd3",
     "showTitle": true,
     "title": "Question 3: The Top 5 Conditions with their frequencies"
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Condition: Healthy, Frequency: 7003\nCondition: Breast Cancer, Frequency: 3454\nCondition: Obesity, Frequency: 2863\nCondition: Pain, Frequency: 2379\nCondition: HIV Infections, Frequency: 1992\n"
     ]
    }
   ],
   "source": [
    "#Question 3: The Top 5 Conditions with their frequencies and filter out values that are not condition\n",
    "\n",
    "top5 = rdd1_splitline \\\n",
    "    .map(lambda x: x.split(\"\\\\t\")) \\\n",
    "    .filter(lambda x: len(x) > 3) \\\n",
    "    .map(lambda x: x[3]) \\\n",
    "    .flatMap(lambda x: x.split(\"|\")) \\\n",
    "    .filter(lambda x: x.strip() != 'COMPLETED') \\\n",
    "    .map(lambda x: (x.strip(), 1)) \\\n",
    "    .reduceByKey(lambda x, y: x + y) \\\n",
    "    .map(lambda x: (x[1], x[0])) \\\n",
    "    .sortByKey(ascending=False) \\\n",
    "    .map(lambda x: (x[1], x[0]))\n",
    "\n",
    "\n",
    "# Output the top 5\n",
    "top_5_conditions = top5.take(5)\n",
    "\n",
    "for condition, frequency in top_5_conditions:\n",
    "    print(f\"Condition: {condition}, Frequency: {frequency}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e6e1079e-710f-427e-8953-eb873e1a0690",
     "showTitle": true,
     "title": "10 Most common sponsors that are not pharmacetical companies"
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[Truncated to first 65536 bytes]\nOut[157]: '\"Company\",\"Parent_Company\",\"Penalty_Amount\",\"Subtraction_From_Penalty\",\"Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting\",\"Penalty_Year\",\"Penalty_Date\",\"Offense_Group\",\"Primary_Offense\",\"Secondary_Offense\",\"Description\",\"Level_of_Government\",\"Action_Type\",\"Agency\",\"Civil/Criminal\",\"Prosecution_Agreement\",\"Court\",\"Case_ID\",\"Private_Litigation_Case_Title\",\"Lawsuit_Resolution\",\"Facility_State\",\"City\",\"Address\",\"Zip\",\"NAICS_Code\",\"NAICS_Translation\",\"HQ_Country_of_Parent\",\"HQ_State_of_Parent\",\"Ownership_Structure\",\"Parent_Company_Stock_Ticker\",\"Major_Industry_of_Parent\",\"Specific_Industry_of_Parent\",\"Info_Source\",\"Notes\"\\n\"Abbott Laboratories\",\"Abbott Laboratories\",\"$5,475,000\",\"$0\",\"$5,475,000\",\"2013\",\"20131227\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid, biliary and peripheral vascular products.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\",\"\"\\n\"Abbott Laboratories Inc.\",\"AbbVie\",\"$1,500,000,000\",\"$0\",\"$1,500,000,000\",\"2012\",\"20120507\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\",\"\"\\n\"Abbott Laboratories Inc.\",\"AbbVie\",\"$126,500,000\",\"$0\",\"$126,500,000\",\"2010\",\"20101207\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\",\"\"\\n\"Abbott Laboratories Puerto Rico, Inc.\",\"Abbott Laboratories\",\"$49,045\",\"$0\",\"$49,045\",\"2009\",\"20090305\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1527129\",\"\",\"\",\"Puerto Rico\",\"San Juan\",\"\",\"\",\"423450\",\"423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"\\n\"Acclarent Inc.\",\"Johnson & Johnson\",\"$18,000,000\",\"$0\",\"$18,000,000\",\"2016\",\"20160722\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"California-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act\",\"\"\\n\"Advanced Medical Optics\",\"Abbott Laboratories\",\"$16,800\",\"$0\",\"$16,800\",\"2004\",\"20040412\",\"employment-related offenses\",\"labor relations violation\",\"\",\"back pay award in unfair labor practices case\",\"federal\",\"agency action\",\"National Labor Relations Board\",\"civil\",\"\",\"\",\"21-CA-36104-001\",\"\",\"\",\"California\",\"Irvine\",\"\",\"92606\",\"333314\",\"333314: Optical Instrument and Lens Manufacturing\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"Extracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\",\"\"\\n\"Advanced Neuromodulation Systems, Inc.\",\"Abbott Laboratories\",\"$2,950,000\",\"$0\",\"$2,950,000\",\"2007\",\"20070702\",\"healthcare-related offenses\",\"HHS civil monetary penalties\",\"kickbacks and bribery\",\"The HHS Inspector General announced that Advanced Neuromodulation Systems, Inc.,  a medical device manufacturer specializing in spinal cord stimulation used for pain management, agreed to pay $2.95 million to settle allegations that it paid kickbacks to physicians in violation of the Civil Monetary Penalties Law (CMPL). The company also entered into a 3-year Corporate Integrity Agreement.\",\"federal\",\"agency action\",\"Health & Human Services Department Office of Inspector General\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://oig.hhs.gov/publications/docs/press/2007/ANS%20Press%20Release.pdf\",\"\"\\n\"Advanced Sterilization Products\",\"Johnson & Johnson\",\"$136,800\",\"$0\",\"$136,800\",\"2014\",\"20140520\",\"environment-related offenses\",\"environmental violation\",\"\",\"The U.S. Environmental Protection Agency announced that an Irvine, Calif. company, Advanced Sterilization Products, has agreed to pay a $136,800 penalty for the sale and distribution of unregistered and misbranded pesticides to veterinary clinics and laboratories nationwide.\",\"federal\",\"agency action\",\"Environmental Protection Agency\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://archive.epa.gov/epapages/newsroom_archive/newsreleases/8e820317c86e4c5685257cde00717855.html\",\"\"\\n\"Advanced Sterilization Products, a division of Ethicon Inc.\",\"Johnson & Johnson\",\"$1,200,000\",\"$0\",\"$1,200,000\",\"2013\",\"20131204\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"\",\"Settlement of a civil money penalty action against Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP\\'s executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.\",\"federal\",\"agency action\",\"Food and Drug Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"California\",\"Irvine\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"JNJ\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377588.htm\",\"\"\\n\"Alere San Diego Inc.\",\"Abbott Laboratories\",\"$10,572\",\"$0\",\"$10,572\",\"2017\",\"20170309\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1813371\",\"\",\"\",\"California\",\"Pomona\",\"828 Towne Center Dr.\",\"91767\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"July 23, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"\\n\"Allergan Inc.\",\"AbbVie\",\"$600,000,000\",\"$0\",\"$600,000,000\",\"2010\",\"20100901\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"American pharmaceutical manufacturer Allergan Inc. has agreed to plead guilty and pay $600 million to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of its biological product, Botox Therapeutic, for uses not approved as safe and effective by the Food and Drug Administration. The resolution included a criminal fine and forfeiture totaling $375 million and a civil settlement with the federal government and the states of $225 million.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/allergan-agrees-plead-guilty-and-pay-600-million-resolve-allegations-label-promotion-botox\",\"\"\\n\"Allergan Inc.\",\"AbbVie\",\"$15,000,000\",\"$0\",\"$15,000,000\",\"2017\",\"20170117\",\"financial offenses\",\"investor protection violation\",\"\",\"Allergan Inc. admitted securities law violations and agreed to pay a $15 million penalty for disclosure failures in the wake of a hostile takeover bid.\",\"federal\",\"agency action\",\"Securities and Exchange Commission\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.sec.gov/news/pressrelease/2017-16.html\",\"\"\\n\"Alpharma Inc.\",\"Pfizer\",\"$42,500,000\",\"$0\",\"$42,500,000\",\"2010\",\"20100316\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Alpharma Inc. agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug Kadian. The settlement resolved allegations that between January 1, 2000 and December 29, 2008 Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug. \",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New York\",\"publicly traded\",\"PFE\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/alpharma-pay-425-million-resolve-false-claims-act-allegations-connection-promotion-drug\",\"\"\\n\"Alpharma, Inc.\",\"Pfizer\",\"$2,500,000\",\"$0\",\"$2,500,000\",\"2004\",\"20040812\",\"competition-related offenses\",\"price-fixing or anti-competitive practices\",\"consumer protection violation\",\"Generic drug manufacturers Alpharma Inc. and Perrigo Company agreed to give up a total of $6.25 million in illegal profits to settle Federal Trade Commission allegations that their agreement to limit competition for over-the-counter store-brand children\\'s liquid ibuprofen drove up prices and violated federal law.\",\"federal\",\"agency action\",\"Federal Trade Commission\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New York\",\"publicly traded\",\"PFE\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.ftc.gov/news-events/press-releases/2004/08/generic-drug-marketers-settle-ftc-charges\",\"\"\\n\"American Pharmaceutical Partners, Inc.\",\"Bristol-Myers Squibb\",\"$160,203\",\"$0\",\"$160,203\",\"2004\",\"20041226\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1379241\",\"\",\"\",\"New York\",\"Grand Island\",\"\",\"14072\",\"32541\",\"32541: Pharmaceutical and Medicine Manufacturing\",\"USA\",\"New York\",\"publicly traded\",\"BMY\",\"pharmaceuticals\",\"pharmaceuticals\",\"March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"\\n\"Amgen Inc.\",\"Amgen\",\"$762,000,000\",\"$0\",\"$762,000,000\",\"2012\",\"20121219\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"U.S. District Judge Sterling Johnson, Jr. accepted a guilty plea by American biotechnology giant Amgen Inc. for illegally introducing a misbranded drug into interstate commerce. The plea is part of a global settlement with the United States in which Amgen agreed to pay $762 million to resolve criminal and civil liability arising from its sale and promotion of certain drugs.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"California\",\"publicly traded\",\"AMGN\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/amgen-inc-pleads-guilty-federal-charge-brooklyn-ny-pays-762-million-resolve-criminal\",\"\"\\n\"Amgen Inc.\",\"Amgen\",\"$24,900,000\",\"$0\",\"$24,900,000\",\"2013\",\"20130416\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Amgen Inc. agreed to pay the United States $24.9 million to settle allegations that it violated the False Claims Act. The company was accused of paying kickbacks  to long-term care pharmacy providers Omnicare Inc., PharMerica Corporation and Kindred Healthcare Inc. in return for implementing \"\"therapeutic interchange\"\" programs that were designed to switch Medicare and Medicaid beneficiaries from a competitor drug to Amgen\\'s Aranesp.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"California\",\"publicly traded\",\"AMGN\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/amgen-pay-us-249-million-resolve-false-claims-act-allegations\",\"\"\\n\"Amgen, Inc.\",\"Amgen\",\"$40,000\",\"$0\",\"$40,000\",\"2011\",\"20110302\",\"employment-related offenses\",\"labor relations violation\",\"\",\"back pay award in unfair labor practices case\",\"federal\",\"agency action\",\"National Labor Relations Board\",\"civil\",\"\",\"\",\"14-CA-30273-001\",\"\",\"\",\"Missouri\",\"St. Louis\",\"\",\"63130\",\"541720\",\"541720: Research and Development in the Social Sciences and Humanities\",\"USA\",\"California\",\"publicly traded\",\"AMGN\",\"pharmaceuticals\",\"pharmaceuticals\",\"Extracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\",\"\"\\n\"Amneal Pharmaceuticals of NY, LLC\",\"Amneal Pharmaceuticals\",\"$99,000\",\"$0\",\"$99,000\",\"2015\",\"20150930\",\"employment-related offenses\",\"employment discrimination\",\"\",\"\",\"federal\",\"agency action\",\"Office of Federal Contract Compliance Programs\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"AMRX\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.dol.gov/ofccp/foia/files/AmnealPharmaceuticalsCA_Redacted.pdf\",\"\"\\n\"Astellas Pharma US Inc.\",\"Astellas Pharma\",\"$7,300,000\",\"$0\",\"$7,300,000\",\"2014\",\"20140416\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"off-label or unapproved promotion of medical products\",\"Astellas Pharma US Inc. agreed to pay $7.3 million to resolve allegations that it violated the False Claims Act in connection with its marketing and promotion of the drug Mycamine for pediatric use, which had not received FDA approval.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Japan\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/astellas-pharma-us-inc-pay-73-million-resolve-false-claims-act-allegations-relating-marketing\",\"\"\\n\"AstraZeneca\",\"AstraZeneca\",\"$250,000\",\"$0\",\"$250,000\",\"2011\",\"20110606\",\"employment-related offenses\",\"employment discrimination\",\"\",\"AstraZeneca agreed to pay $250,000 to 124 women who allegedly were subjected to pay discrimination while working at the corporation\\'s Philadelphia Business Center in Wayne, Pa. The action resolved a lawsuit filed by the U.S. Department of Labor in May 2010 alleging that the company discriminated against female sales specialists by paying them salaries that were, on average, $1,700 less than their male counterparts. \",\"federal\",\"agency action\",\"Office of Federal Contract Compliance Programs\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"Pennsylvania\",\"Wayne\",\"\",\"\",\"\",\"\",\"United Kingdom\",\"\",\"publicly traded\",\"LSE: AZN\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.dol.gov/opa/media/press/ofccp/OFCCP20110829.htm\",\"\"\\n\"AstraZeneca LP\",\"AstraZeneca\",\"$520,000,000\",\"$0\",\"$520,000,000\",\"2010\",\"20100427\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration, the Departments of Justice and Health and Human Services\\' Health Care Fraud Enforcement Action Team.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"United Kingdom\",\"\",\"publicly traded\",\"LSE: AZN\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/pharmaceutical-giant-astrazeneca-pay-520-million-label-drug-marketing\",\"\"\\n\"AstraZeneca LP\",\"AstraZeneca\",\"$46,500,000\",\"$0\",\"$46,500,000\",\"2015\",\"20150706\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"AstraZeneca LP agreed to pay the United States and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"United Kingdom\",\"\",\"publicly traded\",\"LSE: AZN\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/astrazeneca-and-cephalon-pay-465-million-and-75-million-respectively-allegedly-underpaying\",\"\"\\n\"AstraZeneca LP\",\"AstraZeneca\",\"$7,900,000\",\"$0\",\"$7,900,000\",\"2015\",\"20150211\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"United Kingdom\",\"\",\"publicly traded\",\"LSE: AZN\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/astrazeneca-pay-79-million-resolve-kickback-allegations\",\"\"\\n\"AstraZeneca Pharmaceuticals\",\"AstraZeneca\",\"$2,600,000\",\"$0\",\"$2,600,000\",\"2009\",\"20091019\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Mylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical entered into settlement agreements for a total of $124 million to resolve claims that they violated the False Claims Act by failing to pay appropriate rebates to state Medicaid programs for drugs paid for by those programs.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"United Kingdom\",\"\",\"publicly traded\",\"LSE: AZN\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/four-pharmaceutical-companies-pay-124-million-submission-false-claims-medicaid\",\"\"\\n\"AstraZeneca Pharmaceuticals LP\",\"AstraZeneca\",\"$354,900,000\",\"$0\",\"$354,900,000\",\"2003\",\"20030620\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"AstraZeneca Pharmaceuticals LP pleaded guilty in federal district court in Wilmington, Delaware and agreed to pay $354.9 million to resolve criminal charges and civil liabilities in connection with its drug pricing and marketing practices with regard to Zoladex, a drug used primarily for the treatment of prostate cancer. AstraZeneca agreed to pay a criminal fine of $63.9 million as part of pleaded guilty to conspiring to violate the Prescription Drug Marketing Act by causing to be submitted claims for payment for the prescription of Zoladex which had been provided as free samples to urologists. AstraZeneca agreed to settle its federal civil False Claim Act liabilities and to pay the U.S. government $266.1 million to resolve allegations it caused false and fraudulent claims to be filed with the Medicare; another $24.9 million was to be paid to states to resolve similar claims concerning Medicaid.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"United Kingdom\",\"\",\"publicly traded\",\"LSE: AZN\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/archive/opa/pr/2003/June/03_civ_371.htm\",\"\"\\n\"AstraZeneca PLC\",\"AstraZeneca\",\"$5,522,000\",\"$0\",\"$5,522,000\",\"2016\",\"20160830\",\"competition-related offenses\",\"kickbacks and bribery\",\"\",\"\",\"federal\",\"agency action\",\"Securities and Exchange Commission\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"United Kingdom\",\"\",\"publicly traded\",\"LSE: AZN\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.sec.gov/litigation/admin/2016/34-78730.pdf\",\"\"\\n\"Aventis Pharmaceutical Inc.\",\"Sanofi\",\"$95,500,000\",\"$0\",\"$95,500,000\",\"2009\",\"20090528\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Aventis Pharmaceutical Inc. agreed to pay the United States $95.5 million to settle allegations that it violated the False Claims Act by misreporting drug prices in order to reduce its Medicaid Drug Rebate obligations.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"France\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/aventis-pharmaceutical-pay-us-955-million-settle-false-claims-act-allegations\",\"\"\\n\"Aventis Pharmaceuticals Inc.\",\"Sanofi\",\"$190,000,000\",\"$0\",\"$190,000,000\",\"2007\",\"20070910\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"fraud\",\"Aventis Pharmaceuticals Inc. paid the United States and a number of states, as well as the District of Columbia, over $190 million to resolve allegations that the company caused false claims to be filed with Medicare and other federal health programs as a result of the company\\'s alleged fraudulent pricing and marketing of drugs. Aventis, which changed its name to Sanofi-Aventis,  agreed to settle False Claims Act allegations concerning its pricing and marketing of Anzemet, an antiemetic drug used primarily in conjunction with oncology and radiation treatment to prevent nausea and vomiting. \",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"France\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/archive/opa/pr/2007/September/07_civ_694.html\",\"\"\\n\"AVEO Pharmaceuticals Inc.\",\"AVEO Pharmaceuticals\",\"$4,000,000\",\"$0\",\"$4,000,000\",\"2016\",\"20160329\",\"financial offenses\",\"investor protection violation\",\"\",\"The SEC announced fraud charges against a Massachusetts-based biotec\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n$1,200,000,000\",\"$0\",\"$1,200,000,000\",\"2015\",\"20150528\",\"consumer-protection-related offenses\",\"consumer protection violation\",\"price-fixing or anti-competitive practices\",\"The Federal Trade Commission reached a settlement resolving a suit accusing Cephalon, Inc. of illegally blocking generic competition to its blockbuster sleep-disorder drug Provigil. The settlement ensures that Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total of $1.2 billion available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon\\'s illegal conduct.\",\"federal\",\"agency action\",\"Federal Trade Commission\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Israel\",\"\",\"publicly traded\",\"TEVA\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.ftc.gov/news-events/press-releases/2015/05/ftc-settlement-cephalon-pay-delay-case-ensures-12-billion-ill\",\"\"\\n\"CHEROKEE PHARMACEUTICALS LLC\",\"Merck\",\"$10,001\",\"$0\",\"$10,001\",\"2011\",\"20110613\",\"employment-related offenses\",\"benefit plan administrator violation\",\"\",\"Deficient Filer\",\"federal\",\"agency action\",\"Employee Benefits Security Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"Pennsylvania\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"MRK\",\"pharmaceuticals\",\"pharmaceuticals\",\"Included in a dataset downloaded at https://enforcedata.dol.gov/views/data_summary.php\",\"Company is plan administrator. Penalty amount reported in range of $10,001 to $50,000. \"\\n\"Chiron Corporation Ltd\",\"Novartis\",\"$168,500\",\"$0\",\"$168,500\",\"2004\",\"20040604\",\"financial offenses\",\"economic sanction violation\",\"\",\"\",\"federal\",\"agency action\",\"Office of Foreign Assets Control\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Switzerland\",\"\",\"publicly traded\",\"NYSE: NVS\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/06042004.pdf\",\"\"\\n\"Cypress Pharmaceutical Inc.\",\"Currax Pharmaceuticals\",\"$2,800,000\",\"$0\",\"$2,800,000\",\"2012\",\"20120328\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Mississippi-based Cypress Pharmaceutical Inc., its subsidiary Hawthorn Pharmaceuticals Inc. and its CEO, Max Draughn, have agreed to pay $2.8 million to resolve civil allegations under the False Claims Act, the Justice Department announced. The government alleged that between 2003 and 2009, Cypress, Hawthorn and Draughn were responsible for marketing three pharmaceutical products that were not approved as safe and effective by the Food and Drug Administration (FDA). The products were Hylira, a gel used for the treatment of dry skin, Zaclir, an acne treatment and Zacare, another acne treatment.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"privately held\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/mississippi-pharmaceutical-firm-and-ceo-pay-28-million-resolve-allegations-illegal-marketing\",\"\"\\n\"Daiichi Sankyo Inc.\",\"Daiichi Sankyo\",\"$39,000,000\",\"$0\",\"$39,000,000\",\"2015\",\"20150109\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, agreed to pay the United States and state Medicaid programs $39 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce physicians to prescribe Daiichi drugs.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Japan\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/daiichi-sankyo-inc-agrees-pay-39-million-settle-kickback-allegations-under-false-claims-act\",\"\"\\n\"Dava Pharmaceuticals Inc.\",\"Endo International\",\"$11,000,000\",\"$0\",\"$11,000,000\",\"2012\",\"20120208\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Dava Pharmaceuticals Inc. agreed to pay the United States $11 million to settle allegations that it violated the False Claims Act by misreporting drug prices in order to reduce its Medicaid Drug Rebate obligations.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Ireland\",\"\",\"publicly traded\",\"ENDP\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/dava-pharmaceuticals-pay-us-11-million-settle-false-claims-act-allegations\",\"\"\\n\"Dey Inc.\",\"Viatris\",\"$280,000,000\",\"$0\",\"$280,000,000\",\"2010\",\"20101220\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Dey Inc., Dey Pharma L.P. and Dey L.P. Inc. agreed to pay $280 million to settle False Claims Act allegations that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products, knowing that federal health care programs relied on those reported prices to set payment rates.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Pennsylvania\",\"publicly traded\",\"VTRS\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturer-pay-280-million-settle-false-claims-act-case\",\"\"\\n\"Dey, Inc.\",\"Viatris\",\"$18,500,000\",\"$0\",\"$18,500,000\",\"2003\",\"20030611\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"fraud\",\"Dey, Inc., a manufacturer of prescription drugs for the treatment of allergies and respiratory diseases, agreed to pay the United States and the state of Texas $18.5 million to settle allegations of health care fraud.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Pennsylvania\",\"publicly traded\",\"VTRS\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/archive/opa/pr/2003/June/03_civ_350.htm\",\"\"\\n\"DuPont Pharmaceuticals Company\",\"Bristol-Myers Squibb\",\"$6,600\",\"$0\",\"$6,600\",\"2004\",\"20040806\",\"financial offenses\",\"economic sanction violation\",\"\",\"\",\"federal\",\"agency action\",\"Office of Foreign Assets Control\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New York\",\"publicly traded\",\"BMY\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/08062004.pdf\",\"\"\\n\"Eisai Inc.\",\"Eisai\",\"$11,000,000\",\"$0\",\"$11,000,000\",\"2010\",\"20101215\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Irish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary Elan Pharmaceuticals Inc. agreed to pay more than $203 million to resolve criminal and civil liability arising from the illegal promotion of the epilepsy drug Zonegran. In a separate civil settlement, Japanese drug marketer Eisai Inc., which purchased the drug from Elan, will pay $11 million to resolve civil liability for off-label marketing of Zonegran.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Japan\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/pharmaceutical-companies-pay-2145-million-resolve-allegations-label-promotion-zonegran\",\"\"\\n\"Elan Pharmaceuticals Inc.\",\"Perrigo\",\"$31,000\",\"$0\",\"$31,000\",\"2005\",\"20050620\",\"competition-related offenses\",\"export control violation\",\"\",\"\",\"federal\",\"agency action\",\"Bureau of Industry and Security\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Ireland\",\"\",\"publicly traded\",\"PRGO\",\"pharmaceuticals\",\"pharmaceuticals\",\"FOIA204\",\"Source document obtained through a Freedom of Information Act request to the agency.\"\\n\"Elan Corporation PLC\",\"Perrigo\",\"$203,000,000\",\"$0\",\"$203,000,000\",\"2010\",\"20101215\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Irish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary Elan Pharmaceuticals Inc. agreed to pay more than $203 million to resolve criminal and civil liability arising from the illegal promotion of the epilepsy drug Zonegran. In a separate civil settlement, Japanese drug marketer Eisai Inc., which purchased the drug from Elan, will pay $11 million to resolve civil liability for off-label marketing of Zonegran.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Ireland\",\"\",\"publicly traded\",\"PRGO\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/pharmaceutical-companies-pay-2145-million-resolve-allegations-label-promotion-zonegran\",\"\"\\n\"Elan Corporation, plc\",\"Perrigo\",\"$15,000,000\",\"$0\",\"$15,000,000\",\"2005\",\"20050208\",\"financial offenses\",\"accounting fraud or deficiencies\",\"\",\"\",\"federal\",\"agency action\",\"Securities and Exchange Commission\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Ireland\",\"\",\"publicly traded\",\"PRGO\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.sec.gov/litigation/litreleases/lr19066.htm\",\"\"\\n\"Eli Lilly and Company\",\"Eli Lilly\",\"$1,415,000,000\",\"$0\",\"$1,415,000,000\",\"2009\",\"20090115\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Eli Lilly and Company agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration. This resolution included a criminal fine of $515 million, the forfeiture of $100 million in assets, and up to $800 million in a civil settlement with the federal government and the states.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Indiana\",\"publicly traded\",\"LLY\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa\",\"\"\\n\"Eli Lilly and Company\",\"Eli Lilly\",\"$36,000,000\",\"$0\",\"$36,000,000\",\"2005\",\"20051221\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Eli Lilly and Company agreed to plead guilty and to pay $36 million in connection with its illegal promotion of its pharmaceutical drug Evista.\",\"federal\",\"agency action\",\"Justice Department Criminal Division\",\"criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Indiana\",\"publicly traded\",\"LLY\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/archive/opa/pr/2005/December/05_civ_685.html\",\"\"\\n\"Eli Lilly and Company\",\"Eli Lilly\",\"$29,398,734\",\"$0\",\"$29,398,734\",\"2012\",\"20121220\",\"competition-related offenses\",\"Foreign Corrupt Practices Act\",\"\",\"\",\"federal\",\"agency action\",\"Securities and Exchange Commission\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Indiana\",\"publicly traded\",\"LLY\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171487116\",\"\"\\n\"EMD CHEMICALS INCORPORATED\",\"Merck KGaA (EMD)\",\"$13,170\",\"$0\",\"$13,170\",\"2004\",\"20041229\",\"safety-related offenses\",\"motor vehicle safety violation\",\"\",\"OH-2004-0250-US0482\",\"federal\",\"agency action\",\"Federal Motor Carrier Safety Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"Ohio\",\"CINCINNATI\",\"\",\"\",\"\",\"\",\"Germany\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.fmcsa.dot.gov/regulations/enforcement/national-listing-enforcement-cases-subject-name-closed-fiscal-year-2005-pdf\",\"\"\\n\"EMD CHEMICALS INCORPORATED\",\"Merck KGaA (EMD)\",\"$7,614\",\"$0\",\"$7,614\",\"2006\",\"20060523\",\"safety-related offenses\",\"motor vehicle safety violation\",\"\",\"OH-2006-0107-US0482\",\"federal\",\"agency action\",\"Federal Motor Carrier Safety Administration\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"Ohio\",\"CINCINNATI\",\"\",\"\",\"\",\"\",\"Germany\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.fmcsa.dot.gov/regulations/enforcement/national-listing-enforcement-cases-subject-name-closed-fiscal-year-2006-pdf\",\"Year is fiscal year. Date is closing date.\"\\n\"EMD Chemicals, Inc.\",\"Merck KGaA (EMD)\",\"$8,250\",\"$0\",\"$8,250\",\"2007\",\"20070202\",\"financial offenses\",\"economic sanction violation\",\"\",\"\",\"federal\",\"agency action\",\"Office of Foreign Assets Control\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Germany\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/02022007.pdf\",\"\"\\n\"EMD Chemicals, Inc.\",\"Merck KGaA (EMD)\",\"$44,000\",\"$0\",\"$44,000\",\"2007\",\"20070309\",\"competition-related offenses\",\"export control violation\",\"\",\"\",\"federal\",\"agency action\",\"Bureau of Industry and Security\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Germany\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://efoia.bis.doc.gov/index.php/component/docman/?task=doc_download&gid=341&Itemid=\",\"\"\\n\"EMD Millipore Corp.\",\"Merck KGaA (EMD)\",\"$385,000\",\"$0\",\"$385,000\",\"2017\",\"20170206\",\"environment-related offenses\",\"environmental violation\",\"\",\"Under the terms of a Consent Decree lodged in federal court, EMD Millipore Corp. of Jaffrey, N.H., agreed to upgrade its on-site wastewater treatment system to comply with the terms of the company\\'s industrial wastewater discharge permit and prevent pretreatment violations of the federal Clean Water Act (CWA). The company also agreed to pay a civil penalty of $385,000 for alleged violations of the CWA.\",\"federal\",\"agency action\",\"Environmental Protection Agency referral to the Justice Department\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"New Hampshire\",\"Jaffrey\",\"\",\"\",\"\",\"\",\"Germany\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.epa.gov/enforcement/reference-news-release-jaffrey-nh-facility-upgrade-its-wastewater-treatment-systems\",\"\"\\n\"EMD Millipore Corporation\",\"Merck KGaA (EMD)\",\"$2,681,500\",\"$0\",\"$2,681,500\",\"2013\",\"20130731\",\"environment-related offenses\",\"environmental violation\",\"\",\"EMD Millipore Corporation, of Billerica, Mass., has agreed to pay $2,681,500 in civil penalties to settle EPA allegations that it violated the federal pesticide law and regulations on numerous instances over many years.\",\"federal\",\"agency action\",\"Environmental Protection Agency\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"Massachusetts\",\"Billerica\",\"\",\"\",\"\",\"\",\"Germany\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://archive.epa.gov/epapages/newsroom_archive/newsreleases/ce0d13ac337fe52685257bb900603f21.html\",\"\"\\n\"Endo Health Solutions Inc.\",\"Endo International\",\"$192,700,000\",\"$0\",\"$192,700,000\",\"2014\",\"20140221\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo\\'s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration. The resolution included a deferred prosecution agreement and forfeiture totaling $20.8 million and civil false claims settlements with the federal government and the states and the District of Columbia totaling $171.9 million. \",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"deferred prosecution agreement\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Ireland\",\"\",\"publicly traded\",\"ENDP\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/endo-pharmaceuticals-and-endo-health-solutions-pay-1927-million-resolve-criminal-and-civil\",\"\"\\n\"Endo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals\",\"Endo International\",\"$39,000,000\",\"$0\",\"$39,000,000\",\"2015\",\"20151216\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"fraud\",\"The United States Attorney for the Southern District of New York and the Office of Inspector General for the Department of Health and Human Services announced a $39 million settlement against Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals and  Vintage\\'s corporate parent Endo Pharmaceuticals, Inc. in a civil fraud lawsuit.\",\"federal\",\"agency action\",\"U.S. Attorney-Southern District of New York\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Ireland\",\"\",\"publicly traded\",\"ENDP\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/usao-sdny/pr/manhattan-us-attorney-announces-39-million-civil-fraud-settlement-against-qualitest\",\"\"\\n\"Eon Labs Inc.\",\"Novartis\",\"$3,500,000\",\"$0\",\"$3,500,000\",\"2010\",\"20100222\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Eon Labs Inc. agreed to pay the United States $3.5 million to resolve False Claims Act allegations relating to the company\\'s drug Nitroglycerin Sustained Release (SR) capsules.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Switzerland\",\"\",\"publicly traded\",\"NYSE: NVS\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/eon-labs-pays-us-35-million-settle-allegations-submitting-false-claims-medicaid\",\"\"\\n\"Ethex Corporation\",\"KV Pharmaceutical\",\"$27,600,000\",\"$0\",\"$27,600,000\",\"2010\",\"20100302\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"\",\"Ethex Corporation, a wholly owned subsidiary of St. Louis-based drug manufacturer, KV Pharmaceutical Company, pleaded guilty to two felonies and was sentenced in connection with the manufacturing of oversized prescription drug tablets. The government had charged that, despite having knowledge that the two drugs did not meet required specifications, Ethex violated the law by intentionally withholding this information from the Food and Drug Administration (FDA). Given the seriousness of Ethex\\'s conduct and the risk it posed to consumers of its drugs, the Justice Department pursued felony charges. According to charges presented in U.S. District Court in St. Louis, Ethex failed to submit required \"\"field alert reports\"\" to the FDA in 2008 concerning two drugs, propafenone and dextroamphetamine sulfate.  Following the recommendations of a plea agreement, Judge E. Richard Webber sentenced Ethex to pay a fine of more than $23.4 million, pay approximately $2.3 million in restitution to Medicare and Medicaid for their approximate losses, and forfeit nearly $1.8 million to the United States.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Missouri\",\"out of business\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/kv-pharmaceutical-subsidiary-pleads-guilty-two-felonies-regarding-oversized-drugs\",\"\"\\n\"ExecuPharm, Inc.\",\"Parexel International\",\"$5,900\",\"$0\",\"$5,900\",\"2017\",\"20170401\",\"employment-related offenses\",\"Family and Medical Leave Act\",\"\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1808162\",\"\",\"\",\"Pennsylvania\",\"King of Prussia\",\"610 Freedom Business Center Suite 200\",\"19406\",\"\",\"\",\"USA\",\"Massachusetts\",\"privately held\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"July 23, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"\\n\"Forest Laboratories and Forest Pharmaceuticals\",\"AbbVie\",\"$38,000,000\",\"$0\",\"$38,000,000\",\"2016\",\"20161215\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Forest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed to pay $38 million to resolve allegations that they violated the False Claims Act by paying kickbacks to induce physicians to prescribe the drugs Bystolic, Savella, and Namenda.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/forest-laboratories-and-forest-pharmaceuticals-pay-38-million-resolve-kickback-allegations\",\"\"\\n\"Forest Pharmaceuticals Inc.\",\"AbbVie\",\"$164,000,000\",\"$0\",\"$164,000,000\",\"2011\",\"20110302\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Drug manufacturer Forest Pharmaceuticals Inc. was sentenced by U.S. District Judge Nancy Gertner to pay a criminal fine of $150 million and forfeit assets of $14 million following the company\\'s guilty plea in November 2010 to one felony count of obstructing justice, one misdemeanor count of distributing an unapproved new drug in interstate commerce and one misdemeanor count of distributing a misbranded drug in interstate commerce, the Justice Department announced. The company, a subsidiary of New York City-based Forest Laboratories Inc., pleaded guilty to charges related to obstruction of an FDA regulatory inspection, to the distribution of Levothroid, which at the time was an unapproved new drug, and to the illegal promotion of the anti-depressant drug Celexa for use in treating children and adolescents.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/forest-pharmaceuticals-sentenced-pay-164-million-criminal-violations\",\"\"\\n\"Fort Dodge Animal Health\",\"Zoetis\",\"$26,956\",\"$0\",\"$26,956\",\"2004\",\"20041105\",\"financial offenses\",\"economic sanction violation\",\"\",\"\",\"federal\",\"agency action\",\"Office of Foreign Assets Control\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New Jersey\",\"publicly traded\",\"ZTS\",\"pharmaceuticals\",\"animal health products\",\"https://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/11052004.pdf\",\"\"\\n\"Galena Biopharma, Inc.\",\"SELLAS Life Sciences Group\",\"$200,000\",\"$0\",\"$200,000\",\"2017\",\"20170410\",\"financial offenses\",\"accounting fraud or deficiencies\",\"\",\"\",\"federal\",\"agency action\",\"Securities and Exchange Commission\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"New York\",\"publicly traded\",\"SLS\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.sec.gov/litigation/admin/2017/33-10337.pdf\",\"\"\\n\"Genentech Inc.\",\"Roche\",\"$33,500,000\",\"$0\",\"$33,500,000\",\"2016\",\"20160606\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Pharmaceutical companies Genentech Inc. and OSI Pharmaceuticals LLC agreed to pay $67 million to resolve False Claims Act allegations that they made misleading statements about the effectiveness of the drug Tarceva to treat non-small cell lung cancer. The announcement did not indicate how much each company would pay. Here we assume the total was split evenly between them.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"Switzerland\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-companies-pay-67-million-resolve-false-claims-act-allegations-relating-tarceva\",\"\"\\n\"Genzyme Corp.\",\"Sanofi\",\"$22,280,000\",\"$0\",\"$22,280,000\",\"2013\",\"20131220\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Genzyme Corp. agreed to pay $22.28 million to resolve allegations that it marketed, and caused false claims to be submitted to federal and state health care programs for use of, a \"\"slurry\"\" version of its Seprafilm adhesion barrier.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"France\",\"\",\"publicly traded\",\"\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/genzyme-corp-pay-2228-million-resolve-false-claims-allegations-related-slurry-used-patients\",\"\"\\n\"Genzyme Corporation\",\"Sanofi\",\"$32,587,439\",\"$0\",\"$32,587,439\",\"2015\",\"20150903\",\"safety-related offenses\",\"drug or medical equipment safety violation\",\"\",\"Genzyme Corporation, a wholly-owned biotechnology subsidiary of French pharmaceutical company Sanofi, agreed to resolve criminal charges that it violated the federal Food, Drug and Cosmetic Act with regard to the unlawful distribution of Seprafilm, a surgical device it marketed and promoted. As part of the agreed resolution, the department filed a two-count criminal information in the U.S. District Court for the Middle District of Florida charging that between 2005 and 2010, Genzyme caused a medical device to become adulterated and misbranded while being held for sale.  The conduct occurred prior to Sanofi\\'s acquisition of Genzyme, based in Cambridge, Massachusetts, in 2011.  To resolve these charges, Genzyme agreed to'"
     ]
    }
   ],
   "source": [
    "#Pharma unzipped, Let's view the file\n",
    "\n",
    "pharma_file = \"/FileStore/tables/pharma/pharma.csv\"\n",
    "\n",
    "dbutils.fs.head(pharma_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a5d5a6fb-cf2a-4bf9-b491-4d312ae16f4f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[158]: ['\"Company\",\"Parent_Company\",\"Penalty_Amount\",\"Subtraction_From_Penalty\",\"Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting\",\"Penalty_Year\",\"Penalty_Date\",\"Offense_Group\",\"Primary_Offense\",\"Secondary_Offense\",\"Description\",\"Level_of_Government\",\"Action_Type\",\"Agency\",\"Civil/Criminal\",\"Prosecution_Agreement\",\"Court\",\"Case_ID\",\"Private_Litigation_Case_Title\",\"Lawsuit_Resolution\",\"Facility_State\",\"City\",\"Address\",\"Zip\",\"NAICS_Code\",\"NAICS_Translation\",\"HQ_Country_of_Parent\",\"HQ_State_of_Parent\",\"Ownership_Structure\",\"Parent_Company_Stock_Ticker\",\"Major_Industry_of_Parent\",\"Specific_Industry_of_Parent\",\"Info_Source\",\"Notes\"',\n '\"Abbott Laboratories\",\"Abbott Laboratories\",\"$5,475,000\",\"$0\",\"$5,475,000\",\"2013\",\"20131227\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid, biliary and peripheral vascular products.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$1,500,000,000\",\"$0\",\"$1,500,000,000\",\"2012\",\"20120507\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\",\"\"']"
     ]
    }
   ],
   "source": [
    "#Create rdd\n",
    "\n",
    "pharma_rdd = sc.textFile(pharma_file)\n",
    "\n",
    "pharma_rdd.take(3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "46046cd1-5d7b-4fe3-8b0a-a5e7d55d958b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[160]: [['\"Company\"',\n  '\"Parent_Company\"',\n  '\"Penalty_Amount\"',\n  '\"Subtraction_From_Penalty\"',\n  '\"Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting\"',\n  '\"Penalty_Year\"',\n  '\"Penalty_Date\"',\n  '\"Offense_Group\"',\n  '\"Primary_Offense\"',\n  '\"Secondary_Offense\"',\n  '\"Description\"',\n  '\"Level_of_Government\"',\n  '\"Action_Type\"',\n  '\"Agency\"',\n  '\"Civil/Criminal\"',\n  '\"Prosecution_Agreement\"',\n  '\"Court\"',\n  '\"Case_ID\"',\n  '\"Private_Litigation_Case_Title\"',\n  '\"Lawsuit_Resolution\"',\n  '\"Facility_State\"',\n  '\"City\"',\n  '\"Address\"',\n  '\"Zip\"',\n  '\"NAICS_Code\"',\n  '\"NAICS_Translation\"',\n  '\"HQ_Country_of_Parent\"',\n  '\"HQ_State_of_Parent\"',\n  '\"Ownership_Structure\"',\n  '\"Parent_Company_Stock_Ticker\"',\n  '\"Major_Industry_of_Parent\"',\n  '\"Specific_Industry_of_Parent\"',\n  '\"Info_Source\"',\n  '\"Notes\"'],\n ['\"Abbott Laboratories\"',\n  '\"Abbott Laboratories\"',\n  '\"$5',\n  '475',\n  '000\"',\n  '\"$0\"',\n  '\"$5',\n  '475',\n  '000\"',\n  '\"2013\"',\n  '\"20131227\"',\n  '\"government-contracting-related offenses\"',\n  '\"False Claims Act and related\"',\n  '\"kickbacks and bribery\"',\n  '\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid',\n  ' biliary and peripheral vascular products.\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Justice Department Civil Division\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"USA\"',\n  '\"Illinois\"',\n  '\"publicly traded\"',\n  '\"ABT\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\"',\n  '\"\"'],\n ['\"Abbott Laboratories Inc.\"',\n  '\"AbbVie\"',\n  '\"$1',\n  '500',\n  '000',\n  '000\"',\n  '\"$0\"',\n  '\"$1',\n  '500',\n  '000',\n  '000\"',\n  '\"2012\"',\n  '\"20120507\"',\n  '\"healthcare-related offenses\"',\n  '\"off-label or unapproved promotion of medical products\"',\n  '\"\"',\n  '\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Food and Drug Administration referral to the Justice Department\"',\n  '\"civil and criminal\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"USA\"',\n  '\"Illinois\"',\n  '\"publicly traded\"',\n  '\"ABBV\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\"',\n  '\"\"'],\n ['\"Abbott Laboratories Inc.\"',\n  '\"AbbVie\"',\n  '\"$126',\n  '500',\n  '000\"',\n  '\"$0\"',\n  '\"$126',\n  '500',\n  '000\"',\n  '\"2010\"',\n  '\"20101207\"',\n  '\"government-contracting-related offenses\"',\n  '\"False Claims Act and related\"',\n  '\"\"',\n  '\"Abbott Laboratories Inc.',\n  ' B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations',\n  ' that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Justice Department Civil Division\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"USA\"',\n  '\"Illinois\"',\n  '\"publicly traded\"',\n  '\"ABBV\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\"',\n  '\"\"'],\n ['\"Abbott Laboratories Puerto Rico',\n  ' Inc.\"',\n  '\"Abbott Laboratories\"',\n  '\"$49',\n  '045\"',\n  '\"$0\"',\n  '\"$49',\n  '045\"',\n  '\"2009\"',\n  '\"20090305\"',\n  '\"employment-related offenses\"',\n  '\"wage and hour violation\"',\n  '\"Fair Labor Standards Act\"',\n  '\"\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Labor Department Wage and Hour Division\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"1527129\"',\n  '\"\"',\n  '\"\"',\n  '\"Puerto Rico\"',\n  '\"San Juan\"',\n  '\"\"',\n  '\"\"',\n  '\"423450\"',\n  '\"423450: Medical',\n  ' Dental',\n  ' and Hospital Equipment and Supplies Merchant Wholesalers\"',\n  '\"USA\"',\n  '\"Illinois\"',\n  '\"publicly traded\"',\n  '\"ABT\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"March 7',\n  ' 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\"',\n  '\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division',\n  ' which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank',\n  ' in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"'],\n ['\"Acclarent Inc.\"',\n  '\"Johnson & Johnson\"',\n  '\"$18',\n  '000',\n  '000\"',\n  '\"$0\"',\n  '\"$18',\n  '000',\n  '000\"',\n  '\"2016\"',\n  '\"20160722\"',\n  '\"government-contracting-related offenses\"',\n  '\"False Claims Act and related\"',\n  '\"\"',\n  '\"California-based medical device manufacturer Acclarent Inc.',\n  ' a subsidiary of Johnson & Johnson',\n  ' agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Justice Department Civil Division\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"USA\"',\n  '\"New Jersey\"',\n  '\"publicly traded\"',\n  '\"JNJ\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"https://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act\"',\n  '\"\"'],\n ['\"Advanced Medical Optics\"',\n  '\"Abbott Laboratories\"',\n  '\"$16',\n  '800\"',\n  '\"$0\"',\n  '\"$16',\n  '800\"',\n  '\"2004\"',\n  '\"20040412\"',\n  '\"employment-related offenses\"',\n  '\"labor relations violation\"',\n  '\"\"',\n  '\"back pay award in unfair labor practices case\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"National Labor Relations Board\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"21-CA-36104-001\"',\n  '\"\"',\n  '\"\"',\n  '\"California\"',\n  '\"Irvine\"',\n  '\"\"',\n  '\"92606\"',\n  '\"333314\"',\n  '\"333314: Optical Instrument and Lens Manufacturing\"',\n  '\"USA\"',\n  '\"Illinois\"',\n  '\"publicly traded\"',\n  '\"ABT\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"Extracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\"',\n  '\"\"'],\n ['\"Advanced Neuromodulation Systems',\n  ' Inc.\"',\n  '\"Abbott Laboratories\"',\n  '\"$2',\n  '950',\n  '000\"',\n  '\"$0\"',\n  '\"$2',\n  '950',\n  '000\"',\n  '\"2007\"',\n  '\"20070702\"',\n  '\"healthcare-related offenses\"',\n  '\"HHS civil monetary penalties\"',\n  '\"kickbacks and bribery\"',\n  '\"The HHS Inspector General announced that Advanced Neuromodulation Systems',\n  ' Inc.',\n  '  a medical device manufacturer specializing in spinal cord stimulation used for pain management',\n  ' agreed to pay $2.95 million to settle allegations that it paid kickbacks to physicians in violation of the Civil Monetary Penalties Law (CMPL). The company also entered into a 3-year Corporate Integrity Agreement.\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Health & Human Services Department Office of Inspector General\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"USA\"',\n  '\"Illinois\"',\n  '\"publicly traded\"',\n  '\"ABT\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"https://oig.hhs.gov/publications/docs/press/2007/ANS%20Press%20Release.pdf\"',\n  '\"\"'],\n ['\"Advanced Sterilization Products\"',\n  '\"Johnson & Johnson\"',\n  '\"$136',\n  '800\"',\n  '\"$0\"',\n  '\"$136',\n  '800\"',\n  '\"2014\"',\n  '\"20140520\"',\n  '\"environment-related offenses\"',\n  '\"environmental violation\"',\n  '\"\"',\n  '\"The U.S. Environmental Protection Agency announced that an Irvine',\n  ' Calif. company',\n  ' Advanced Sterilization Products',\n  ' has agreed to pay a $136',\n  '800 penalty for the sale and distribution of unregistered and misbranded pesticides to veterinary clinics and laboratories nationwide.\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Environmental Protection Agency\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"California\"',\n  '\"Irvine\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"USA\"',\n  '\"New Jersey\"',\n  '\"publicly traded\"',\n  '\"JNJ\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"https://archive.epa.gov/epapages/newsroom_archive/newsreleases/8e820317c86e4c5685257cde00717855.html\"',\n  '\"\"'],\n ['\"Advanced Sterilization Products',\n  ' a division of Ethicon Inc.\"',\n  '\"Johnson & Johnson\"',\n  '\"$1',\n  '200',\n  '000\"',\n  '\"$0\"',\n  '\"$1',\n  '200',\n  '000\"',\n  '\"2013\"',\n  '\"20131204\"',\n  '\"safety-related offenses\"',\n  '\"drug or medical equipment safety violation\"',\n  '\"\"',\n  '\"Settlement of a civil money penalty action against Advanced Sterilization Products',\n  ' a division of Ethicon Inc.',\n  ' a Johnson & Johnson company',\n  ' and two of ASP\\'s executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.\"',\n  '\"federal\"',\n  '\"agency action\"',\n  '\"Food and Drug Administration\"',\n  '\"civil\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"California\"',\n  '\"Irvine\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"\"',\n  '\"USA\"',\n  '\"New Jersey\"',\n  '\"publicly traded\"',\n  '\"JNJ\"',\n  '\"pharmaceuticals\"',\n  '\"pharmaceuticals\"',\n  '\"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377588.htm\"',\n  '\"\"']]"
     ]
    }
   ],
   "source": [
    "#Split by line and delimiter\n",
    "\n",
    "pharma_rdd1 = pharma_rdd \\\n",
    "    .flatMap(lambda x: x.split('\\n')) \\\n",
    "    .map(lambda line: line.split(\",\"))\n",
    "\n",
    "pharma_rdd1.take(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "438db353-af1e-416d-8ad5-586e287db6d7",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[172]: ['Parent_Company', 'Abbott Laboratories', 'AbbVie', 'AbbVie', 'Inc.']"
     ]
    }
   ],
   "source": [
    "#Extract Parent Company\n",
    "pharma_rdd2 = pharma_rdd1 \\\n",
    "    .map(lambda x: x[1][1:-1]) \\\n",
    "    .filter(lambda x: x.strip() != \"\")\n",
    "\n",
    "pharma_rdd2.take(5)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f30747ea-40d6-4c5a-ad4e-41ca051a90ce",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[170]: [(' Sponsor ', 'NCT Number '),\n (' Sangath ', '\"NCT03630471 '),\n (\" Alzheimer's Society of Brant, Haldimand Norfolk, Hamilton Halton \",\n  '\"NCT05992571 '),\n (' Society for Family Planning Research Fund ', 'NCT01854671 '),\n (' Assistance Publique - Hôpitaux de Paris ', 'NCT03820271 ')]"
     ]
    }
   ],
   "source": [
    "#From rdd1 extract NCT Number and sponsor\n",
    "\n",
    "rdd_sponsor = rdd1 \\\n",
    "    .flatMap(lambda x: x.split('\\n')) \\\n",
    "    .map(lambda line: line.split(\"\\\\t\")) \\\n",
    "    .map(lambda x: (x[6], x[0]))\n",
    "\n",
    "# Print the first few elements to verify the extraction\n",
    "rdd_sponsor.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {},
     "inputWidgets": {},
     "nuid": "0a5ab37c-8280-4054-820c-16609da559f6",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "application/vnd.databricks.v1+notebook": {
   "dashboards": [],
   "language": "python",
   "notebookMetadata": {
    "mostRecentlyExecutedCommandWithImplicitDF": {
     "commandId": 1401034296588560,
     "dataframes": [
      "_sqldf"
     ]
    },
    "pythonIndentUnit": 4
   },
   "notebookName": "Soliu_Fatai_rdd",
   "widgets": {}
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
